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Abstract 
The extent of effective regeneration in the adult mammalian brain following 
structural injury has been an issue of contention for the last several decades. 
Historical views proposed that the adult brain was set in a state of stasis, preventing 
effective regenerative alterations and functional recovery following brain trauma. 
The irreversible loss of function following injury to the adult mammalian brain has 
been attributed to an intrinsic inability of damaged neurons to re-initiate growth 
following injury, which is further compounded by a non-facilitative environment. 
However, accumulating evidence, based on diverse models of experimental neuronal 
and brain lesion, have challenged two major dogmas in neuro-repair research, 
namely, that neurons from the adult mammalian brain are incapable of intrinsically 
driven regeneration, and that neurogenesis is strictly restricted to developmental 
periods. Collectively, these studies have provided compelling evidence indicating 
that the adult brain may possess a vast intrinsic capacity for repair following injury. 
Furthermore, strategies aimed at facilitating neuronal replacement or re-establishing 
lost neuronal connections have made remarkable inroads into understanding the 
potential for injury-induced plasticity in the adult brain. 
Despite these advances, however, no effective treatment currently exists to target the 
full repertoire of pathological alterations that contribute to permanent loss of 
function following acquired brain injury. A broader understanding of the specific 
molecular and cellular events responsible for the limit in brain repair is still required, 
particularly for therapeutic interventions to effectively complement and enhance 
endogenous brain repair mechanisms. This thesis, therefore, sought to address three 
specific aspects associated with the intrinsic capacity for brain and neuronal repair 
following structural injury. Initially, the neurogenic potential of the injured adult 
brain was evaluated in an experimental model of structural brain injury by examining 
populations of proliferating and progenitor cells, to determine whether these cell 
populations have the capacity to undergo neuronal differentiation and contribute to 
neuronal replacement in injured brain tissue. Secondly, the reactive and regenerative 
alterations associated with the neural response to structural brain injury vol 
investigated in a range of neuronal and glial cell populations to determine particular 
alterations that may be indicative of neuronal regeneration and brain healing. 
Finally, utilising an in vitro model of axonal injury in which neurons can be studied 
in relative isolation, free of compounding glial responses, the intrinsic regenerative 
potential of individual mature brain neurons was determined and the mechanisms 
underlying this response were characterised through comparison with developing 
neurons and application of agents that specifically disrupt the cytoskeleton. 
Results from this study highlighted several important aspects of the neural response 
to injury indicating that, rather than responding passively, the adult brain mounts an 
adaptive repair process. These alterations involved the coordinated activation of 
both neuronal and glial cell populations, which ultimately resulted in the restoration 
of relatively normal cytoarchitecture. Specifically, adaptive injury-induced 
alterations included the activation of various cell populations, particularly neural 
progenitor cells, astrocytes and microglia, which may contribute to brain healing; 
evidence of re-vascularisation surrounding the lesion site; and regenerative neuronal 
changes, such as a profuse axonal sprouting response and an up-regulation of 
regeneration-associated genes. In summary these findings indicate that the adult 
vi 
mammalian brain possesses a remarkable intrinsic capacity for repair following 
injury and highlight several aspects of this response that may be therapeutically 
targeted to enhance brain repair following injury. 
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Chapter 1 
General background and introduction 
1.1 Overview 
Traumatic brain injury (TBI) is the most common cause of death and disability in 
individuals under the age of 45 years in developed nations, and places an enormous 
socio-economic and medical burden upon society. A common consequence of 
trauma to the head is widespread axonal disruption, or diffuse axonal injury (DAI), 
in which neural circuitry is disrupted or lost throughout the brain. Importantly, the 
majority of neurons within the mature mammalian brain are present at birth and do 
not divide. Thus, the loss or disruption of even a small number of neurons may 
result in the interruption of thousands of neural connections and widespread 
dysfunction of the circuits into which they integrate. 
Head trauma frequently results in both primary and secondary brain damage. 
Primary damage results from mechanical forces that create deformation of blood 
vessels, neurons and glia at the time of the injury. Primary damage may 
subsequently evoke secondary alterations, such as ischemia, hypoxemia, swelling, 
raised intracranial pressure and infection. These changes generate an evolving 
pathology. The ultimate outcome of this process is relative the severity of the initial 
injury. Severe injuries generally result in axonal tearing at the time of trauma, 
however, more commonly axons are deformed by the initial insult and undergo 
reactive changes that result in axonal disconnection by a delayed process. Numerous 
cell populations are activated in response to brain injury. However, whether these 
cells play a largely inhibitory or facilitative role in the post-injury sequela remains to 
be fully elucidated. 
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Historically, regeneration in the mature mammalian brain was believed to be 
impossible. However, an accumulating body of literature from the last several 
decades indicates that the damaged brain may instigate active repair processes. 
Indeed, several recent studies have indicated that the mammalian brain retains 
remarkable plasticity into adulthood. From a neuronal perspective, regenerative 
attempts may manifest as the elaboration of new axons or axonal sprouts from pre-
existing neurons and/or the generation and integration of new neurons from resident 
populations of neural progenitor or precursor cells. Whether injury-induced axonal 
sprouting and neurogenesis result in the restoration of neural connectivity and 
functionality remains contentious and it is generally agreed that if the repair process 
is purely reliant on endogenous capacity, regeneration is limited. 
Endogenous adaptive and compensatory mechanisms may allow partial restoration of 
neural tissue. Additionally, various strategies are utilised to slow the progression of 
detrimental brain alterations following trauma. However, no treatment currently 
exists that effectively replaces or regenerates damaged neurons, re-establishes 
neuronal connectivity and restores function. It is likely that such a therapy would be 
multi-target based, to include appropriate inhibition or enhancement of the various 
factors that are required for successful regeneration. In this regard, research efforts 
are now being aimed at unravelling the reasons why endogenous brain repair is 
limited and ways in which this can be extrinsically manipulated through, for 
example, manipulation of homeostatic mechanisms, application of growth factors or 
other therapeutic agents, inhibition of known regeneration inhibitors and 
transplantation of peripheral nerve grafts or neural progenitor cells. 
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Whether these experimental approaches will translate into clinical treatments for 
head trauma remains to be elucidated. However, in the advancement of successful 
treatments for brain injury it is imperative to consider the possibility of maladaptive 
responses, which have already been demonstrated following various forms of brain 
lesion. To this end, this thesis will seek to investigate how the mature mammalian 
brain responds to focal cortical injury and how individual neocortical neurons 
undergo potential regenerative adaptation. The findings from this thesis will be 
discussed in regard to an accumulating literature supporting both adaptive and 
maladaptive neural responses following neuronal injury. 
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1.2 The mammalian brain 
Comprised of literally hundreds of billions of highly specialised neuronal and glial 
cells, the brain is the most complex, intricate, and highly organised organ in the 
human body. Thus, it is intriguing to imagine that the mammalian brain begins as a 
layer of neuroepithelial cells surrounding a fluid-filled ventricular compartment 
(Conover and Allen, 2002). The relatively large size and high complexity of the 
adult human brain, and particularly the cerebral cortex, is responsible for providing 
distinctively human mental capabilities. In this regard, one of the most remarkable 
features of the human brain is the convoluted surface of the cerebral hemispheres, 
which provide the structural basis for higher brain functions that set humans ahead of 
any other animals in terms of mental capacity (Nolte, 2002). The brain can be 
broadly divided into grey and white matter. Grey matter consists predominantly of 
neuronal cell bodies and dendrites and is highly vascularized, whereas white matter 
is composed primarily of axons, the majority of which are ensheathed by specialised 
central nervous system (CNS) myelinating glial cells. 
1.2.1 Organisation of the adult mammalian neocortex 
Although the cerebral cortex is just a few millimetres thick, it is comprised of a 
phenomenal number of neurons, estimated to be around 25 billion, and comprises up 
to 80% of the human brain (Nolte, 2002; Markram et al., 2004). As illustrated in 
Figure 1.1, the neocortex is a six-layered structure, denoted layer I through VI, from 
the most superficial to deep layer (Nolte 2002; Silberberg et al., 2005). The cortical 
laminae are generated by variations in cell body size and density throughout the 
cortical depth (Parnavelas, 2000). Each layer contains a different complement of 
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Figure 1.1 The six layers of the mammalian neocortex 
The diagram above depicts the six layers of the neocortex, demonstrating 
neuronal arborisation, packing density of neuronal cell bodies and the 
distribution of myelin within each of the layers. As illustrated the cortical 
laminae can be defined based on the predominant cell type within each layer. 
Adapted from Nolte J: The Human Brain, New York, 2002, McGraw-Hill 
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neurons, which can be loosely divided into two groups based primarily on their 
morphological properties: pyramidal cells and cortical interneurons, or non-
pyramidal cells (Peters and Jones, 1984). Pyramidal neurons possess a pyramidal-
shaped soma, from which a prominent apical dendrite is elaborated and extends up 
towards the pial surface. Basal dendrites extend laterally from the base of the soma. 
The axon of pyramidal cells, which is usually myelinated, generally extends from the 
base of the soma, opposite to the apical dendrite, but may arise from a basal dendrite 
(Feldman, 1984). Thus, pyramidal cells have extensive dendritic arborisations that 
elaborate specialised protrusions (dendritic spines), large cell bodies and a long 
projecting axon. Interneurons incorporate a sub-population of cortical neurons with 
a vast array of morphological features and molecular identities (Parnavelas, 2000). 
Interneurons are generally identified by the absence of a prominent apical dendrite 
and the presence of few, if any, dendritic spines - although specific sub-types of 
interneurons may have dendritic spines equivalent to pyramidal neurons (Fairen et 
al., 1984; Marlcram et al., 2004). Thus, interneurons have less extensive dendritic 
arborisations, a short, locally projecting axon and a small cell body (Hof et al., 1999; 
Nolte, 2002; Markram et al., 2004). Pyramidal neurons are the primary 
glutamatergic excitatory cells of the neocortex, whereas interneurons predominantly 
provide inhibitory input (Fairen et al., 1984; Peters and Jones, 1984; Markram et al., 
2004). 
The layers of the neocortex can be distinguished based on the predominant cell 
population (Figure 1.1). Interneurons exist in all layers of the neocortex, although 
the distribution of a specific interneuron sub-type may vary between cortical laminae 
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(Hof et al, 1999; Markram et al., 2004). Conversely, pyramidal neurons are 
primarily contained within layers II to VI and comprise approximately 70-80% of all 
neocortical neurons (Peters and Jones, 1984; Markram et al., 2004; Voelker et al., 
2004; Silberberg et al., 2005). Layer I, the molecular layer, is relatively cell free. 
Layers II and IV, the external and internal granular layers are comprised of relatively 
small locally projecting granular or stellate cells, whereas layers III and V contain 
characteristic large cortical pyramidal cells and are thus designated the external and 
internal pyramidal layers, respectively. The pyramidal cell layers contain 
predominantly neurons that project long axons to other regions of the CNS. The 
axons of pyramidal neurons in layer III terminate on neurons in other regions of the 
ipsilateral and contralateral hemisphere, termed intra- and inter-hemispheric 
connections respectively, whereas axons of pyramidal neurons in layer V project to 
more distant targets, terminating on neurons outside the cerebral cortex or in 
subcortical areas (Silberberg et al., 2005). The innermost layer, layer VI, is 
comprised of modified fusiform-shaped pyramidal cells. In addition to the laminar 
the organisation of the neocortex, the neocortex also has a distinct columnar 
organisation with several structures, including the apical dendrites of pyramidal cells, 
cortical afferents, axons of some intra-cortical cells and the cell bodies of cortical 
neurons, arranged perpendicular to the cortical surface. 
Synaptic transmission within the neocortex follows a distinct and highly complex 
pattern, with integration both within and between the cortical laminae (reviewed by 
Silberberg et al., 2005). Briefly, thalamic input primarily enters layer IV and is 
passed onto layer III pyramidal cells that, in turn, project to layer II. Layers II and 
6 
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III also receive input from association brain regions and provide descending input to 
layer V pyramidal cells. Depending on their type, layer V pyramidal neurons either 
project to subcortical regions, comprising the major source of neocortical output, or 
to the contralateral hemisphere. Layer V pyramidal cells also project to layer VI, 
forming both cortico-cortical interconnections and corticothalamic feedback circuits. 
A majority of neocortical pyramidal cells also project their dendrites into layer I of 
the neocortex, forming an additional level of cortical processing and integration. 
Interactions between cortical pyramidal cells and interneurons facilitate highly 
integrated cortical processing. 
1.2.2 Development of the mammalian neocortex 
Extensive and tightly regulated patterns of neuronal proliferation and migration are 
responsible for transforming the dorsal embryonic forebrain into the adult cerebral 
cortex (Noctor et al., 2004). Corticogenesis, the process of development of the 
cortex, has been widely described (for example see reviews by Frisen et al., 1998; 
Parnavelas, 2000; Nadarajah and Parnavelas, 2002; Honda et al., 2003; Kubo and 
Nakajima, 2003; Marshall et al., 2003). 
1.2.2.1 Origin, source and division of neocortical destined neurons 
The cortex develops from a highly proliferative neuroepithelium during embryonic 
development. Depending on their type, cortical neurons are generated in two 
proliferative regions of the embryonic cortical telencephalon. As embryonic 
development proceeds, a pseudo-stratified region in the neuroepithelium lining the 
lateral ventricles, known as the ventricular zone (VZ), primarily gives rise to 
7 
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excitatory cortical projection neurons (Noctor et al., 2002). Additional neurons, as 
well as postnatally derived glial cells, are generated in the subventricular zone 
(SVZ), located adjacent to the VZ (Noctor et al., 2002). Conversely, cortical 
interneurons are predominantly generated in a specialised region in the ventral 
telencephalon of the developing brain, the ganglionic eminence, which forms the 
basal ganglia of the adult brain (Parnavelas, 2000). 
All cortical neurons differentiate from precursor cells within specific regions of the 
embryonic brain, which are capahle of generating astrocytes, oligodendrocytes and 
neurons (Figure 1.2). Importantly, neural precursor cells may undergo different 
forms of division depending on developmental stage and the daughter cells to be 
generated (reviewed by Frisen et al., 1998) (Figure 1.3). In this regard, symmetrical 
progenitor cell divisions generate new progenitor cells and expand the progenitor 
population, asymmetrical progenitor cell divisions generate single neurons and 
symmetrical terminal divisions generate two neurons, but deplete the progenitor 
population (Noctor et al., 2004). 
1.2.2.2 Development of the neocortex proceeds through distinct stages 
The ventricular neuroepithelium initially spans the entire cortex and undergoes rapid 
thickening and differentiation into distinct zones during corticogenesis. As displayed 
in Figure 1.3, development of the mammalian cerebral cortex occurs in two distinct 
stages (reviewed by Frisen et al., 1998; Parnavelas, 2000; Nadarajah and Parnavelas, 
2002; Honda et al., 2003; Kubo and Nakajima, 2003; Marshall et al., 2003). 
Initially, the first generation of post-mitotic neurons moves out of the VZ to margin 
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Figure 1.2 Diagrammatic representation of stem cell differentiation in 
the CNS 
Stem cells are multi-potent cells, capable of self-renewal. In defined regions of 
the embryonic and adult CNS, these cells continually produce neural progenitor 
cells capable of differentiating into the three primary neural cell types, namely 
neurons, astrocytes and oligodendrocytes. Stem and progenitor cells contribute 
to cell turnover throughout life. However, the generation and integration of new 
neurons is restricted to discrete regions of the adult mammalian brain under 
normal conditions, but may be influenced by a variety of environmental and 
other factors, some of which include injury, exercise and stress. 
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Figure 1.3 Development of the mammalian neocortex 
In embryonic development the dorsal forebrain gives rise to the neocortex. 
Progenitors destined to differentiate into pyramidal neurons are derived from the 
ventricular zone (V'Z), whereas progenitors destined to differentiate into cortical 
interneurons are predominantly derived from the medial and lateral ganglionic 
eminences (MGE and LGE, respectively) in the ventral forebrain. Interneuron 
progenitors migrate tangentially to the dorsal forebrain. The neocortex develops in 
2 distinct stages. In stage 1, post-mitotic neurons migrate to the pial margin of the 
cerebral wall, forming a pre-plate (PP). In stage 2, the pre-plate splits to form the 
marginal zone (MZ), cortical plate (CP) that will form layers II to VI of the 
neocortex, and sub-plate. Neurons reach their destination in the cortical plate by 
radial migration, either by somal translocation or by glial-guided locomation along 
the fibres of radial glial cells. The cortex is generated in an inside-out fashion. 
Adapted from Nadarajah B and Parnavelas J: Modes of neuronal migration in the developing 
cerebral cortex: Nature Reviews Neuroscience, 2002, 3, 423-432. 
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of the cerebral wall, to form a pre-plate adjacent to the VZ. 
The pre-plate subsequently splits to form the marginal zone, cortical plate and sub-
plate. The cortical plate is the primary destination of newly generated migrating 
neurons and is bordered at its upper and lower margins by the marginal zone and 
sub-plate, respectively. The marginal zone forms at the pial surface. It contains 
specialised pioneer neurons, or Cajal-Retzius cells, and will ultimately form layer I 
of the adult cortex. Below this, the cortical plate is generated, which will eventually 
constitute cortical layers II through to VI. During corticogenesis, migrating neurons 
take up their position in the cortical plate in a deep to superficial pattern. In this 
regard, the cortex is generated in an inside-out fashion. The intermediate zone will 
ultimately comprise the sub-cortical white matter. Importantly, although the cortical 
layers are largely established during gestation, neuronal connectivity and myelination 
continue well beyond birth (Nolte, 2002). 
Towards the end of neurogenesis, an additional zone, the SVZ, is generated between 
the ventricular and intermediate zones. This zone harbours precursor cells that, in 
the perinatal period, give rise predominantly to glial cells including astrocytes and 
oligodendrocytes and in adulthood give rise to specific populations of migrating 
neuronal progenitors, largely destined for the olfactory bulb (Marshall et al., 2003). 
Expansion of the SVZ in late gestation and early postnatal life is concomitant with 
the disappearance of the VZ (Nadarajah and Parnavelas, 2002). 
9 
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1.2.2.3 Modes of neuronal migration in the developing neocortex 
Patterns of neuronal migration in the embryonic cortex are an intense area of 
research. Nadarajah and Parnavelas (2002), in addition to Kriegstein and Noctor 
(2004) have recently provided excellent reviews summarising(these 'data, as detailed 
below. Interestingly, the migration of neurons form the VZ to their final position in 
the cortex is not direct and has been shown to involve four distinct phases (reviewed 
by Kriegstein and Noctor, 2004). In phase one, cells migrate from their birth-place 
in the VZ to the SVZ. Cells then become multipolar and pause in the SVZ or lower 
intermediate zone (phase two). Some neurons subsequently undergo retrograde 
movement towards the ventricle (phase three), prior to radial migration to their final 
destination in the cortical plate (phase four). The primary mechanisms of neuronal 
migration thought to underlie corticogenesis are radial and tangential migration. 
Radial migration is the migration of neurons from the VZ towards the pial surface, 
whereas tangential migration involves cell movement that is parallel to the surface of 
the brain. Thus, radial migration largely dictates columnar cortical organisation, 
whereas tangential migration may underlie the development of increased cellular and 
laminar complexity (Park and Rao, 2002). 
Radial migration is the primary method of migration in the developing cerebral 
cortex and can be sub-divided into two broad categories, somal translocation and 
glial-guided locomotion, which have recently been demonstrated by Nadarajah et al. 
(2001, 2003). Somal translocation is characterised by a fast rate of migration 
involving the attachment of a leading process to the pial surface and subsequent 
shortening and thickening of this process to draw the neuron to its final position in 
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the cortex (Kubo and Nakajima, 2003). This mode of migration is primarily utilised 
by early-born neurons (Nadarajah et al., 2001). Glial-guided locomotion 
predominantly involves the movement of cells destined to differentiate into cortical 
pyramidal cells. The rate of glial-guided locomotion is slower than that of somal 
translocation, involving a saltatory pattern of movement of migrating neurons along 
the radially extending fibres of radial glial cells, which traverse the entire thickness 
of the cortex (Nadarajah et al., 2001). Neurons migrating along radial glial cells 
demonstrate distinct bipolar morphology, with a thick leading and thinner trailing 
process (Kubo and Nakajima, 2003). Somal translocation may occur during early 
stages of cortical development, when the cortex is relatively thin and glial-guided 
migration may predominate at later stages, when the cortex is thicker and more 
difficult to navigate (Nadarajah and Parnavelas, 2002; Kubo and Nakajima, 2003) 
(Figure 1.3). 
Accumulating data indicate that, in addition to their role in guiding migrating 
neurons, radial glial cells may have much broader functions. For instance, Noctor et 
al. (2002, 2004) have recently shown that a majority of cycling VZ cells have 
morphological, molecular and physiological features characteristic of radial glial 
cells and thus propose that radial glia have a unique role in the VZ, where they 
initially generate new neurons and subsequently guide their neuronal progeny along 
radially extending fibres during corticogenesis. This process has been implicated in 
the development of functional radial units within the neocortex, whereby sustained 
contact between radial glial cells and their progeny may form local micro-networks 
spanning the cortical laminae (Noctor et al., 2001). The formation of radial units is 
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proposed to underlie the increase in cortical surface area without comparable 
increase in thickness during mammalian evolution (Rakic, 2000). 
Importantly, a third form of radial migration, termed multipolar migration has 
recently been discovered, characterised by net radial migration, interspersed with 
episodes of tangential migration (Tabata and Nakajima, 2003). This mode of 
migration might be incorporated into phase two of radial migration (Krigstein and 
Noctor, 2002). Nadarajah et al. (2003) have also described a sub-population of 
migrating cells they term 'branching cells'. These cells are characterised by multiple 
rapidly extending and retracting processes, similar to those described by Tabata and 
Nakajima (2003), and elaborate a branched leading process that, distinct from the 
somal locomoting cells does not contact the pial surface, but rather displays 
exploratory behaviour (Nadarajah et al., 2003). Branching cells may represent a sub-
population of cortical interneurons (Nadarajah et al., 2003) 
The second major form of neuronal migration in the developing cortex is tangential 
migration, whereby neurons (generally interneurons) move parallel to the brain 
surface along axons or other neurons. In this regard, interneurons derived from the 
ventral telencephalon ganglionic eminence migrate tangentially to the VZ and then 
radially to their finally resting position in the cortex (Figure 1.3). Collectively, 
studies of cortical neuron migration indicate that the processes of cortical 
development and neuronal migration are complex, involve transitions between 
distinct phases and may involve heterogenous patterns of migration for any single 
cell type (Tabata and Nakajima, 2003; Kriegstein and Noctor, 2004). 
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1.2.2.4 Regulation of neurogenesis and neuronal migration during corticogenesis 
Proliferation and differentiation within the developing brain must be tightly regulated 
to ensure correct cell numbers and appropriate cell types are generated (Frisen et al., 
1998). The proliferation, differentiation, migration and morphologic development of 
neural precursors is dependent upon spatio-temporal interactions between 
endogenous cellular processes and exogenous molecular signals, including a variety 
of growth factors, signalling molecules, hormones, extracellular matrix molecules, 
cell adhesion molecules and other cell surface proteins, soluble and membrane-
bound factors and neurotransmitters (reviewed by Cameron et al., 1998; Park and 
Rao, 2002; Sobeih and Corfas, 2002; Honda et al., 2003; Guan and Rao, 2003; Hagg, 
2005). Precursors become responsive and unresponsive to specific combinations of 
molecular signals as they proliferate, differentiate and mature. Exogenous signals 
may be generated by both the radial glial cells, along which neurons migrate and 
Cajal-Retzius cells in the marginal zone of the embryonic cortex (Soriano and Del 
Rio, 2005). 
The process of neuronal migration during development is heavily reliant upon 
interactions between guidance cues in the micro-environment and alterations in the 
neuronal cytoskeleton. In this regard, migrating and differentiating neurons must 
appropriately translate guidance cues into cytoskeletal rearrangements. Some of 
these signals are common to the process of axon outgrowth and pathfinding (Park 
and Rao, 2002; Sobeih and Corfas, 2002). Involvement of the neuronal cytoskeleton 
during migration of cortical neurons has recently been summarised by Bielas and 
Gleeson (2003). Neuronal migration is sensitive to genetic mutations as well as a 
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variety of chemical, physical and biological factors. Thus, disruption of the various 
components involved in neuronal migration at different stages of cortical 
development can result in a variety of developmental malformations and related 
disorders (Golden, 2001; Bielas and Gleeson, 2003; Kubo and Nakajima, 2003). 
1.2.2.5 Identity of neural stem cells and origin of adult -born neurons 
The SVZ persists into adulthood as the largest site of neurogenesis in the adult brain 
(Conver and Allen, 2002). The SVZ is comprised of four major cell types; 
ependymal cells that line the ventricle, astrocytes, newly generated neuroblasts and 
transitory amplifying progenitor cells with immature phenotypes (Doetsch et al., 
1997). The identity of the SVZ stem cells capable of supporting neurogenesis 
remains elusive (Barres, 1999; Morshead, 2004), but has been proposed as either the 
ependymal cell (Johansson et al., 1999) or the SVZ astrocyte (Doetsch et al., 1999). 
However, stem cells are essentially self-renewing multi-potent immature cells, 
contradictory to the notion that highly specialised cells such as astrocytes or 
ependymal cells form the stem cell population in the developing and adult brain. 
Although some studies have suggested that ependymal cells may function as stem 
cells in the adult brain, recent studies have demonstrated that ependymal cells are 
generated from radial glial cells during embryonic and early postnatal development, 
are not a reservoir of adult stem cells and do not divide following differentiation 
(Spassky et al., 2005). Thus, processes of dedifferentiation, reprogramming and 
transdifferentiation may be involved in the elaboration of other mature cell 
phenotypes from mature ependymal cells and astrocytes (Wagers and Weissman, 
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2004; Conover and Allen, 2002), although this notion remains controversial (Wagers 
and Weissman, 2004). Importantly, neural stem cells may in fact be a sub-
population of SVZ derived astrocyte- or ependymal-like cells (Conover and Allen, 
2002). Due to the conflicting identification of SVZ stem cells and different 
methodologies utilised to perform these studies, further investigation is required to 
resolve this 'identity crisis' (reviewed by Morshead, 2004). 
1.2.3 Cell types in the brain 
Despite its complexity the brain is composed of just two principal cell types, neurons 
and glia. Neurons are the basic functional units of the brain, responsible for 
collecting, processing and conveying information. They are, however, unable to 
function effectively without a supportive glial milieu. 
1.2.3.1 Glial cells 
An array of glia cell populations, including astrocytes, oligodendrocytes, microglia, 
and ependymal cells, are intimately associated with neurons and perform important 
roles during development, maturation, plasticity and repair of the CNS. During 
development glial cells provided scaffold and guidance support to growing neurons. 
In the adult, these cells are responsible for performing a variety of nutritive, 
physiological, and structural functions. The predominant CNS grey and white matter 
glial populations, astrocytes and oligodendrocytes respectively, vastly outnumber 
neurons in a ratio of approximately 10:1 (Nolte, 2002). 
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1.2.3.1.1 Astrocytes 
Astrocytes may be divided into two major populations — protoplasmic astrocytes 
reside in the grey matter and fibrous astrocytes reside in the white matter — however, 
both types have essentially the same features. Astrocytes are stellate-shaped cells 
with a well defined cytoskeleton and small cell body (3-5[1m). Astrocytes play 
important structural and homeostatic roles in the brain (Nolte, 2002). They provide 
neurons with structural support and contribute to formation of the blood brain 
barrier. Astrocytes also play crucial roles in CNS metabolism and in homeostatic 
regulation of the ionic and molecular environment, for example they regulate 
extracellular potassium concentration, are involved in neurotransmitter uptake and 
produce neurotrophic factors, which contribute to neuronal development and are 
implicated in the neural response to injury. Astrocytes perform particular roles 
following brain injury, where they undergo a stereotypical sequence of reactive 
alterations referred to as reactive gliosis, culminating in the formation a glial scar at 
the lesion margin (Maxwell et al., 1997; Raivich et al., 1999)Xhis structure acts to 
segregate the damaged from non-damaged tissue, but may inhibit neuronal 
regeneration (Fawcett and Asher, 1999). 
1.2.3.1.2 Oligodendrocytes 
Oligodendrocytes are the predominant glial cell type within the CNS white matter, 
where they form myelin sheaths that encase axons and aid in axonal conduction. 
Oligodendrocytes also have small cell bodies (1-3pm) and elaborate an array of 
branched projections (Nolte, 2002). Although an individual oligodendrocyte 
myelinates numerous axons, each axon is only myelinated by a single 
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oligodendrocyte. This is contrary to the peripheral nervous system (PNS) where 
several Schwann cells are responsible for the myelination of a single axon (Totora 
and Grabowski, 1996). CNS myelin, contrary to myelin in the PNS, contains factors 
inhibitory to axonal growth, which may inhibit axonal regeneration following injury 
(Fawcett and Asher, 1999; Bandtlow and Schwab, 2000; Watkins and Barres, 2002), 
but may confine developing neurites to correct trajectories during development 
(Nagashima et al., 1999; Goldberg and Barres, 2000). 
1.2.3.1.3 Microglia 
Microglia, or CNS-resident macrophages, are smaller than astrocytes and 
oligodendrocytes and are viewed as the primary immune cell type of the CNS. The 
origin of microglia is still disputed, with studies suggesting that they may arise from 
mesodermal, neuroectodermal or monocytic sources (reviewed by Cuadros and 
Navascues, 1998; Kaur et al., 2001). Following entry into the CNS, microglial 
precursors undergo a defined sequence of events involving dispersion and 
differentiation to generate a brain-resident population of cells (Cuadros and 
Navascues, 1998; Navascues et al., 2000). Microglia develop a ramified morphology 
as they settle within the brain and form a population of brain-resident macrophages 
(Barron, 1995; Navascues et al., 2000). During brain development, microglia 
function as phagocytic cells that remodel the developing tissue (Barron, 1995), 
whereas in the adult brain they are believed to participate in dynamic immune-
surveillance functions (Nimmerjahn et al., 2005). Microglia play a distinct and 
crucial role in the neural response to injury where they migrate to sites of injury, 
multiply and develop into brain macrophages responsible for clearing neuronal 
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debris and destroying pathogens (Thomas, 1992; Lotan and Schwartz, 1994; Aihara 
et al., 1995; Barron, 1995; Ravivich et al., 1999). Macrophages may also be 
extruded from circulation in response to injury (Kaur et al., 2001). 
1.2.3.1.4 Ependymal cells 
Ependymal cells line the ventricles of the brain and central canal of the spinal cord. 
Regions of the ventricular epithelium form specialised secretory tissue, which is 
associated with invaginations of small blood vessels. This tissue is knownas the 
choroid plexus and is responsible for producing cerebrospinal fluid. The ependymal 
cells lining the ventricles extend cilia into the ventricular cavity, which contribute to 
cerebrospinal fluid circulation (Nolte, 2002). 
1.2.3.2 Neural progenitor cells 
In the mature brain, neural progenitor cells are a population of precursor cells that 
give rise to the restricted cell phenotypes, which are specific to the CNS. Unlike 
many other organs, the mature mammalian brain is largely regarded as a relatively 
stable organ, which undergoes limited cell, and particularly neuronal, turnover. 
Although cell proliferation is widespread in the developing brain, just two primary 
proliferative zones are retained in the adult brain, the SVZ of the anterior lateral 
ventricles and the dentate gyrus of the hippocampus (Doetsch and Hen, 2005). The 
SVZ, in particular, is viewed as the princiiial germinal region of the adult brain and 
is comprised of neural progenitor cells capable of differentiating into neurons, 
astrocytes and oligodendrocytes (Doetsch et al., 1997, 1999; Conover and Allen, 
2002; Doetsch, 2003; Marshall et al., 2003; Mignone et al., 2004; Abrous et al., 
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2005; Doetsch and Hen, 2005). Additionally, neural progenitor cells capable of 
extensive migration and integration have been demonstrated in several other brain 
regions (reviewed by Emsley et al., 2005). 
1.2.3.3 Neurons 
Neurons are the information processing units of the brain, and nervous system in 
general. Electrical and chemical signals are used to convey information both within 
and between individual neurons. The process of information collection, integration, 
and transmission is reflected by a highly specialised morphological organisation. 
Thus, neurons are functionally and anatomically polarised to conduct electrical 
signals in one direction and, although neurons vary vastly in shape and size, all 
neurons have the same basic morphological features. The soma, varying in size from 
5 to 100tim in diameter, supports the metabolic and synthetic requirements of the 
rest of the neuron (Nolte, 2002). Specialised extensions of the soma, collectively 
referred to as neurites, constitute neural circuitry. Dendrites are branched neurites, 
with a distinct proximal to distal taper, which increase the cell surface area for 
receiving information. Regions of the dendritic membrane, post-synaptic densities, 
are specialised to receive synaptic input. Some dendrites, particularly, but not 
exclusively, those of pyramidal cells, possess specialised dynamic membrane 
protrusions, or dendritic spines, which contain post-synaptic densities (Ethel! and 
Pasquale, 2005). Dendritic spines are variable in both morphology and relative 
permanence (Knott et al., 2002; Ethell and Pasquale, 2005). Neurons also elaborate 
a single slender process, the axon, which is responsible for conveying electrical 
signals to target cells via specialised terminal synaptic boutons. 
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1.2.3.3.1 The neuronal cytoskeleton 
The characteristic and elaborate neuronal morphology is dictated and maintained by 
the neuronal cytoskeleton, a rigid yet highly dynamic intricate intracellular scaffold 
(Burgoyne, 1991; Bear et al., 2001). Owing to its dynamic nature the neuronal 
cytoskeleton is implicated in several fundamental cellular functions such as mitosis, 
differentiation, motility, intracellular transport and synaptic transmission (Hirokawa, 
1991; Maccioni and Cambiazo, 1995). As displayed in Figure 1.4, the neuronal 
cytoskeleton is comprised of three fibrillar systems, namely microtubules, actin 
microfilaments and neurofilaments. Although these three systems may be viewed as 
discrete entities, they are intimately associated and undergo highly regulated 
interactions to function as a single organelle (Burgoyne, 1991). Immediately 
underneath the axolemma lies the cortical cytoskeleton, a meshwork of actin 
filaments and an array of associated proteins. Deeper within the axoplasm is a core 
cytoskeleton composed of interwoven microtubules and neurofilaments, which are 
linked by an assortment of cross-linking and other related proteins (Nixon, 1991). 
Intriguingly, up to 99% of a neuron's cytoplasm may be contained within the axon 
(Nixon and Sihag, 1991; Nixon and Shea, 1992; Nixon, 1998). However, the 
machinery for protein synthesis, issl substance, is generally excluded from this 
neuronal compartment. Axons, therefore, rely heavily on active axonal transport 
mechanisms to bi-directionally transfer molecules between somal and axonal 
compartments and within the axoplasm. The axonal cytoskeleton plays a pivotal role 
in axonal transport and itself must be transported into the axon. Axonally destined 
core cytoskeletal proteins (such as neurofilaments and tubulin) are predominantly 
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Figure 1.4 Diagrammatic representation of the neuronal cytoskeleton 
The neuronal cytoskeleton is composed of three fibrillar systems, 
microfilaments, neuronal intermediate filaments (neurofilaments) and 
microtubules. Microfilaments are the smallest diameter cytoskeletal 
component and are composed of helically intertwined strands of polymerised 
actin molecules. Microtubules are tube-like structures, composed of tubulin 
molecules (consisting of a- and I3-tubulin sub-units). Microtubules are the 
largest diameter cytoskeletal component. Neurofilaments, unlike 
microfilaments and microtubules, are composed of subunits with a 
filamentous structure. The diameter of neurofilaments is intermediate between 
microfilaments and microtubules. 
Adapted from Bear M, Connors B and Paradiso M; Neuroscience: Exploring the brain, 
Maryland, 2001, Lippincott Williams & Wilkins. 
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synthesised in the neuronal soma and subsequently transported into the axon via slow 
axonal transport, in a process known as slow component a (Sca) (Nixon, 1991), 
which relies on active metabolic processes (Galbraith et al., 1999). Slow component 
b (Scb) is the mode by which other cytoskeletal proteins and certain glycolytic 
enzymes are transported (Nixon, 1991). Membrane bound vesicles are transported 
by fast axonal transport mechanisms. Whether neurofilament and tubulin monomers 
are predominantly transported in a polymerised or un-polymerised form remains 
controversial (Lariviere and Julien, 2004). The axonal cytoskeleton is regionally 
specialised and locally regulated and as cytoskeletal proteins and assembled 
polymers are synthesised and transported into the axon, they continually exchange 
with those in stationary and slower moving cytoskeletal structures (Nixon, 1991). 
1.2.3.3.1.1 Microfilaments 
The microfilament cytoskeleton is a highly dynamic network of intermeshed actin 
filaments. Individual globulin, or G-actin, monomers polymerise to form 
filamentous, or F-actin. These filaments then form helical structures, referred to as 
microfilaments (Bear et al., 2001) (Figure 1.4). Actin filaments are capable of rapid 
assembly and disassembly and are predominantly localised to areas of high cell 
motility (Bamburg and Bernstein, 1991). The structure of the microfilament 
cytoskeleton is under the regulation of a variety of actin-associated proteins 
(Bamburg and Bernstein, 1991; da Silva and Dotti, 2002; Korey and Van Vactor, 
2000). Moreover, the actin cytoskeleton and associated proteins link the 
extracellular matrix to intracellular signalling cascades via membrane-associated 
complexes, or focal adhesion and adherens junctions (da Silva and Dotti, 2002). 
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1.2.3.3.1.2 Microtubules 
Microtubules are tube-like structures composed of tubulin (Hirokawa, 1991; Bear et 
al., 2001). Individual tubulin molecules, consisting of a- and 13-tubulin, polymerise 
to form protofilaments. A total of 13 protofilaments aggregate around a hollow core 
to form a microtubule (Bear et al., 2001; Nolte, 2002). Microtubules are polarised 
and arranged longitudinally in neurites and radially in the soma. Microtubule 
positive ends always point to the periphery in the soma and distally in the axon, 
however, microtubules display mixed orientation within dendrites (Brandt, 1998). 
Microtubules participate in maintenance of neuronal morphology, motility, 
intracellular transport, modulation of interactions with cell surface receptors, cell 
attachment and neuronal plasticity (Burgoyne, 1991). Axonal microtubules have 
specialised functions in structural support, axonal transport and axonal growth 
(Nixon, 1991; Hoffman and Cleveland, 1988; Suter and Forscher, 2000). 
An extensive network of microtubule-associated proteins (MAPs) coats the surface 
of microtubules. MAPs link microtubules to cytoskeletal and cellular structures 
(Tucker, 1990; Burgoyne, 1991; Hirokawa, 1991; Maccioni and Cambiazo, 1995; 
Mandelkow and Mandelkow, 1995; Drewes et al., 1998; Nixon, 1998) and are 
considered putative organisers of neuronal morphology (Matus, 1991). Through 
phosphorylation-dependent interactions, MAPs stabilise microtubules and regulate 
microtubule spacing (Maccioni and Cambiazo, 1995; Mandelkow and Mandelkow, 
1995; Tanaka and Sabry, 1995). Notably, tau and MAP-2 are examples of MAPs, 
confined to the axonal and somato-dendritic compartments, respectively (Tucker, 
1990; Byrgoyne, 1991; Hirokawa, 1991; Mandelkow and Mandelkow, 1995). 
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1.2.3.3.1.3 Neuronal intermediate filaments 
Neurofilament triplet proteins, commonly referred to as neurofilaments, together 
with a-internexin, comprise the neuronal intermediate filament family of type IV 
intermediate filament proteins (Lariviere and Julien, 2004) (Figure 1.5A). Unlike the 
globular sub-units comprising microfi laments and microtubules, all neuronal 
intermediate filament proteins are comprised of filamentous proteins, which are 
coiled into a tight spring-like configurations, making them mechanically very strong 
(Bear et al., 2001). Whereas individual a-internexin filaments self-assemble to form 
homopolymers, neurofilaments are obligate heteropolymers, comprised of three sub-
units designated NF-L, NF-M and NF-H based on their relative molecular masses 
(Nixon and Sihag, 1991; Shaw, 1991; Lee and Cleveland, 1994, 1996; Lariviere and 
Julien, 2004). 
NF-M and NF-H subunits have distinctive carboxy terminal tail domains (or 'side-
arms') that protrude from the core filament (Figure 1.5B), vary in length between 
subunits and undergo extensive phosphorylation (Steinert and Roop, 1988; Nixon 
and Sihag, 1991; Chertoff et al., 1995; Lee and Cleveland, 1996), which increases 
the angle between the core filament and side-arm to increase the spacing between 
individual neurofilaments (Nixon and Sihag, 1991; Shaw, 1991; Lee and Cleveland, 
1996). Thus, neurofilaments are implicated in the control of axonal calibre 
(Hoffman et al., 1984, 1985, 1987; Sakaguchi et al., 1993; Julien, 1999; Hall et al., 
2000; Perrone Capano, 2001), as well as the dynamic function of other cytoskeletal 
components (Julien and Grosveld, 1991; Julien and Mushynski, 1998). 
Neurofilaments form the most stable component of the neuronal cytoskeleton, but 
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Figure 1.5 Diagrammatic representation of type IV neuronal intermediate 
filament proteins 
(A) Type IV neuronal intermediate filament proteins include the neurofilament triple 
proteins, NF-L, NF-M and NF-H, commonly referred to as neurofilaments, as well 
as a-internexin. These proteins comprise the main intermediate filament component 
of the cytoskeleton of most mature CNS neurons. Neuronal intermediate filaments 
have a distinct filamentous structure. (B) Neurofilament triplet proteins are 
polymers of NF-L, NF-M and NF-H subunits. NF-M and NF-H possess carboxy 
terminal tail domains (or 'side-arms') that protrude from the core filament, vary in 
length between sub-units and undergo phosphorlylation to increase inter filament 
spacing. 
(A) Adapted from Lariviere R and Julien J-P: Functions of intermediate filaments in neuronal 
development and disease: J.Neurobiol, 2004, 58 131-148. 
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possess dynamic properties and can vary in size and composition along the axonal 
length, where they may undergo local turnover (Nixon and Sihag, 1991; Okabe, 
1993; Nixon, 1998; Chan et al., 2003). 
Neuronal intermediate filaments are representative of mature neurons and thus 
expression of these proteins increases concomitant with decreases in other 
development-associated proteins including nestin and peripherin (Lariviere and 
Julien, 2004). Importantly, neurofilament expression is dramatically elevated after 
synapse formation, axonal diameter expansion and myelination (Nixon and Shea, 
1992; Lee and Cleveland, 1996). The succession of neuronal intermediate filament 
expression facilitates the transition of a developing neuron, from a highly plastic 
mitotic cell, to a post-mitotic highly polar structure with distinct morphological 
features (Nixon and Sihag, 1991; Nixon and Shea, 1992). Additionally, the 
distribution of neurofilaments is not uniform; neurofilaments are generally more 
abundant in axons than dendrites and are more heavily phosphorylated in the axonal 
than somato-dendritic cellular compartment (Shaw, 1991). 
1.2.3.3.2 Neuronal development 
The dynamic nature of the neuronal cytoskeleton is crucial to neuronal development 
and enables developing neurons to migrate to their correct final destination, elaborate 
processes and form appropriate interconnections. Neuronal development has been 
extensively documented (for example reviews see Goslin et al., 1988; Tanaka and 
Sabry, 1995; Tessier-Lavigne and Goodman, 1996; Brandt, 1998; Yamaguchi, 2001; 
da Silva and Dotti, 2002). Neurons acquire their characteristic morphology through 
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a stereotypical sequence of events that varies depending on neuronal type and 
whether growth is occurring in vivo or in vitro (for review see da Silva and Dotti, 
2002). Initially spherical cells, neurons undergo a complex process called 
neuritogenesis, involving dissolution of cell symmetry, membrane budding and the 
elaboration of fine protrusions (neurites) from the perikarya (da Silva and Dotti, 
2002). In vivo, a majority of neuroblasts elaborate a solitary neurite, which serves as 
a migrational guide and usually forms an axon. Once migration is complete, the 
somal membrane is again disrupted and neurites, which will form future dendrites, 
are generated. Conversely, in vitro neurons initially extend multiple, 
morphologically indistinguishable processes (minor neurites) and one minor neurite 
rapidly elongates, forming an axon. Developing neurites continually extend and 
retract and may, especially in their infancy, retract altogether. 
Growing neurites are tipped by characteristic highly motile "direction sensing" 
structures, termed growth cones, which determine the directional growth of the 
neurite and are the sites at which new components are added to the growing plasma 
membrane (Gungabissoon and Bamburg, 2003). Growth cones, consisting of a 
microtubule-rich central domain and actin-rich peripheral zone (Figure 1.6), are 
responsible for translating extracellular guidance signals into the cytoskeletal 
rearrangements that dictate axonal morphology and the final route of axonal growth 
(Tanaka and Sabry, 1995; Brandt, 1998). The unique arrangement of the actin 
cytoskeleton within growth cones in believed to underlie their high motility. The 
actin-rich peripheral domain of growth cones is composed of remarkably motile 
protrusions called filopodia and lamellipodia, which are short-lived and continually 
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Figure 1.6 Diagrammatic representation of the major components of the 
developmental growth cone 
In the developmental axonal growth cone, neurofilaments are generally restricted 
to the neurite shaft. Microtubules are prominent in the growth cone central 
domain and actin microfilaments comprise the primary cytoskeletal component of 
the highly motile filopodia and lamellipodia, where they are arranged as bundles 
and veils, respectively. 
Microtubules Neurofilaments 	Actin microfilaments 
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extend and retract. Filopodia are slender tubular protrusions in which actin filaments 
are tightly bundled and longitudinally orientated. Lamellipodia are fan-like 
structures, consisting of dense meshworks of actin filaments, which often form 
between filopodia (Korey' and Van Vactor, 2000; Gallo and Letourneau, 2000). 
Actin elongation in the growth cone periphery drives filopodial and lamellopodial 
elongation (Gungabisson and Bamburg, 2003). 
Two distinct but related mechanisms regulate axonal growth. Firstly, a fast transient 
scanning by filopodia and lamellipodia, predicts the direction of future elongation, 
and secondly, a slower orientation of the proximal growth cone establishes the final 
orientation of the newly formed section of axonal shaft (Brandt, 1998). 
Orchestration of actin treadmilling (polymerisation and depolymerisation), and 
myosin-dependent retrograde transport of actin subunits dictates the behaviour of the 
actin cytoskeleton in the peripheral domain of the growth cone, enabling exploration 
of the local environment (Brandt, 1998; Mallavarapu and Mitchison, 1999; Korey 
and Van Vactor, 2000; Gallo and Letourneau, 2000). Microtubules extend into the 
actin-rich peripheral domain to explore the internal environment of the growth cone 
(Tanaka and Sabry, 1995; Gallo and Letourneau, 2000; Suter and Forscher, 2000). 
Microtubule assembly and bundling in the desired direction of growth with 
concomitant quiescence and coalescence of remaining growth cone structures, results 
in the formation of a new portion of axonal shaft, which is remarkably un-dynamic 
compared to the growth cone (Gallo and Letourneau, 2000). 
Both progressive events (neuritogenesis and axonal outgrowth) as well as regressive 
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events (neuronal death, axonal retraction and neurite pruning) act synergistically to 
orchestrate the final pattern of neuronal circuitry within the mature brain (Luo and 
O'Leary, 2005). Ultimately, function of the nervous system depends on the highly 
specific pattern of neuronal connectivity formed between neurons during 
development (Bandtlow and Schwab, 2000). This pattern of connectivity is 
determined by the precise targeting of axons to the cells they will eventually 
innervate (Gungabisson and Bamburg, 2003). Thus, development of the nervous 
system, and brain in particular, is magnificently complicated and strictly regulated, 
involving a multitude of cell types, internal and external guidance cues as well as 
numerous associated factors. Although the brain may be subject to several 
developmental defects, the mature brain is by no means resilient to insult. The 
complexity and intricacy of neural circuitry in the adult brain confers particular 
vulnerability to a variety of insults including chemical, physiological and physical 
lesions as well as, or in addition to, disruptions in homeostatic mechanisms 
generating neurotoxic alterations in biochemical and metabolic pathways. 
Additionally, the combined influences of environment, genes and/or age may render 
the brain vulnerable to a variety of neurodegenerative diseases. 
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1.3 Traumatic brain injury 
TBI, any injury to the head that results in brain damage, is a major cause of 
mortality and morbidity, contributing to the leading cause of death under the age of 
45 years in developed nations (Adams, 1992; Egeler-Peerdeman, 1993). 
Importantly, head injury often affects individual in the most productive years of their 
lives, causing death or brain injuries ranging from mild to severe (Duff, 2001; Finnie 
and Blumbergs, 2002). Additionally, head injury has been implicated in the 
development of neurodegenerative diseases, such as Alzheimer's disease later in life 
(Smith et al., 1999; Graham et al., 2000; King et al., 2000a; Vickers et al., 2000; 
Jellinger et al., 2001). Severe head injury often causes overt brain damage resulting 
in widespread neuronal dysfunction. However, even mild brain trauma can elicit an 
insidious cascade of cellular changes that culminate in neuropathology. Neuronal 
damage is particularly serious because neurons in the mature CNS are generally post-
mitotic and unable undergo cell division. Thus injury induced neuronal loss results 
in permanent alterations in the structure of the nervous system, which are often 
accompanied by long lasting functional changes (Kelly, 1981). 
1.3.1 Types of brain injury 
Due to the combined influences of injury type, severity and factors intrinsic to the 
patient, brain injury has a vast array of manifestations. However, the principal 
mechanisms causing brain injury can be divided into two broad categories: contact 
and non-contact injury (Finnie and Blumbergs, 2002). Contact injuries may be 
penetrative or non-penetrative. This form of injury results from an object striking the 
head, often generating local effects such as scalp laceration, skull fracture and 
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extradural haematoma. Non-contact injuries are non-penetrative and result from 
dynamic inertial forces that rapidly rotate the brain within the skull. Both contact 
and non-contact injuries are capable of generating focal, multifocal and diffuse 
lesions (Povlishock and Katz, 2005). Focal lesions incorporate focal cortical 
contusion as well as both deep and extracerebral haemorrhage. In addition, shock 
waves generated at the site of impact may travel through the skull and brain, possibly 
causing contusions and intracerebral haemorrhage remote from the site of impact. 
Differential movement between the brain and the cranium may also generate diffuse 
injuries in which pressure gradients within the brain tissue create shear, tensile and 
compressive forces (Adams, 1992; Steward et al, 1999). Figure 1.7 highlights some 
of the forces involved in TB!. 
Common manifestations of diffuse brain injury include diffuse axonal injury (DAI) 
and diffuse vascular injury (DVI), where axons and microvessels, respectively, are 
disrupted throughout the brain (Povlishock and Christman, 1995; Maxwell et al., 
1997; Smith and Meaney, 2000; Sahuquillo and Poca, 2002; Povlishock and Katz, 
2005). Importantly, DAI may occur in the absence of other parenchymal alterations 
and is therefore common in mild to moderate head trauma (Povlishock and Becker, 
1985; Christman et al., 1997; Maxwell et al., 1997; Graham et al., 2000; Smith and 
Meaney 2003; Povlishock and Katz, 2005). Additionally, brain injury may also 
evoke a variety of generalised abnormalities such as neuroexcitation and metabolic 
changes (Povlishock and Katz, 2005). Rotational/angular acceleration of the head, 
often occurring in falls, car crashes and sports injuries, is a common cause of diffuse 
brain damage and may cause both acute and chronic neurological symptoms as well 
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Figure 1.7 Diagrammatic representation of potential forces involved in 
traumatic brain injury 
During head injury, the brain may undergo both focal and diffuse injuries. Focal 
injures occur when the head strikes and object or vice versa and may involve skull 
fracture, brain contusion and haemorrhage. Alternatively, or additionally, the 
brain may move within the skull causing multi-focal injuries. Differential 
movement between the brain and cranium also results in shearing strains 
throughout the brain parenchyma, which may generate both diffuse axonal and 
diffuse vascular injuries. 
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as psychiatric deficits. The brain regions affected by such damage are generally 
those important for social behaviour, memory and movement (Hamberger et al., 
2003). 
1.3.2 Primary and secondary brain damage 
Primary damage following brain injury can be classified as any neural disruption that 
occurs at the time of injury (Maxwell et al., 1997; Graham et al., 2000; Finnie and 
Blumbergs, 2002). Such damage may involve neuronal and glial cell populations as 
well as disruption to brain vasculature. In this regard, cells and blood vessels may be 
sheared, torn or stretched at the time of injury casing haemorrhage, axonal damage 
and immediate cell death (Finnie and Blumbergs, 2002). However, primary injuries 
often culminate in a range of secondary alterations. Secondary events develop over a 
period of hours, days or weeks following the initial trauma (Graham et al., 2000). 
Secondary perturbations include ischemia, excitotoxicity, spreading neurotoxicity 
due to disruption of ionic homeostasis and tissue destruction, energy failure, cerebral 
swelling, initiation of necrotic and apoptotic neuronal death cascades, neuronal 
degeneration due to downstream deafferentiation/denervation and inflammation, 
which may in turn compound other responses and add to the spread of neurotoxic 
effects (Maxwell et al., 1997; Finnie and Blumbergs, 2002; Bayir et al., 2003; Chen 
et al., 2003a; Liou et al., 2003; Povlishock and Katz, 2005). Secondary alterations 
may be diffuse and/or focal depending on the form of the initial injury. 
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1.3.3 Models of brain injury 
Several in vivo models of brain injury have been developed with the aim of providing 
insight into improving the treatment of head trauma and therefore reducing the 
mortality, morbidity and costs associated with this condition. A variety of in vitro 
models have also been developed to complement the in vivo models and may provide 
a more complete representation of the neuronal response to brain trauma. 
Surprisingly, the evolution of degenerative and regenerative changes following a 
traumatic incident are highly reproducible across both in vivo and in vitro models, 
despite the simplified nature of the latter, and follow a predictable sequence over 
time (for recent reviews see Maxwell et al., 1997; King et al., 2000a; Vickers et al., 
2000; Finnie and Blumbergs, 2002). However, it should be noted that there is a 
certain level of failure in the translation of experimental investigations to the clinical 
scenario of TBI (Statler et al., 2001). 
1.3.3.1 In vivo models of TBI 
In vivo experimental models of head injury primarily aim to simulate the types of 
brain damage that occur in human head trauma (Adams, 1992; Graham et al., 2000; 
Finnie and Blumbergs, 2002). In this regard, a variety of lesion models have been 
developed. Animal models generally induce a controlled mechanical injury that is 
reproducible, quantifiable and clinically relevant (Finnie and Blumbergs, 2002). 
However, any single model is not capable of replicating the full repertoire of forces 
involved in human head injury (Statler et al., 2001). In vivo brain injury models can 
be broadly divided into impact acceleration, non-impact (inertial) acceleration and 
direct brain deformation. Thus, the mode of injury for each of these models involves 
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direct impact on the skull, acceleration of the head without impact and direct 
deformation of the brain through the exposed dura/cortex, respectively (reviewed by 
Graham et al., 2000; Finnie and Blumbergs, 2002). Acceleration/inertial models 
mimic forces inflicted on the brain in situations such as vehicle accidents. Despite 
their similarity to human brain injury, many injury models in involving primates 
(primarily contact and non-contact acceleration models) involve specific economic 
and ethical implications and therefore have largely been replaced by rodent or non-
primate animal studies. In this regard, acceleration injuries are usually performed in 
species such as sheep and pigs, which have gyrencephalic brains similar to humans 
(Finnie and Blumbergs, 2002). 
The most widely used in vivo brain injury models are fluid-percussion and controlled 
cortical impact, or cortical contusion, models — both of which involve direct brain 
deformation (Finnie and Blumbergs, 2002). Fluid-percussion models produce injury 
by creating pressure transients in the cranium using a device that transmits pressure 
waves hydraulically (Steward, 1999). The resulting elastic deformation of the brain 
resembles a direct impact injury (Adams, 1992). Pneumatically driven mechanical 
impactors can be used to produce a controlled compression of the exposed brain 
(Adams, 1992; Steward, 1999), or can directly impact on the ,skull, resulting in skull 
fractures in addition to brain damage (Steward, 1999). Both fluid-percussion and 
control cortical impact techniques are capable of producing DAI (Adams, 1992). 
Another model involves stretching the optic nerve in the adult guinea pig (Jafari et 
al., 1997, 1998; Maxwell et al., 1997), which can produce axonal damage that is 
morphologically identical to DAI in humans (Adams, 1992). Defined surgical lesion 
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(eg King et al., 2001; Chung et al., 2002, 2003) and excitotoxic models have also 
been developed, which produce relatively comparable consequences (reviewed by 
Steward, 1999). 
Although in vivo models aim to replicate various aspects of human head trauma they 
are often inherently simplified and do not incorporate certain key, clinically relevant 
factors such as multiple trauma, secondary insults (for example hypotension and 
hypoxemia, intracranial hypertension and cerebral oedema), gender, age, alcohol 
consumption, genetic predisposition, frontal lobe injury, intracranial haemorrhage 
And surgical intervention (for review see Statler et al., 2001). Furthermore, Statler et 
al. (2001) highlight several additional factors that are implicated in clinical cases of 
TBI. For instance, fever, seizures, electrolyte disturbances and blood transfusion 
thresholds. Additionally, coma and administration of neurointensive care monitoring 
and management (for example choice of anaesthetics, use of sedatives, inspired 
oxygen concentration, hemodynamic support and surgical decompression) are often 
not addressed in animal models (Statler et al., 2001). Despite their obvious set 
backs, the importance of animal models cannot, however, be underestimated as they 
are proving extraordinarily useful in elucidating many of the molecular, biochemical 
and cellular factors implicated in the sequela of TBI. In this respect, certain models 
and animal species are more suited to investigating the various aspects of human 
brain trauma, such as rodent versus large animal and models, which produce focal as 
opposed to diffuse lesions. 
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1.3.3.2 In vitro models of TBI 
The establishment of neuronal culture models has allowed extensive study into 
neuronal development and the neuronal response to injury. Cultured neurons are 
easily accessible and economical. Additionally, cultured cells can be chemically, 
genetically or physically manipulated and monitored with relative ease, particularly 
through live cell imaging technologies (Bekkers, 1997). Cultured neurons can be 
exposed to a variety of physical insults that may be implicated in TBI. Such insults 
include acceleration, compression, shear, stretch and transection (see review by 
Morrison et al., 1998). Cultures of dissociated neural tissue involve removing 
explants of tissue and plating them as dissociated cell suspensions. It is important to 
note that many studies are performed using neuron-like cell lines, for example 
neuroblastoma lines, or neurons from the PNS, rather than primary CNS derived 
cultures, which are more difficult to culture and manipulate. Additionally, very few 
neuronal injury models are able to generate specific axonal injury (Dickson et al., 
2000; Chung et al., 2002; Haas et al., 2004; Taylor et al., 2005) and instead tend to 
be models of global neuronal trauma (Morrison et al., 1998). 
The major disadvantage of neuronal cultures is that much of the three-dimensional 
architecture of the intact nervous system is lost. Therefore, anatomical data and the 
role of brain vasculature cannot be examined. Nevertheless, these models are 
important for investigating the morphological and physiological response of single 
cells, are particularly amenable to manipulation and provide a major platform for the 
initial testing of neuro-therapeutic agents. Moreover, neuronal slices can be 
harvested from the intact brain. Cultured brain slices retain much of the connectivity 
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typical of the origin from which they were removed. Importantly, tissue for both 
slice and dissociated cell culture can be removed from either embryonic or 
neurologically mature animals. A variety of neuron-like cell lines also exist. Taken 
together, data derived from the vast array of in vivo and in vitro experimental brain 
and neuronal injury models has provided valuable insight into the mechanisms 
involved in the neuronal response to injury. 
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1.4 The neuronal response to injury 
Data gathered from both experimental models of neuronal injury and cases of human 
TBI indicate that neurons undergo a stereotypical sequence of reactive and 
potentially regenerative alterations following injury (Maxwell et al., 1997). 
Importantly, DAI often occurs in the absence of other parenchymal alterations, 
particularly in mild to moderate brain injuries (Maxwell et al., 1997; Smith and 
Meaney, 2003, Povlishock and Katz, 2005). Axonal injury, in turn, may signal 
characteristic alterations in the soma (Vickers et al., 2000), as discussed below. 
1.4.1 Axonal injury 
Axonal injury is present in human head trauma of varying severity as well as in 
numerous experimental models of brain injury (Gennarelli, 1996). Due to their 
relatively long-distance projection and fragility, axons are particularly vulnerable to 
injuries involving rapid acceleration/deceleration and rotational forces (Maxwell et 
al., 1997; Smith and Meaney, 2000). In this regard, widespread axonal damage, or 
DAI, is a frequent consequence of such trauma (Gennarelli, 1996; Vickers et al., 
2000). DAI is the most common cause of vegetative state following brain trauma 
(Adams, 1992) and, in severe head injuries, axonal damage is associated with 
significant mortality (Gennarelli, 1996). Extensive axonal disruption results in the 
loss of multiple synaptic connections throughout the brain parenchyma and, in turn, 
the disruption of the circuits into which they are integrated. 
Whether axonal disconnection, or axotomy, occurs during an injury or sometime 
later, the eventual consequence is the formation of two axonal segments. The 
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severed axonal ends seal over almost immediately following disconnection, 
separating the axon into a proximal and distal portion, which retract away from one 
another and begin to swell due to the continued anterograde and retrograde transport 
of organelles and other material, including mitochondria, vesicles, multivesicular 
bodies and neurofilaments (Kelly, 1981). The distal fragment becomes completely 
separated from its neuron of origin, whereas the proximal segment remains attached 
to the soma. Around the injury site rapid myelin degeneration occurs. 
Axonal disconnection results in metabolic deprivation within the distal axonal 
segment. The distal axonal fragment, therefore, undergoes a degenerative response, 
referred to as Wallerian degeneration. As degeneration in the distal segment 
proceeds, the myelin sheath draws back from the axon and degrades, the axon beads 
and degenerates and the resultant debris is phagocytosed and recycled by glial cells 
(Kelly, 1981). Interestingly, utilising in vivo live imaging techniques, 
Kerschensteiner at al. (2005) have shown that the severed terminals of both the 
proximal and distal axonal segments of primary sensory neurons initially undergo a 
rapid phase of die-back, termed acute axonal degeneration, which is distinct from the 
slower Wallerian degeneration observed within the distal axonal segment. Once the 
distal segment degenerates, its postsynaptic targets are also often disrupted and may 
die. Furthermore, pre-synaptic cells may also be affected due to target loss. Thus, a 
lesion at one site in the CNS can cause widespread disruption involving distant cells, 
according to the connections interrupted by the lesion. 
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1.4.1.1 Primary versus secondary axotomy 
TBI may cause axons to be torn immediately at the time of injury. However, studies 
in both animals and humans, involving mild, moderate and severe injuries, indicate 
that axotomy usually occurs via a delayed or secondary process (reviewed by 
Maxwell et al., 1997; Graham et al., 2000). In delayed axotomy, subtle disruptions 
at the time of injury are believed to result in several detrimental changes, including 
damage to the axolemma or axoplasm, and alterations in ionic homeostasis 
(particularly calcium ions) that ultimately culminate in axonal disconnection. 
Axonal disconnection typically occurs at least several hours following injury 
(Graham et al., 2000). Altered ionic concentrations, particularly in influx of calcium 
ions, are postulated to cause abnormal activation of various calcium-regulated 
enzymes, such as calpains, resulting in disruption of axonal cytoarchitecture 
(Maxwell et a., 1997; Graham et al., 2000). Interestingly, a variety of cytoskeletal 
proteins, including the microtubule-associated proteins, MAP-2 and tau, as well as 
neurofilaments can act as substrates for the calcium-dependant calpains (Zhang et al., 
2000). Disruption of calcium regulation and abnormal enzyme-activation may 
therefore initiate a cascade of events resulting in axonal collapse, impeded 
axoplasmic transport, axonal swelling (due to organelle accumulation) and ultimately 
axotomy (Adams, 1992; Gennarelli, 1996; Maxwell et al., 1997; Graham et al., 
2000). Alternatively, or additionally, direct disruption to the neuronal cytoskeleton, 
may result in impeded axonal transport, swelling and disconnection. Whether direct 
or enzyme-activated, disruption to the axonal cytoskeleton and axonal transport are 
viewed as fundamental factors contributing to axonal discontinuity (Maxwell et al., 
1997; Graham et al., 2000). 
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1.4.1.2 Cytoskeletal alterations 
Studies in animals and humans demonstrate that TBI often results in DAI via a 
process of delayed axotomy, the final manifestation of which is determined primarily 
by the severity of the initial injury, as discussed above. Importantly, disruption of 
axolemmal permeability at the time of injury may be a key factor in the post-injury 
response (Maxwell et al., 1997; Graham et al., 2000; Smith and Meaney, 2000). In 
this regard, brain trauma, without disruption of the axolemma tends to cause 
cytoskeletal misalignment, whereas more severe injury, in which axolemmal 
permeability is compromised, typically results in loss, accumulation or compaction 
of certain cytoskeletal components (Maxwell et al., 1997; Graham et al., 2000) 
(Figure 1.8). This suggests that alterations in the neuronal cytoskeleton may be 
central to the neuronal response to injury. Indeed, numerous studies (eg Hoffman et 
al., 1987, 1993; Goldstein et al., 1988; Hoffman and Cleveland, 1988; Muma et al, 
1990; Nixon and Shea, 1992) have shown that following axonal injury and during 
regenerative attempts neurofilament expression is down-regulated, whereas 
expression of other cytoskeletal elements is elevated, suggesting that ,the sequence of 
cytoskeletal gene expression occurring in development is recapitulated during 
regenerative attempts (Hoffman and Cleveland, 1988;' Lee and Cleveland, 1996). 
Interestingly, B-amyloid has been shown to accumulate within the brain following 
injury (Smith et al., 1999). B-amyloid is an integral transmembrane glycoprotein 
synthesized in the neuronal perikarya and transported into axons. It is proteolytically 
cleaved from the larger precursor molecule, B-amyloid precursor protein (APP). 
Immunohistochemical labelling for APP is now widely used to differentiate injured 
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Figure 1.8 Schematic overview of pathological events that are postulated 
to result from diffuse axonal injury of varying severities 
Essentially, mild and moderate head injuries may cause cytoskeletal disruption 
either directly or through aberrant enzyme activation. Cytoskeletal disruption 
impedes axonal transport and may ultimately result in axonal disconnection 
through a delayed, or secondary, process. Axons may undergo secondary 
axotomy in following severe head trauma, or may be axotomised at the time of 
injury. 
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from non-injured axons (Graham et al., 2000). Both APP and 13-amyloid accumulate 
within neurons following injury and are implicated in the pathology of Alzheimer's 
disease (Smith and Meaney, 2000; Vickers et al., 2000). In this respect, brain injury 
has been proposed as a risk factor for the development of Alzheimer's disease later 
in life (Vickers et al., 2000; Jellinger et al., 2001). 
1.4.1.2.1 Alterations in microtubules following axonal injury 
Microtubules and their associated motor proteins are fundamental to the process of 
fast axonal transport, forming an assemblage along which membrane-bound vesicles 
are continually conveyed to distal axonal regions. Although axons can completely 
recover from mild compression, more severe levels of compression \iiiay irreversibly 
block fast axonal transport due to mechanical breakage of the axoplasm (Gallant, 
1992). Several studies have shown a reduction in the levels of microtubules in areas 
of axonal disruption (Hoffman et al., 1984, 1985; Jafari et al., 1997, 1998; Maxwell 
and Graham, 1997; Adlard et al., 2000). This loss is most notable at the nodes of 
Ranvier (Maxwell and Graham, 1997) and may be accompanied by a loss of tau and 
dendritic MAP-2 in the damaged neurons (Saatman et al., 1998; Zhang et al., 2000). 
Alternatively Smith et al. (1999) observed accumulations of tau in axonal stumps 
following acceleration injury. It has been postulated that a post-traumatic calcium 
influx (particularly in severe axonal injury) contributes to the generation of an intra-
axonal environment favouring microtubule dissolution, which subsequently results in 
a focal disruption of fast axonal transport (Graham et al., 2000). In this respect, 
Maxwell et al. (1997) suggest that fast axonal transport continues in areas where 
microtubules remain intact, distant to the focal area of their loss. This may in turn 
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result in the accumulation of cytoskeletal and other cellular organelles at several sites 
along the damaged axons, thus contributing to multi-focal axonal swelling. 
1.4.1.2.2 Alterations in neurofilaments following axonal injury 
The neurofilament intermediate filament cytoskeleton is an important structural 
component of the neuron. Neurofilaments provide tensile strength as well as 
stabilising neuronal structure (Hamberger et al., 2003). Neurofilament disruption, 
therefore, has profound effects on neuronal structure and function (Posmantur et al., 
2000). Neurofilaments provide neurons with mechanical strength by resisting the 
compressive forces of the local environment (Hoffman et al, 1984; Cleveland et al., 
1991). Additionally, neurofilament density is relatively constant over a wide range 
of axonal calibres (Julien and Grosveld, 1991); thus larger axons will tend to contain 
a greater number of neurofilaments than smaller axons. It is therefore plausible that 
different sized axons respond in different ways when damaged, particularly when 
inflicted with tensile strain (Maxwell et al., 1997). Indeed, Reeves et al. (2005) have 
recently demonstrated that axon calibre, and associated myelinationl influence axonal 
recovery following injury. 
Neurofilaments are present in all major compartments of the neuron except the axon 
terminals, where calcium-activated proteases, such as calpains are thought to be 
responsible for their breakdown (Schlaepfer, 1987). Neurofilament degradation by 
calpains possibly provides feedback information to the perikarya, signalling normal 
synaptic function (King et al., 2000a). In the perikarya and dendrites, 
serine/threonine phosphatases may maintain neurofilaments in a predominantly 
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dephosphorylated form, while in the axon protein kinases extensively phosphorylate 
these filamentous structures (Maxwell et al., 1997). Following injury neurofilament 
phosphorylation and distribution is altered. Abnormally phosphorylated 
neurofilaments tend to accumulate in the perikarya, while neurofilaments within the 
axons may become dephosphorylated. Neurofilament phosphorylation in the soma is 
believed to impede neurofilament transport into the axon, subsequently contributing 
to decreased axon calibre following axonal damage (Schlaepfer, 1987). Using a 
rotational acceleration injury in the rabbit, which generated a force equivalent to that 
occurring in human head trauma, Hamberger et al. (2003) demonstrated alterations in 
the distribution of the high molecular weight subunit of the neurofilament triplet 
protein, NF-H, where phosphorylated NF-H accumulated in the neuronal perikarya 
and was lost from axons in several brain regions. 
In the post-traumatic period, neurofilaments can be observed in distended axonal 
regions as well as infiltrating axon terminals, possibly indicating a disruption in 
calpain mediated neurofilament breakdown (King et al., 2000a). Additionally, in 
vitro (Dickson et al, 2000) and in vivo (King et al., 2000b, 2001) studies have 
demonstrated extensive accumulations of neurofilaments into ring- and bulb-like 
structures in severed axonal stumps. Both structures lacked microtubules and 
appeared to contain a dense core of organelles (including mitochondria), surrounded 
by either a whorl (in ring-like structures) or dense ball (in bulb-like structures) of 
neurofilaments. Interestingly, these damaged axons exhibit similar morphological 
changes to a subtype of dystrophic neurites in Alzheimer's disease (King et al., 
2000b). Nixon (1998), noted that despite access to an expended axoplasmic space in 
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the acute swellings that develop at the transected axonal tips, neurofilaments remain 
bundled. Additionally, neurofilaments can persist in both proximal and distal axonal 
stumps for long periods. Hall and Lee (1995) suggest this may be due to a steric 
protection offered by the remaining filamentous structure. 
Numerous investigations have demonstrated neurofilament compaction within the 
axon shaft following axonal injury. Studies by Jafari et al. (1997, 1998) and 
Povlishock et al. (1997) suggest that neurofilament compaction is associated with 
disruption of the axolemma, which may or may not manifest, depending of the 
severity of injury. In this regard, in injuries where axolemma permeability is not 
disrupted, focal neurofilament disarray and misalignment occurs, but at more severe 
levels of axonal injury, neurofilament compaction occurs (Maxwell et al., 1997). 
However, Chung et al. (2005) have demonstrated that neurofilament compaction may 
also occur following relatively mild axonal stretch injury. Neurofilament 
compaction occurs within minutes of injury and may persist for hours (Maxwell et 
al., 1997). Although the mechanisms leading to neurofilament compaction remain to 
be elucidated, compaction is thought to be the result of loss and/or collapse of 
neurofilament side-arms, with concomitant preservation of filamentous structure. 
Accumulating literature provides evidence for both scenarios (reviewed by Maxwell 
et al., 1997). 
Altered interaction between protein lcinases and phosphatases may occur following 
axonal injury, causing neurofilament sidearm collapse. Alternatively, post-traumatic 
disruption of calcium homeostasis may abnormally activate proteolytic calpains, 
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which cleave the neurofilament side-arms from the core filamentous structure. Both 
processes could theoretically lead to a reduction in intra-filament spacing and 
therefore neurofilament compaction. Some studies have shown a reduction in the 
levels of neurofilaments occurring in areas of axonal disruption (Hoffman et al., 
1984, 1985; Maxwell and Graham, 1997) and Zhang et al. (2000) demonstrated the 
loss of phosphorylated neurofilaments is delayed when compared to the reactive 
changes occurring in other cytoskeletal components. 
1.4.2 Cell body reaction 
Because axonal transport occurs in both the anterograde and retrograde direction 
following axonal disconnection, signals from the disconnected distal axonal segment 
are no longer sent to the soma. This lack of input may in turn evoke alterations in 
the soma. Changes in the soma may culminate in cell atrophy, death or survival 
(Kelly, 1981; Tuszynski and Gage, 1995; Singleton et al., 2002; Selzer, 2003). Often 
the damaged neuron survives. In this instance, the soma and remaining portion of 
the injured axon undergo reactive changes involving the specific regulation of 
proteins, particularly cytoskeletal components, in preparation for an attempt at 
sprouting or regeneration (King et al., 2000a). This process is referred to as the "cell 
body" or "retrograde" reaction and is characterised by perikaryal hypertrophy, 
displacement of the nucleus to the cell periphery and dispersion of the Nissl 
substance (Torvik, 1976). 
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1.5 Regeneration and repair following brain injury 
Accumulating evidence indicates that brain injury evokes an adaptive sequence of 
alterations directed at healing and remodelling, much like the wound healing reaction 
observed in other tissues such as the skin (Maxwell et al., 1990; Hunt et al., 2000; 
King et al., 2001; Yamaguchi and Yoshikawa, 2001; Oehmichen, 2004). In this 
regard, many of the cell populations disrupted by the lesion or affected by secondary 
events and signalling cascades are the same cellular populations that are involved in 
brain healing. Thus, astrocytes, microglia/macrophages, oligodendrocytes, neurons, 
neural progenitor cells and brain vasculature have all been shown to undergo 
adaptive alterations in the aftermath of a physical injury (Maxwell et al., 1990; 
Christman et al., 1997; DeIler and Frotscher, 1997; Fujita et al., 1998; Pastor et al., 
2000; Vickers et al., 2000; King et al., 2001; Kozorovitskiy and Gould, 2003; Finnie 
and Blumbergs, 2002; Tonchev et al., 2003; Chen et al., 2003a; Lee et al., 2003; 
Brazel and Rao, 2004; Lie et al., 2004; Davalos et al., 2005; Emsley et al., 2005). 
Astrocytes undergo a process of reactive astrogliosis involving proliferation, 
hypertrophy and the secretion of various factors that culminate in the formation of a 
glial scar (Maxwell et al., 1990; Ridet et al., 1997; Raivich et al., 1999; Kernie et al., 
2001; McGraw et al., 2001; Chirumamilla et al.,.2002; Chen et al., 2003a, b). This 
structure effectively segregates the injured from non-injured tissue to prevent the 
spread of cytotoxicity. Brain-resident microglia are also activated to transform into 
phagocytosing macrophages and along with macrophages derived from the 
circulatory system act to clear cell debris from the lesion site (Thomas, 1992; Lotan 
and Schwartz, 1994; Bruce-Keller, 1999; Stence et al., 2001; Carbonell et al., 2005; 
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Davalos et al., 2005). More long-term alterations include tissue re-modelling, which 
may involve maturation of the glial scar, angiogenesis (or vascular growth) and 
attempted neuronal regeneration (Maxwell et al., 1990; King et al., 2001). Damaged 
axons in most regions of the mature CNS do not spontaneously regenerate and 
instead tend to undergo an abortive regenerative response restricted to the local 
neuropil (Cotman et al., 1994; Kapfhammer, 1997; Rhodes and Fawcett, 2004). 
1.5.1 Inhibitors of regeneration in the adult CNS 
The incapacity for axonal regeneration in the adult CNS has been ascribed to a range 
of factors including an intrinsic incapacity of CNS neurons to re-initiate growth, 
myelin and myelin-associated factors, the development of glial scars, cavitation of 
the injured tissue, a lack of growth factors or support cells and the presence of 
growth inhibitors (Fawcett, 1992, 1997; Berry et al., 1994; Caroni, 1998; Fawcett 
and Asher, 1999; Bandtlow and Schwab, 2000; Goldberg and Barres, 2000; Qiu et 
al., 2000). Thus, axonal regeneration is limited by the ability of neurons to extend 
new processes in a non-permissive environment (Compston, 1995). Berry et al. 
(1994) postulate that during normal development some of these mechanisms may act 
to confine growing axons to their appropriate pathways, thus limiting overgrowth 
and preventing the mixing of functionally different fibre systems. For example, CNS 
myelination is associated with cessation of axon growth (Nagashima et al., 1999) and 
loss of neuronal plasticity (Goldberg and Barres, 2000). Myelination may, therefore, 
provide growth inhibitory signals as the nervous system nears maturity. 
Myelination alone does not appear sufficient to prevent regeneration, as studies 
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conducted by Nagashima et al. (1999) have demonstrated that although central white 
matter substantially inhibits neuronal regeneration, both myelin-rich CNS white 
matter and relatively myelin-free CNS grey matter have this capability. 
Additionally, Davies et al. (1997) found that regenerating mature axons were able to 
extend for considerable distances in un-injured CNS white matter tracts. Thus, it is 
likely that injured, rather than un-injured, CNS tissue contains components which are 
inhibitory to axonal re-growth (Rhodes and Fawcett, 2004). In this respect, 
formation of the glial scar, including incorporation of inhibitory extracellular matrix 
molecules, is also a major molecular and physical barrier to axons regeneration 
(Fawcett and Asher, 1999; Rhodes and Fawcett, 2004). 
1.5.2 Mechanisms of endogenous neuronal regeneration 
Neurons respond to injury with a complex sequence of morphological, biochemical 
and gene expression alterations, some of which may be directed towards sprouting, 
regeneration, synaptogenesis and even the generation of entirely new neurons (Deller 
and Frotscher, 1997; Christman et al., 1997; King et al., 2000a; Magavi et al., 2000; 
Pastor et al., 2000; Kernie et al., 2001; Rice et al., 2003). In this regard, axonal 
sprouting and neurogenesis are the two major mechanisms by which lost neuronal 
connections and degenerated neurons can be replaced. 
1.5.2.1 Axonal sprouting 
Axons in the CNS often respond actively, rather than passively, to injury and may 
undergo a distinctive sprouting response or regenerative attempt. Importantly, 
axonal regeneration and axonal sprouting are two distinct responses to axotomy, 
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which may occur at the proximal stump of surviving injured axons. Regeneration 
implies successful restoration of the specific contacts between an axotomised neuron 
and its target, whereas sprouting describes the abortive response of the proximal 
stump to regenerate, leading to multiple local axonal collaterals without the 
restoration of normal connectivity (Berry et al., 1994; DeIler and Frotscher, 1997). 
Collateral sprouting from uninjured axons may also occur following axonal injury 
(Deller and Frotscher, 1997), possibly due to availability of vacant synaptic territory 
(McKinney et al., 1997). Thus, injury in the CNS may induce a dramatic 
reorganisation of surviving circuitry manifesting as axonal sprouting. 
Although the PNS is capable of regeneration over relatively long distances, 
regeneration in the CNS is comparably very limited, however, can be promoted in a 
facilitative environment. Differences in the glial cells that perform myelination 
appear to be pivotal in unravelling the disparity between the regenerative capacities 
of the CNS and PNS (Watkins and Barres, 2002). Axons of the CNS are firmly 
enclosed in myelin membranes produced by oligodendrocytes, whereas Schwann 
cells perform myelination in the PNS. Myelin within the PNS is rapidly removed 
following axonal injury. Conversely, this process takes considerably longer in the 
CNS, indicating that certain components of CNS myelin are likely to inhibit 
regeneration (Watkins and Barres, 2002). Additionally, in the PNS, myelin sheaths 
may not be disrupted, or myelinating cells may form new myelin conduits to guide 
and nurture regenerating axons (Kelly, 1981). 
The level of severity of TBI plays an important role in the manifestation DAI (Figure 
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1.8). It has been postulated that if TBI occurs in the absence of parenchymal change 
(as it often does in less severe trauma), axons are well equipped to mount a 
regenerative attempt (Christman et al., 1997). Following injury, cytoskeletal 
responses in the axon and perikarya appear to be directed towards axonal 
regeneration and synaptogenesis. A key event in axonal survival and the potential 
for regeneration is a substantial reorganisation of the cytoskeleton (Christman et al., 
1997). Neurofilaments may play a crucial role in determining whether and how 
central neurons regenerate following axon transection (Hall and Yao, 2000) as 
indicated by the disrupted regeneration exhibited by neurofilament-deficient mice 
(Zhu et al., 1997) and quail (Jiang et al., 1996) following peripheral nerve injury. 
It has be demonstrated, both in vitro (Dickson et al., 2000) and in vivo (Christman et 
al., 1997; King et al., 2001), that axons can mount a regenerative attempt, which is 
associated with cytoskeletal reorganisation and accompanied by an up-regulation of 
GAP-43. GAP-43, a neuron specific growth and membrane-associated 
phosphoprotein, is one of the most abundant proteins in neuronal growth cones, 
where it is implicated in filopodial motility, axon guidance, synaptogenesis and 
synaptic plasticity (Brandt, 1998). It is therefore not surprising that its expression is 
down-regulated in the mature CNS, but elevated during neuronal development and 
regeneration (Goslin et al., 1988; Cantallops and Routtenberg, 1999). 
1.5.2.2 Neurogenesis 
The long held belief that adult neurons are post-mitotic, terminally differentiated and 
held in a rather static state, lacking the capacity to re-enter the cell cycle or 
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regenerate following injury is being increasingly challenged. Although mature 
neurons within the brain are generally regarded as post-mitotic, accumulating data 
indicate that various forms of brain lesion are capable of evoking a neurogenic 
response at sites both directly and indirectly associated with the lesion (Magavi et al., 
2000; Kernie et al., 2001; Rice et al., 2003). In this regard, new neurons may be 
generated from parenchymal-resident progenitor cells or from stem or progenitor 
cells located within germinal regions of the adult brain, such as the SVZ (Emsley et 
al., 2005). Additionally, some studies have also indicated that migrating neuroblasts, 
produced throughout life and largely destined for the olfactory bulb, may be 
recruited to sites of brain injury (Ramaswamy et al., 2005). 
During brain development and exit from the cell cycle extracellular signals may 
initiate a genetic program that results in the commitment of a progenitor cell to a 
particular differentiated state (Brewer, 1999). One of the triggers for neurogenesis in 
the adult brain may be injury-induced neuronal death. Indeed, Magavi et al. (2000) 
demonstrated that targeted apoptosis in the neocortical grey matter resulted in the 
neuronal differentiation of parenchymal-resident neural progenitor cells. 
Additionally, several studies have demonstrated the existence of neuronal stem cell 
populations in the adult CNS that can give rise to new neurons when the brain is not 
compromised (Kuhn et al., 1996; Eriksson et al., 1998; Gould et al., 1999; Johansson 
et al., 1999; Cameron and McKay, 2001; Bernier et al., 2002, Bedard and Parent, 
2004) as well as in response to various lesion paradigms (Magavi et al., 2000; Kernie 
et al., 2001; Braun et al., 2002; Chen et al., 2003b; Rice et al., 2003; Tonchev et al., 
2003). 
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1.5.3 Therapeutic interventions following TBI 
There are currently no treatments available to effectively counteract the sequence of 
neurodegenerative changes following TBI. Brain trauma and subsequent axonal 
injury may lead to degeneration and death of affected neurons or an attempt at 
regeneration by the damaged neurons. Regenerative attempts manifest as extensive 
axonal sprouting (Christman et al., 1997; Dickson et al., 2000; King et al., 2001) or 
the generation of new neurons (Picard-Riera et al., 2004). Additionally, although 
early studies suggested that DAI resulted from axonal tearing at the time of injury, 
later investigations have emphasised that this form of direct axonal injury is usually 
only present following severe brain trauma (reviewed by Maxwell et al., 1997). It is 
now recognised that axonal damage frequently results from delayed axotomy, that is 
axonal disruption occurring several hours following an injury, which is triggered by 
subtle disruptions at the time of injury (for reviews see Povlishock and Christman, 
1995; Povlishock and Jenkins, 1995; Maxwell et al., 1997; King et al., 2000a; 
Vickers et al., 2000). 
Delayed neurodegenerative events indicate that a therapeutic window exists in which 
brain damage and its progression can be slowed, halted or even reversed (Adams, 
1992; Smith and Meaney, 2000; Finnie and Blumbergs, 2002), improving long-term 
prognosis. Several therapies have been show to decrease neuronal damaged and 
degeneration following brain injury. For example hypothermia (13iiki et al., 1999; 
Povlishock et al., 1999, Liou et al., 2003; Strauch et al., 2005) and Cyclosporin A 
(CsA) infusion (Sullivan et al., 1999, 2000; Okonkwo et al., 1999a, b, 2003; Strauch 
et al., 2005) demonstrate neuroprotective effects when administered in the post- 
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injury period. Hypothermia is a global neuroprotective approach, which might 
provide antiexcitotoxic, and antioxidant effects, reduce metabolic demands, prevent 
intracranial hypertension and reduce the activity of destructive enzymes (Liou, 
2003). CsA, an immunosuppressive drug, limits the inflammatory response, which 
may have detrimental effects in exacerbating neural injury and is thought to inhibit 
opening of the mitochondrial permeability transition pore and related abnormalities, 
such as disrupted calcium homeostasis and release of apoptosis-related components 
(Biiki et al., 1999; Sullivan et al., 1999, 2000, 2005; Orrenius et al., 2003). 
Disrupted calcium homeostasis has been implicated in many aspects of the axonal 
response to injury. Povlishock et al. (1999) have shown that calcium chelators may 
have a protective effect following brain trauma in axons where axolemmal 
permeability is disrupted. Additionally, neuroexcitotoxicity has been postulated to 
result from excessive glutamate release following neuronal trauma. In this respect, 
competitive and non-competitive antagonists of the glutamate receptor, N-methyl-D-
aspartate (NMDA), have been shown to have therapeutic effects (Graham et al., 
2000). 
1.5.4 Promoting neuronal regeneration following TM 
Numerous experimental approaches are currently being tested for their ability to 
promote CNS axonal regeneration (Selzer et al., 2003). For example, implantation of 
growth-promoting cells, such as olfactory ensheathing cells or peripheral nerve 
Schwann cells (Stichel et al., 1999) may act as a bridge and facilitate invasion of the 
lesion area by newly generated axonal sprouts. Additionally, immature neurons can 
be used to replace damaged cells and microglial cells used to remove cellular debris 
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(Frisen et al., 1998; Pincus et al., 1998; Kruger and Morrison, 2002; Lie et al., 2004; 
Mitchell et al., 2004; Schouten et al., 2004; Kulbatski et al., 2005; Taupin, 2005). 
Blocking myelin and other associated regeneration inhibitors, for example using 
antibodies or competitive antagonist peptides for certain receptors, as well as 
administering neurotrophic substances or counteracting the glial scar may all be 
mechanisms by which CNS regeneration can be facilitated (Bregman et al., 1995; 
Keirstead et al., 1998; Vanek et al., 1998; Watkins and Barres, 2002). A rapidly 
developing area of neuroregeneration research also involves the transplantation of 
various stem or progenitor cells, which may be induced to differentiate into neurons 
and glial cells to replace those degenerated by injury. Moreover, stem cells may be 
genetically engineered to produce factors that facilitate neuronal regeneration (for 
recent reviews see CaIza et al., 2004; Mitchell et al., 2004; Picard-Riera et al., 2004; 
Schouten et al., 2004; Pluchino et al., 2005). 
Using in vitro and in vivo models, Fournier et al. (2003) demonstrated that inhibiting 
various steps in the Rho signalling pathway (which is pivotal in regulating the actin 
dynamics) resulted in enhanced neurite outgrowth on inhibitory substrates reduced 
glial scar formation following lesion as well as promoting axonal regeneration and 
functional recovery. Watkins and Barres (2002) review recent work indicating that 
blockade of NgR, a common receptor for the three different myelin proteins, Nogo, 
myelin-associated glycoprotein (MAG) and oligodendrocyte-myelin glycoprotein 
(0Mgp) enhances CNS repair and functional recovery following injury. Indeed, 
GrandPre et al. (2002) have developed a competitive antagonist peptide, NEP1-40, 
which blocks Nogo-66 (one of the two domains of Nogo-A, an isoform of Nogo) and 
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has the capacity to enhance axonal regrowth, with limited functional recovery 
following spinal cord injury in rats.* 
The extent of functional recovery following injury to the adult CNS remains 
controversial. However, it is now becoming apparent that certain populations of 
mature CNS neurons have a remarkable capacity to regenerate if the appropriate 
growth environment is provided (reviewed by Fawcett and Geller, 1998; 
McKerracher, 2001), indicating that mature central neurons do retain an intrinsic 
capacity for axonal regeneration and the lack of regeneration may be more attributed 
to inhibitory factors in the CNS environment. Several studies have established that 
the hippocampus is particularly plastic and able to restore function by adaptive 
regenerative changes following injury including both axonal sprouting and 
neurogenesis (for example DeIler and Frotscher, 1997; Cameron and McKay, 2001; 
Jin et al., 2001; Braun et al., 2002). However, functional regeneration in the 
neocortex is a more disputed topic and few studies have specifically addressed the 
role of neurogenesis and sprouting in contributing to brain healing following focal 
structural cortical injury. 
1.5.5 Implications of aberrant neuronal regeneration 
Although research efforts are now directed at replacing lost neurons and promoting 
axonal growth in the inhibitory environment of the CNS following injury, 
experimental endeavours should be treated with a certain degree of caution if they 
are to be translated to the clinical setting. For emerging along side the considerable 
advances that have led to the discovery and production of potential therapeutic 
* Nogo and the Nogo receptor, NgR, are postulated as primary myelin-associated inhibitors. Accordingly, a , 54 
significant increase in regenerative axonal sprouting occurs following treatment with agents that neutralise these ) 
! components. Interestingly, however, gene knockouts of both Nogo and NgR confer relatively limited protection to 
! myelin-associate axonal growth inhibition. These findings indicate that the effects of Nogo-NgR neutralising ! 
! agents may go beyond the inhibition of these myelin components and/or that Nogo-NgR are not as pivotal in ! 
axonal regeneration as previously thought (reviewed by Hsuan and Tang, J. Neurochemistry, 2005,94,865-847). _ 	. 
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agents for CNS trauma have been hints that promoting neurogenesis, neuritogenesis 
or synaptogenesis in an unregulated manner may generate adverse effects. Indeed, 
McKinney et al. (1997) have demonstrated that many of the new connections that 
form when damaged axons sprout and re-synapse with targets are hyperexcitable. 
Additionally, post-lesion sprouting and neurogenesis has also been implicated in the 
generation of abnormal circuitry in other brain lesion paradigms (Jacobs et al., 2000; 
Parent, 2002; Parent and Lowenstein, 2002). These findings indicate that aberrant 
sprouting and/or abnormal integration of newly born neurons in existing neural 
circuits may be implicated in the delayed development of post-traumatic epilepsy. 
Post-traumatic epilepsy is a common consequence of traumatic head injury 
(Willmore, 1995; Jacobs et al., 2000; Santhakumar et al., 2001). The onset of 
epileptic seizures typically occurs 1 to 3 years after head injury and the likelihood of 
seizure evolution is correlated with the severity of the initial injury (Willmore, 1995). 
McKinney et al. (1997) postulate that the delay occurring between brain injury and 
the onset of post-traumatic epilepsy may be attributed to the time required for the 
elaboration of new axonal processes and formation of new synaptic connections. 
Importantly, the gradual, albeit partial, recovery of function often observed following 
human brain injury may also be attributable to processes involving injury-induced 
neurogenesis, axonal sprouting, synaptogenesis and general brain plasticity. Clearly 
any intervention that prevents post-traumatic neurodegeneration, inappropriate 
axonal sprouting or maladaptive neurogenesis and enhances adaptive neural 
responses has the potential to substantially improve the prognosis of TB!. A great 
deal of emphasis is therefore being placed upon developing strategies to promote 
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neural repair following injury. However, many of the basic mechanisms underlying 
endogenous repair mechanism are not fully understood and need to be discovered to 
prevent aberrant outcomes. 
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Aims 
Despite an accumulating literature regarding the capacity for neural remodelling and 
regeneration following structural brain injury many aspects of this response remain 
elusive. This thesis will, therefore, seek to explore the reactive and regenerative 
alterations associated with the neural response to physical injury in the adult 
mammalian brain in an acute model of structural injury to the rodent neocortex. 
Additionally, the intrinsic regenerative potential of individual mature brain neurons, 
free of their normal glial matrix, will be assessed in an in vitro model of axonal 
injury. To meet these goals a variety of procedures will be utilised, including 
immunohistochemical, molecular and imaging techniques, to examine the 
morphological, cellular and molecular events that characterise the neural response to 
injury. Specific emphasis will be placed upon investigating the potential for 
induction of frank neuronal replacement following injury, alterations within the 
damaged neurons themselves which may be indicative of an intrinsic capacity for 
regeneration, and the role of the neuronal cytoskeleton in neuronal regenerative 
events, as the mechanisms underlying these processes are currently poorly 
understood. 
Specific aim 1 
To determine the contribution proliferating and progenitor cells make towards 
brain healing following acute focal brain injury and whether these cells undergo 
neuronal differentiation which contributes to neuronal replacement within 
injured brain tissue 
57 
Chapter 1 
Recent data suggest that injury-induced proliferating and progenitor cells may 
participate in brain healing and cell replacement in a wide range of experimental 
brain lesion models. However, the potential for neurogenesis in typically non-
neurogenic brain regions, such as the neocortex, and in response to acute structural 
brain injuries has not yet been fully established. Therefore, to address this aim, a 
rodent model of structural injury specific to the neocortical grey matter of the 
somatosensory cortex was utilised. The cellular response to acute neocortical injury 
was investigated utilising a battery of antibodies for proliferating, progenitor, 
immature and mature neural cell types and alterations in nestin, a marker of putative 
neural progenitor cells, was extensively investigated using immunohistochemical and 
quantitative real time RT-PCR. These studies aimed to determine the ultimate fate of 
injury-induced proliferating and progenitor cells and the potential for these cells to 
contribute towards neuronal replacement in the injured adult neocortex. 
Specific aim 2 
To investigate the reactive and regenerative changes that characterise the 
neural response to physical injury and explore the co-ordinated alterations, in 
both neuronal and glial cell populations, in contributing to this response 
The extent to which the adult brain undergoes recovery following injury remains 
controversial. Indications of brain healing have been demonstrated following 
various brain lesions, however, the extent of neuro-glial regeneration remains 
questionable. Utilising the in vivo model of structural brain injury from Aim 1, the 
response of various populations of neural cells, including neurons, astrocytes, 
microglia and macrophages as well as alterations in brain vasculature and CNS 
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myelin, were analysed with immunohistochemical techniques. 	Additionally, 
quantitative one-step real-time RT-PCR was utilised to examine alterations in gene 
expression of specific neuronal cytoskeletal- and growth-associated proteins, to 
determine whether neuronal alterations evoked by injury at the cellular level are 
reflected by complementary changes in gene expression. One specific sub-aim of 
this study was to assess injury-induced alterations in a-internexin, which, along with 
the neurofilament triplet proteins, is a member of the neuronal intermediate filament 
family of proteins. Although the neurofilament triplet proteins have been widely 
cited as being disrupted and undergoing abnormal accumulation in response to brain 
injury in the adult, a-internexin is largely viewed as a developmentally important 
protein and few data exist demonstrating the role of a-internexin in injury and 
neuronal regeneration. 
Specific aim 3 
To determine the cytoskeletal mechanisms utilised by axotomised CNS neurons 
during regenerative events and how these changes compare to initial neurite 
development 
The axonal cytoskeleton plays a crucial role in initial neurite outgrowth and 
elongation and has been proposed to be important in axonal sprouting and/or 
regeneration. This aim examines the cytoskeletal alterations, specifically the reactive 
and regenerative changes that characterise the axonal response to physical injury. To 
meet this aim a novel in vitro model of axonal injury was utilised, whereby 
neocortical neurons from rat embryos were grown in culture to relative maturity. 
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The growth conditions of this system promoted neuronal aggregation and axonal 
fasciculation. Axonal bundles were then transected, under microscope guidance. 
The response of normally reacting and cytoskeletally perturbed axons was analysed 
using multi-labelling immunohistochemistry, live cell imaging and transmission and 
scanning electron microscopy. Specifically, all major components of the axonal 
cytoskeleton were examined including the neuronal intermediate filament proteins a-
internexin, NF-L, NF-M and NF-H, microtubules (and their associated proteins) and 
microfilaments. Cytoskeletal perturbations were performed by the addition of 
cytoskeletal stabilising and destabilising agents, including latrunculin A, taxol and 
nocodazole. 
In summary this study explores, characterises and clarifies the reactive and 
regenerative events that constitute the consequences of physical injury to mature 
CNS neurons. These studies are imperative in understanding the regenerative 
potential of nerve cells in the adult mammalian brain and provide insight into aspects 
of the post-injury neural response that may be targeted through therapeutic 
intervention to facilitate adaptive alterations in the neural response to physical injury. 
Results from this investigation will enhance current knowledge regarding the basic 
mechanisms underlying neuronal and axonal regeneration and have clinical 
implications regarding appropriate targets for therapeutic intervention during 
neuronal degenerative and regenerative events. 
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Experimental procedures 
All experimental procedures were based on investigating the specific cellular and 
molecular alterations evoked following structural neuronal or brain injury using 
either an in vivo or in vitro model of physical injury, as detailed below. 
2.1 Experimental procedures relating to in vivo structural brain 
injury 
2.1.1 General animal conditions and care 
All experimental procedures involving animals were approved by the Animal Ethics 
Committee for Animal Experimentation of the University of Tasmania and are in 
accordance with the Australian code of practice for the care and use of animals for 
scientific purposes. Animals were obtained from the Central Animal House 
(University of Tasmania). For all procedures, adult male Hooded Wistar rats (250- 
270g corresponding to approximately 7.5 weeks old) were utilised. Animals were 
housed in standard conditions (20°C, 12/12 hours light/dark cycle), with access to 
food and water ad libitum. Animals were monitored daily for signs of illness and 
stress. Water, food and bedding were replenished twice weekly. 
2.1.2 In vivo structural brain injury 
Focal injures to the rodent neocortex were performed as previously described (King 
et al., 2001). 	Briefly, following intraperitoneal administration of anaesthetic 
(pentobarbitone sodium, 72mg/kg, Abbot Laboratories, Paramatta, NSW, Australia) 
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and analgesic (Carprogen, 4mg/kg, Pfizer), animals were immobilised in a Stoelting 
stereotaxic frame. After retracting the scalp, a burr hole was drilled into the skull, 
5mm anterior and 4.5mm lateral to lambda and a focal injury was made in the 
somatosensory cortex (Pan l region) by lowering a 25 gauge Hamilton needle to a 
depth of 1.5mm into the grey matter (Figure 2.1). The needle was left in place for 
ten minutes prior to removal and suturing of the wound. Animals were terminally 
anaesthetised (pentabarbitone sodium, 140mg/kg) at a range of post-injury time 
intervals up to 84 days following injury (n = 3-4 per time point). Using gravity feed, 
blood was cleared by transcardial perfusion of 0.01M phosphate buffered saline 
(PBS) for two minutes. Brains were processed for either immunohistochemistry or 
quantitative real time RT-PCR. For RNA extraction and real time RT-PCR, the 
brain was removed from the skull and processed as described in Section 2.1.5. For 
immunohistochemical analysis, blood was cleared by gravity feed with 0.01M PBS. 
Additionally, the tissue was fixed by gravity feed perfusion with 4% 
paraformaldehyde (PFA)/0.01M PBS for five minutes. 
2.1.3 BrdU preparation and animal injection 
To examine populations of proliferating cells animals were administered with the 
thymidine analogue, 5-Bromo-2'-deoxyuridine (BrdU, Sigma, St Louis, MO) by 
intraperitoneal injection. A 12.5mg/m1 solution of BrdU was prepared in 7mM 
Na0H/0.9% NaC1, and filter sterilised. Animals were injected with BrdU twice 
daily (25mg/kg/day) between 1 and 6 days post-injury and were transcardially 
perfused (4% PFA/0.01M PBS) at 7, 21 or 42 days post-injury. Prior to 
immunohistochemistry, antigen retrieval was performed by incubating tissue sections 
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Figure 2.1. Diagrammatic representation of in vivo focal 
neocortical structural injury model. A, top view; B, coronal section 
OB, olfactory bulb; Ce, cerebellum; Br, brain stem; CC, corpus callosum; LV, 
lateral ventricle; St, striatum 
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in 2M HCI for one hour at 37°C, followed by three neutralisation washes in 0.1M 
borate buffer (pH 8.5). Immunohistochemistry was performed as described Section 
2.1.4, utilising an antibody directed against BrdU (BD Biosciences, Table 2.1). 
2.1.4 Immunohistochemistry and staining of rat brain tissue sections 
Prior to immunohistochemistry, brains were post-fixed in 4% PFA/0.01M PBS for 
24 hours and subsequently cryoprotected in solutions of 18% and 30% sucrose. 
Coronal brain sections were cut at 40Rm on a freezing microtome to include the 
entire injury site or equivalent region in control brains. Tissue sections were 
incubated simultaneously in combinations of primary antibodies (Table 2.1) for two 
hours at room temperature followed by overnight incubation at 4°C. Mouse, rabbit 
and guinea pig primary antibodies were visualised with Alexa Fluor goat anti-mouse, 
goat anti-rabbit or goat anti-guinea pig secondary antibodies as appropriate 
(Molecular Probes, dilution 1:1000), however BrdU and PCNA - were visualised with 
anti-mouse rat-adsorbed Fluorescein secondary antibody (dilution 1:500, Vector 
Laboratories, Burlingame, CA, USA). Additionally, to examine microglial and 
perivascular cells following injury, brain sections were incubated in the presence of 
Isolectin IB4 , Alexa Fluor 594 conjugate (Molecular Probes, 1:100). All primary and 
secondary antibodies as well as Isolectin IB 4 were diluted in 0.3% Triton X-100 in 
0.01M PBS. Controls, omitting the primary antibody were processed concurrently to 
ensure they lacked immunoreactivity for the cellular components under investigation. 
{* Proliferating cell nuclear antigen (PCNA) is an endogenous cell replication marker, essential for DNA synthesis. ,63  
In fixed tissue, PCNA antibodies will label cells in various phases of the cell cycle, that were proliferating..at the I 
, time of tissue fixation. Conversely, BrdU is an artificial thymidine analogue that, when administered to an 
, anima/cell will incorporate into DNA during S-phase of the cell cycle and is thus useful for retrospectively 
' tracking cell proliferation. Utilised in combination, PCNA and BrdU allow the dynamics of cell proliferation and 
cell fate to be determined and provide a more complete picture of cell proliferation that either marker used alone. 
Table 2.1. Primary antibodies utilised in immunofluorescent cell labelling 
Antibody Type Immunoreactivity Dilution Supplier 
Anti-NF-L R 68kD neurofilament triplet 
light/low molecular weight subunit 
1:1000 Novus 
Biologicals 
Anti-NF-M R 150kD neurofilament triplet 
medium molecular weight subunit 
1:2000 Serotec 
Anti-NF-H R 200kD neurofilament triplet 
heavy/high molecular weight 
subunit 
1:2000 Serotec 
Anti-parvalbumin R Interneuron calcium-binding 
protein 
1:2000 Swant 
Anti-calretinin R Interneuron calcium-binding 
protein 
1:2000 Chemicon 
International 
Anti-ferritin R Microglial iron-binding protein 1:2000 Dako 
Anti-GFAP R Glial fibrillary acidic protein 1:2000 Dako 
Anti-tau R Phosphorylation independent tau 1:5000 Dako 
Anti-NSE R Neuron-specific enolase 1:500 Dako 
Anti-a-internexin R Class IV intermediate filament 
subunit, distinct from 
neurofi lament triplet 
1:2000 Novus 
Biologicals 
Anti-a-internexin M Class IV intermediate filament 
subunit, distinct from 
neurofilament triplet 
1:1000 Chemicon 
Anti-synaptophysin M Presynaptic vesicles 1:100 Boehringer 
Mannheim 
Anti-GAP43 M Growth-associated protein 43 1:1000 Sigma 
Anti -nestin M Intermediate filament protein 
specific for neural progenitor cells 
1:1000 BD 
Biosciences 
Anti-NeuN M Post-mitotic neuronal nuclei 1:100 Chemicon 
International 
M Neuron specific 13-tubulin subunit 1:5000 Promega 
Anti-MAP2 M Microtubule associated protein 2 1:1000 Chemicon 
International 
Anti-PCNA M Proliferating cell nuclear antigen 1:500 Zymed 
Anti-BrdU M Bromodeoxyuridine, thymidine 
analogue 
1:500 BD 
Biosciences 
Anti-BrdU M Bromodeoxyuridine 1:1000 Sigma 
Anti-myelin/ 
oligodendrocyte 
specific protein 
M Oligodendrocytes and CNS myelin 1:500 Chemicon 
Anti -SMI312 MC Phosphorylated neurofilaments 1:5000 Sternberger 
Anti -Doublecorti n GP Microtubule associated protein 
specific for migrating neuroblasts 
1:1000 Chemicon 
R, Rabbit polyclonal antibody; M, mouse monoclonal antibody; MC, mouse 
monoclonal cocktail; GP, guinea pig polyclonal antibody 
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2.1.5 Total RNA extraction 
Animals were terminally anaesthetised and transcardially perfused with 0.01M PBS 
(n = 4 per time point) at 1, 7, 14 and 28 days post-injury. Non-injured, age-matched 
controls corresponding to the 1 and 28 day post-injury time point (n = 3 per time 
point) were processed concurrently. Following removal, all brains were snap frozen 
in liquid nitrogen and stored for later dissection. Prior, to dissection brains were 
thawed slightly and a 2mm coronal section of tissue was harvested from each brain, 
to include the injury site, or equivalent region in control brains. RNA extraction was 
performed using the TRIzol® method according the manufacture's instructions 
(Invitrogen, Carlsbad, CA, USA), under RNase-free conditions. Tissue samples were 
homogenized in 500[11 TRIzol ® reagent using a lml syringe with a 26G, followed by 
29G, needle attached. 
2.1.6 Quantitative one-step real-time RT-PCR 
Quantitative analysis of mRNA levels was performed using the QuantiTect one-step 
SYBR Green RT-PCR Kit (Qiagen, Doncaster, VIC, Australia), following the 
manufacturers instructions, with minor modifications. Briefly, all amplification _ 
reactions were carried out in duplicate with 2Ong of total RNA per reaction. Each 
reaction contained 1 x QuantiTect SYBR Green (containing HotStarTaq DNA 
Polymerase, buffer, dNTP mix, SYBR Green I, reference dye and 5mM MgC1 2), 
0.5[1,M of forward and reverse primers and 0.1R1 of QuantiTect RT Mix (containing 
Omniscript and Sensiscript Reverse Transcriptases) in a total of 101.1.1. Quantitative 
real-time RT-PCR was performed using the Rotorgene 3000 (Corbett Research, 
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Sydney, NSW, Australia). Amplification conditions included 30 minutes at 55°C 
(reverse transcription), 15 minutes at 95°C (inactivation of reverse transcriptase and 
activation of HotstartTaq Polymerase), and then 45 cycles at 94°C for 15 seconds 
(denaturation), 55°C for 30 seconds (annealing), 72°C for 30 seconds (extension and 
data acquisition). Additionally, a melt curve analysis was performed at the end of 
each run at 60-95°C. For each run, no-template-controls as well as cDNA and RNA 
standards were included for each primer set to identify potential genomic DNA 
contamination and to check reaction efficiency, respectively. Standard curves for 
each primer set were performed using total rat brain RNA and samples were 
normalised with the housekeeping gene, GAPDH. Primers sequences were all 
approximately 20 base pairs in length and produced amplicons ranging in size from 
150-450 base pairs (Table 2.2). Primer sequences for 13111-tubulin and NF-L were 
obtained from Pernas-Alonso et al. (1999). Sequences for all other primer pairs, 
including NF-H, GAP-43, a-internexin, nestin and GAPDH, were designed using the 
Primer Express Software (Applied Biosystems, Foster City, CA, USA). 
2.1.6.1 Statistical analysis 
All data are reported as a mean fold change relative to non-injured control brains ± 
standard error of the mean (SE). Microsoft Excel was used to prepare data/graphs 
and determine statistical significance. A p value of < 0.05 was considered 
statistically significant. Preliminary statistical analysis was performed to determine 
whether the young (age matched to the 1 day post-injury) and old (age-matched to 
the 28 day post injury) control groups differed significantly from one another in the 
expression of each gene examined (n = 3 in each group). No statistically significant 
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Table 2.2. Primer pairs for one-step quantitative real-time RT-PCR 
Gene/Primer 	Sequence 5'-3' 	 Nucleotide size 
GAPDH 
Forward 	TTCATTGACCTCAACTACAT 	20 
Reverse 	GTGGCAGTGATGGCATGGAC 20 
Nestin 
Forward 	AGCTCTTGGAACCCTGTTCA 	20 
Reverse 	CTGCCTCGCTTTCTTCTCTG 20 
GAP-43 
Forward 	TGTCAAACCGGAGGATAAGG 	20 
Reverse 	TGCATCGGTAGTAGCAGAGC 20 
a -internexin 
Forward 	GGTACAAGTVVAAGTTCGCCA 	21 
Reverse 	TGCCCAATGCTATCCTGGTAG 21 
13 III- tubulin 
Forward 	TTGCAGCTGGAGAGAATCAA 	20 
Reverse 	CTCGGCACCCTCTGTGTAGT 20 
NF-L 
Forward 	ATGAGCAGGAGATCCGTGATCT 	22 
Reverse 	CAGGAAGGCTATCTCGTCCATC 	22 
NF-H 
Forward 	AGCTGCTCGGTCAGATTCAG 	20 
Reverse 	GCATCCGTGTTCACTTTGG 19 
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differences in mRNA levels between these control groups were indicated for any of 
the genes examined, therefore, these control groups were pooled (n = 6). 
2.2 Experimental procedures relating to in vitro neuronal injury 
2.2.1 Primary dissociated neocortical neuron culture preparation 
Primary dissociated cortical neuron cultures were prepared from rat embryos at 18 
days of gestation using standard techniques (Banker and Goslin, 1998) and grown in 
NeurobasalTM media, to selectively promote the growth of neuronal cells (Brewer et 
al., 1993; Brewer, 1995, 1997). Pregnant Hooded Wistar rats were killed by CO 2 
exposure. Embryos were rapidly removed using sterile techniques, placed on ice 
and, following removal of the skull and meninges, the neocortical hemispheres were 
dissected out and placed in 10mM HEPES buffer (in 0.01M PBS), pre-warmed to 
37°C. Cortical tissue was dissociated by enzymatic digestion (0.025% trypsin) and 
gentle agitation at 37°C for 20 minutes. Enzymatic digestion was halted by rinsing 
the tissue in fresh 10mM HEPES buffer and dissociation was completed by gentle 
trituration using a lml pipette. 
Prior to plating, cell viability was assessed using trypan blue vital dye exclusion. 
Cells were plated, at a density of 4.5 x 105 cells/coverslip, onto circular 19mm 
diameter glass coverslips (Marienfeld, Lauda-Koenigshoten, Germany), immersed in 
an initial plating media, consisting of NeurobasalTM  media, 10% foetal bovine serum, 
2% B-27 supplement (all from Invitrogen BRL, Life Technologies, Grand Island, 
NY, USA), 0.5mM L-glutamine, 25RM glutamate and lml/L gentamicin. Coverslips 
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had previously been nitric acid treated and pre-incubated in 1 mg/ml poly-L-lysine 
(Sigma, St. Louis, MO, USA) in borate buffer (pH 7.4) overnight, before being 
placed into individual wells of 12-well microplates (Iwaki, Tokyo, Nihonbashi, 
Japan), each containing 2ml of initial plating media. Cultures were maintained in a 
37°C humidified atmosphere of 5% CO2 for up to 28 days. After 1 day in vitro 
(DIV), the initial plating media was removed and replaced with a "subsequent", 
serum-free growth media containing Neurobasal Tm media, 2% B-27 supplement, 0.5 
mM L-glutamine and 3ml/L gentamicin. Half the volume of culture media was 
replenished every 3 to 4 days with fresh subsequent growth media. 
2.2.2 In vitro axonal injury 
Axonal injury was performed as described by Dickson et al. (2000). At 20 DIV, 
coverslips were transferred to individual 35mm sterile plastic Petri dishes (Iwaki, 
Nihonbashi, Tokyo, Japan) and allowed to re-acclimatise to the incubator conditions. 
At 21 DIV, individual axonal bundles, interconnecting discrete neuronal aggregates, 
were transected under microscope guidance using a 12cm Barkan goniotomy curved 
blade diamond knife (Altomed, London, England). Thick axonal bundles, adherent 
to the underlying substrate were selected for transection. The knife blade was 
carefully pressed upon the appropriate axonal bundles to completely transect the 
axons and form a cell-free lesion between two previously interconnected neuronal 
aggregates. Cuts were made equidistant between neuronal aggregates to produce 
lesions approximately 50-150Rm wide. Several (10-15) injuries were made per 
coverslip. Cultures were removed from the incubator for no longer than 5 minutes 
(as longer durations compromised neuronal integrity). Cultures were re-incubated 
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for a range of time points following injury (as described in individual chapters). 
2.2.3 Immunohistochemistry and staining of cultured neocortical cells 
Cultured neurons were fixed in 4% PFA at room temperature for 30 minutes. 
Indirect double immunofluorescent labelling was utilised to visualise the distribution 
of specific cellular components in developing neurites as well as injured and non-
injured mature axons. Briefly, cultured monolayers were incubated in combinations 
of mouse and rabbit primary antibodies for two hours at room temperature, followed 
by incubation in secondary antibodies for one hour at room temperature. Mouse and 
rabbit primary antibodies were visualised with goat anti-mouse and goat anti-rabbit 
Alexa Fluor 488 1m and 594TM  secondary antibodies (Molecular Probes, Eugene, OR, 
USA, dilution 1:1000) as appropriate. To label for filamentous actin, cultures were 
incubated with AlexaFluor 488 phalloidin (Molecular Probes, Eugene, OR, USA, 
dilution 1:200), at room temperature for 30 minutes subsequent 
immunohistochemistry. Following washing, coverslips were mounted onto glass 
slides using Permafluor mounting media (Immunotech, Marseille, Cedex, France). 
All antibodies were diluted in 0.3% Triton X-100 in 0.01M PBS. Controls, omitting 
the primary antibodies, were processed concurrently and lacked immunoreactivity 
for the cellular components under investigation. 
2.3 Microscopy 
All fluorescence labelled sections and cell monolayers were viewed with a Leica 
DMIRB or DMLB2 microscope equipped with a range of objectives. Filter blocks 
within the microscope enabled both selective and combined visualisation of 
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fluorescence labelled epitopes within each specimen. Digital images were captured 
with an Optronics Magnifire cooled CCD camera (Optronics, Chelmsford. MA, 
USA) attached to a G4 Macintosh computer (Apple Computers, Cupertino, CA, 
USA), using Magnifire Software. 
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Acute structural injury to the brain induces substantial 
alterations in cell proliferation and endogenous 
progenitors cells directed towards brain healing 
3.1 Introduction 
The adult mammalian brain is incapable of undergoing full structural and functional 
restoration following physical injury, however, accumulating evidence indicates that 
the damaged brain undergoes a specific sequence of adaptive alterations directed at 
tissue healing, which may involve the recruitment of endogenous proliferating and 
progenitor cells. Understanding the mechanisms employed by the damaged brain to 
self-heal is of paramount importance in devising effective therapies to treat brain 
injury. In this regard, similar to other tissues, structural injury to the brain evokes a 
distinct sequence of events indicative of a wound healing response. A tissue wound, 
defined as a morphologic-functional disruption of the continuity of a tissue structure 
(Oehminchen, 2004), induces a healing response involving distinct phases of 
coagulation, inflammation, proliferation, migration and remodelling (Maxwell et al., 
1990; Hunt et al., 2000; Yamaguchi and Yoshikawa, 2001; Oehminchen, 2004) and 
may involve processes directed at tissue regeneration or repair. Regeneration 
essentially infers the complete restoration of injured tissue, whereas repair involves 
the replacement of lost tissue with scar tissue and is associated with varying degrees 
of functional recovery. 
Injury to the CNS evokes tissue specific processes directed at healing and scar 
formation, including the activation of a variety of glial cell populations, which 
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ultimately contribute to formation of a glial scar and may create an environment 
inhibitory to neuronal regeneration (Fawcett and Asher, 1999). With regard to tissue 
healing, the discovery of proliferating and progenitor cells with neurogenic potential 
in the adult mammalian brain has widespread implications for brain recovery 
following injury (Kozorovitskiy and Gould, 2001; Brazel and Rao, 2004). Indeed, 
altered cell proliferation and changes in neural progenitor cell populations have been 
demonstrated in diverse models of experimental brain lesion and are proposed to 
contribute to post-lesion brain recovery (Clarke et al., 1994; Duggul et al., 1997; 
HoImin et al., 1997; Li and Chopp, 1999; Sahin Kaya et al., 1999; Kernie et al., 
2001; Arvidsson et al., 2002; Chirumamilla et al., 2002; Shi et al., 2002; Chen et al., 
2003a; Nakamura et al., 2003; Tonchev et al., 2003; Douen et al., 2004; Salman et 
al., 2004). 
Interestingly, the SVZ of the anterior lateral ventricles is regarded as the primary 
germinal zone of the adult brain and, in addition to the hippocampal dentate gyrus, 
retains neurogenic potential into adulthood (for recent reviews Conover and Allen, 
2002; Abrous et al., 2005; Doetsch and Hen, 2005). Indeed, populations of 
progenitor and proliferating cells in the SVZ give rise to more restricted progenitor 
phenotypes, generating astrocytes, oligodendrocytes and neurons, and contribute to 
cell turnover throughout life (Lendahl et al., 1990; Lois and Alvarez-Buylla, 1993; 
Weiss et al., 1996; Doetsch et al., 1999; Alvarez-Buylla and Doetsch, 2002; Conover 
and Allen, 2002; Limke and Rao, 2002; Okano, 2002; Marshall et al., 2003; Mignone 
et al., 2004). Moreover, neural progenitors have also been demonstrated in several 
typically non-neurogenic brain regions (reviewed by Emsley et al., 2005). Thus, the 
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recruitment of proliferating and progenitor cells from the SVZ, as well as 
parenchymal-resident progenitor cells, are postulated sources for cell replacement 
following brain lesion. Ultimately, injury-induced proliferating and progenitor cells 
may generate new neurons and/or glia (Gu et al., 2000; Magavi et al., 2000; Jin et al., 
2001; Chen et al., 2003a, b; Douen et al., 2004; Salman et al. 2004). Collectively, 
reports of injury-induced neuro- and glio-genesis indicate intrinsic repair 
mechanisms are initiated in the damaged brain (review by Pluchino et al., 2005). 
However, whether brain injury evokes a neurogenic response that contributes to 
functional recovery remains contentious. 
In light of accumulating data implicating cell proliferation and progenitor cell 
differentiation as mechanisms of brain repair following injury, the current study 
utilised a model of acute focal injury to the rat neocortex to examine the contribution 
of these cells towards brain healing. This injury model produces a wound-like lesion 
within the grey matter of the neocortex (King et al., 2001). Immunohistochemical 
and quantitative real-time RT-PCR techniques were used to examine the spatio-
temporal alterations and neurogenic potential of injury induced proliferating and 
progenitor cells. The cellular response to acute neocortical injury was investigated 
utilising a battery of antibodies for proliferating, progenitor, immature and mature 
neural cell types. Injury-induced alterations in neural progenitor cells were identified 
based on expression of the embryonic cytoskeletal protein, nestin. Findings from 
this study are discussed with regard to an emerging body of literature indicating that 
the damaged brain undergoes endogenous repair, involving cell proliferation, glial 
activation and, potentially, neurogenesis. 
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3.2 Experimental procedures 
3.2.1 Immunohistochemistry of rat brain tissue sections 
Following in vivo structural brain injuries as described in Section 2.1.2, Figure 2.1, a 
battery of antibodies, directed at different neural cell populations and differentiation 
states, was utilised to determine the response and fate of proliferating, progenitor and 
glial cells as well as immature and mature neurons. Immunohistochemistry was 
performed as described in Section 2.4.1, using antibodies specific for a variety of 
different neural cell populations (see Table 3.1 below). Specific antibody details are 
provided in Table 2.1. BrdU and PCNA were utilised to identify proliferating cells. 
Neural progenitor cells were examined based on expression/content of the embryonic 
cytoskeletal protein, nestin, which has previously been associated with this cell 
population (Lendahl et al., 1990; Dahlstrand et al., 1995; Taupin and Gage, 2002; 
Michalczyk and Ziman, 2005). Doublecortin (DCX), a microtubule-associated 
protein specific for migrating and differentiating neuroblasts (Francis et al., 1999; 
Gleeson et al., 1999) and potentially indicative of neurogenesis (Couillard-Depres'et 
al., 2005) was utilised to determine the potential recruitment of migrating neuroblasts 
to the injury site. Neuron-specific 13111-tubulin was utilised to identify early neurons, 
whereas mature pyramidal neurons and non-pyramidal/interneurons were 
distinguished based on immunolabelling for the neuronal intermediate filament 
proteins, NF-M and a-internexin, or calcium binding proteins, calretinin and 
parvalbumin, respectively. Activated microglia/macrophages were visualised based 
on labelling for the iron binding protein ferritin and astrocytes were identified based 
on GFAP immunoreactivity. 
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To determine alterations in different cell populations following cortical injury, rats 
were terminally anaesthetised (pentabarbitone sodium, 140mg/kg) at 1, 7, 14, 21, 42 
and 84 days following injury (n=3 per time point) and transcardially perfused with 
4% PFA/0.01M PBS. Non-injured, age-matched controls corresponding to the 1, 42 
and 84-day post-injury time points (n=3 per time point) were also perfused. For 
double labelling of nestin versus BrdU or PCNA, a sequential labelling protocol was 
performed whereby tissue sections were first incubated with anti-BrdU/PCNA 
antibody, followed by saturation with anti-mouse rat-adsorbed Fluorescein secondary 
antibody (dilution 1:50). Nestin immunolabeling was subsequently performed with 
anti-mouse AlexaFluor 594 secondary antibody. Negative controls, omitting the 
primary antibodies, were processed concurrently to ensure the absence of non-
specific labelling. This protocol was a satisfactory method of labelling as nestin and 
BrdU/PCNA were localised to different cellular compartments, negating the 
possibility of ambiguous labelling. 
Table 3.1. Antibodies utilised to identify different neural cell populations 
Cell type 
Proliferating cells 
Neural progenitor cells 
Neuroblasts 
Young neurons 
Pyramidal neurons 
Interneurons 
Astrocytes 
Activated microglia and macrophages 
Marker  
BrdU 
PCNA 
Nestin 
Doublecortin 
13III-tubulin 
NF-M 
a-internexin 
Calretinin 
Parvalbumin 
GFAP 
Ferritin 
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3.2.2 Immunofluorescence quantitation 
To determine alterations in nestin protein levels within perilesion tissue, the intensity 
of immunolabelling was quantitatively assessed by optical density measurements 
(Adobe Photoshop 7) from regions immediately bordering the injury site (Figure 3.1) 
and used as a relative measure of alterations in protein level following needle injury 
to the rat neocortex. Images were captured with a 40x objective immediately lateral 
and medial to the injury site, or in equivalent regions of non-injured control brains 
and mean optical density measurements were quantitated relative to non-injured 
control tissue. To limit discrepancies in the period each brain section was exposed to 
both ambient and immunofluorescent light, immunofluorescence images required for 
analysis were captured from several brain sections at each time point on the same 
day and at the same camera exposure level. 
3.2.3 Quantitative one-step real-time RT-PCR 
To determine alterations in nestin mRNA levels following cortical injury, rats were 
terminally anaesthetised at 1, 7, 14 and 28 days following injury (n = 4 per time 
point). Non-injured, age-matched controls corresponding to the 1 and 28 day post-
injury time points (n = 3 per time-point) were also perfused. Tissue was dissected 
from three regions within each brain section (Figure 3.1): the lesion site, perilesion 
tissue immediately lateral and medial to the lesion and the SVZ, including some sub-
cortical white matter. Medial and lateral perilesion tissue samples for each brain 
were pooled. Tissue was processed for mRNA analysis as described in Section 
2.1.6, utilising forward and reverse primers for nestin and GAPDH displayed in 
Table 2.2. 
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Figure 3.1 Diagrammatic representation of sites from which 
tissue was harvested for RNA extraction to be assessed by 
quantitative real time RT-PCR analysis 
Tissue was harvested from three brain regions: (1) the lesion site, 
(2) perilesion tissue and (3) the SVZ. Tissue from the perilesion 
region was pooled prior to RNA extraction. Tissue harvested 
from the SVZ included some sub-cortical white matter. CC, 
corpus callosum; SVZ, subventricular zone; St, striatum. 
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3.3 Results 
3.3.1 Alterations in cell proliferation in response to acute neocortical injury 
Proliferating cells were assessed utilising the mitotic markers, BrdU and PCNA. 
BrdU and PCNA immunopositive nuclei were rarely observed within non-injured 
tissue sections, where cell proliferation was limited and generally restricted to the 
SVZ and pial covering, with 'occasional labelled nuclei distributed elsewhere in the 
brain parenchyma. However, cell proliferation was a prominent feature of the 
lesioned neocortex (Figure 3.2). At 1 day post-injury, BrdU immunoreactive nuclei 
were present within perilesion tissue (Figure 3.2A), as well as the SVZ and corpus 
callosum (Figure 3.2B). By 7 days following injury, both BrdU and PCNA labelling 
was extensive. BrdU immunoreactive proliferating cells were distributed in a broad 
zone surrounding the injury site (Figure 3.2C) and extending into the corpus • 
callosum and SVZ (Figure 3.2D) and PCNA labelled cells were distributed in a 
similar pattern (Figure 3.2E and F). Over the time course examined, BrdU 
immunoreactive nuclei decreased in the ipsilateral lesioned neocortex. At 21 days 
following injury, proliferating cells were generally restricted to sites immediately 
surrounding the lesion (Figure 3.2G) and, by 42 days following injury, these cells 
were retained within a narrow band at the lesion border (Figure 3.2H). 
3.3.2 Alterations in nestin expression and distribution in response to acute 
neocortical injury 
The injury-induced response of a population of endogenous neural progenitor cells 
was assessed based on the cellular expression/content of nestin. Figure 3.3 illustrates 
76 
Figure 3.2 	Acute structural neocortical injury induced a substantial increase 
in cell proliferation 
Immunofluorescence labelling for proliferation markers, BrdU and PCNA following 
transient localised injury to the rat somatosensory cortex. At 1 day following injury, 
BrdU immunoreactive nuclei were scattered sporadically within perilesion tissue (A) 
as well as in the corpus callosum and SVZ (B). By 7 days following lesions, BrdU 
immunoreactive nuclei were abundant and distributed within the lesion cavity as well 
as in a broad zone surrounding the lesion site (C) and extending into the corpus 
callosum and SVZ (D). Labelling for PCNA at 7 days post-injury demonstrated a 
similar labelling pattern to that observed for BrdU at the lesion site (E) and within 
the SVZ (F). By 21 days following injury, BrdU immunoreactive nuclei were more 
restricted in distribution and were localised predominantly to the perilesion region 
(G), forming a narrow band at the lesion border by 42 days post-injury (H). Dotted 
lines indicate the lesion border. SVZ, subventricular zone; CC, corpus callosum; 
LV, lateral ventricle. 
Scale bar: A, B, F = 100um; C, D, E, G, H = 200um. 
7d post-infufyperitesion BrdU 
7d post injury SVZ PCNA 
42d post-injury penlesion BrdU 
id post-injury penlesion 13(dU 
7d post-injury penlesion PCNA 
21d post Injury penlesion BrdU 
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alterations in the distribution of nestin immunoreactivity over a time course ranging 
from pre-injury to 84 days post-injury. Nestin immunoreactive cells were not 
evident in the neocortex of control non-injured brains (Figure 3.3A), although some 
labelling was observed in the periventricular region. In response to injury, nestin 
labelling became a prominent feature of the ipsilateral cortical tissue. At 1 day post-
injury, occasional nestin immunoreactive cells were observed within the deeper 
cortical laminae and corpus callosum, emanating from the SVZ (Figure 3.3B, C and 
D). By 7 days post-injury, nestin immunoreactive profiles were localised throughout 
the neocortical laminae and were especially abundant within the perilesion tissue 
(Figure 3.3E). Nestin immunolabelling was also evident at later post-injury time 
intervals, however, from 14 days post-injury, distinct nestin immunoreactive cellular 
profiles were less frequent (Figure 3.3F) and nestin immunoreactivity became 
progressively restricted to a narrow zone surrounding the injury site. By 42-84 days 
post-injury, a remnant of relatively low nestin immunoreactivity was observed lining 
the lesion cavity (Figure 3.3G), a region in which a dense plexus of GFAP 
immunoreactive astrocytes has previously been demonstrated to form in this lesion 
model (King et al., 2001, see also Chapter 4). Alterations in the re-distribution of 
nestin cells within the neocortex were restricted to the ipsilateral cortex and were not 
observed in cortical tissue contralateral to the lesion. 
Alterations in nestin gene expression, in response to localised neocortical injury, 
were examined at 1, 7, 14 and 28 days post-injury utilising quantitative real time RT-
PCR, based on changes in nestin mRNA levels in tissue from the injury site, the 
perilesion region and the SVZ, relative to equivalent regions from non-injured 
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Figure 3.3 	Acute structural to the rodent neocortex induced substantial 
alterations in the distribution of nestin 
Nestin labelling in the non-injured cortical parenchyma was negligible (A). At 1 day 
post-injury, occasional nestin-labelled cells were observed within the corpus 
callosum, extending from the SVZ, but not perilesion tissue (B, boxes in B are 
represented in C and D as high magnification images). By 7 days following injury, 
nestin labelling was abundant, extending in a broad zone surrounding the lesion (E) 
and although still present at 14 days following injury, nestin labelling was reduced to 
a narrow zone in the perilesion tissue (arrow in F denotes perilesion nestin labelling). 
Although nestin labelling was retained within the perilesion tissue up to 42 days 
following injury it was restricted to a narrow zone in original lesion tract (arrow in 
G). Dotted lines in B, E, F and G define the lesion border. 
Scale bar: A, B, E, F, G = 80t.tm; C, D = 201m 
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control brains (Figure 3.4A). Nestin mRNA levels were significantly (p < 0.05) and 
maximally increased in tissue from all three brain regions at 1 day following injury, 
with fold increases of 9.70 ± 1.40 (SE), 6.38 ± 1.61 (SE) and 5.61 ± 2.67 (SE) in the 
lesion site, perilesion tissue and SVZ tissue, respectively. Significant increases in 
nestin mRNA expression persisted until 14 days post-injury in both the lesion site 
and perilesion tissue. To determine whether alterations in nestin mRNA levels were 
reflected in equivalent changes at the protein level, we quantitated relative nestin 
immunofluorescence levels within the perilesion tissue, corresponding to regions 
from which tissue was harvested for quantitative real-time RT-PCR analysis. 
Quantitative immunofluorescence was performed on tissue sections from 1, 7, 14, 
21, 42 and 84 days post-injury. Nestin labelling was negligible in control cortical 
tissue. Likewise, at 1 day post-injury, nestin immunoreactivity was insignificant, 
with infrequent nestin cells present within the cortical parenchyma. However, 
quantitation of nestin immunofluorescence demonstrated a significant elevation (p < 
0.05) in nestin protein in perilesion tissue from 7 days post-injury, which persisted 
across all subsequent time points examined (Figure 3.4B). This response was most 
marked at 7 days post-injury, indicated by a 2.18 ± 0.14 (SE) fold increase in nestin 
within the perilesion tissue relative to non-injured controls. 
As previously mentioned, immunoreactivity for nestin was most abundant at 7 days 
post-injury, at which time a band of nestin immunopositive cells extended from the 
SVZ to the lesion site (Figure 3.5A). Although this labelling pattern was prominent 
within perilesion grey matter (Figure 3.5B), nestin-labelled cells were also abundant 
within the corpus callosum and SVZ (Figure 3.5C). Moreover, nestin-labelled cells 
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Figure 3.4 	Acute structural neocortical injury evoked statistically significant 
increases in nestin expression and immunofluorescence levels 
Nestin mRNA levels were assessed in 3 brain regions, the lesion site, perilesion 
tissue and the SVZ at 1, 7, 14 and 28 days following injury. Nestin mRNA levels 
were significantly and maximally elevated at 1 day post injury in all 3 brain regions 
investigated and this increase persisted until 14 days post injury in both the injury 
site and perilesion tissue (A). Nestin immunofluorescence levels were quantitated in 
perilesion tissue. No alteration was observed in nestin immunofluorescence until 7 
days post injury. Although nestin immunofluorescence peaked at 7 days following 
injury, levels remained significantly increased at all subsequent time points assessed 
up to 84 days post injury (B). 
p < 0.05. Error bars are standard error of the mean 
A Fold alteration in nestin mRNA levels following focal structural injury to the rodent neocortex 
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Figure 3.5 	Nestin-labelled cells were distributed between the SVZ and injury 
site by 7 days following injury 
Immunofluorescence labelling for nestin within the ipsilateral hemisphere at 7 days 
post-injury following transient localised injury of the rat somatosensory cortex. By 7 
days post-injury nestin immunoreactive profiles were present in tissue extending 
from the SVZ and corpus callosum up to the injury site (A). Nestin-labelled cells 
were particularly abundant within perilesion tissue (B) and within the SVZ (C). 
Dotted line in A denotes the lesion border. CC, corpus callosum; SVZ, 
subventricular zone; LV, lateral ventricle. 
Scale bar: A = 80011m B, C, = 200vm. 
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displayed variable morphological features, which correlated with distance from the 
lesion site and the brain region in which the cells were localised (Figure 3.6). For 
example, while nestin cells were elongated and displayed parallel arrangement, 
perpendicular in orientation to the lesion border, within the immediate perilesion 
tissue (Figure 3.6A), nestin cells in the cortical parenchyma demonstrated a dendritic 
morphology (Figure 3.6B). Furthermore, nestin cells were narrow and elongated 
within the sub-cortical white matter (Figure 3.6C), but displayed more spindle-like 
morphology with distinct rounded cell bodies within the SVZ (Figure 3.6D). 
Sequential labelling for nestin and BrdU or PCNA demonstrated that a substantial 
proportion of the endogenous nestin cell population was mitotically active in the 
cortical parenchyma and SVZ (Figure 3.7A and B respectively). However, although 
BrdU/PCNA immunoreactive profiles were present in a broad zone between the 
lesion site and ipsilateral SVZ, concomitant with the presence of nestin cells within 
this region, numerous BrdU/PCNA nuclei were not localised to nestin positive cells. 
3.3.3 Cells expressing nestin following acute neocortical injury 
Previous reports have indicated that nestin may be re-expressed in different 
populations of mature neural cells types in a variety of experimental brain lesion 
paradigms (see discussion). Double labelling immunofluorescence studies were 
performed to determine whether this was a possibility in our brain lesion model. 
Tissue sections were double labelled for nestin relative to a selection of markers 
(Figure 3.8) for microglia/macrophages (ferritin), astrocytes (GFAP) and neurons 
(NF-M, a-internexin, calretinin and parvalbumin). Neuronal markers were selected 
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Figure 3.6 	Acute structural neocortical injury induced alterations in the 
morphology of nestin-labelled cells, which were associated with the brain region 
to which these cells were localised 
The diagrammatic representation of the ipsilateral injured brain displayed below 
indicates the brain region from which each image was taken. Nestin cells were 
elongated and arranged parallel to one another within perilesion tissue (A), but 
demonstrated stellate morphology at within the cortical parenchyma at site more 
distant to the lesion (B). In the corpus callosum nestin cells were elongated (C), 
whereas they demonstrated rounded somas, emanating spiky processes within 
periventricular tissue (D). Arrows denote examples of nestin-labelled cells in each 
image. LV, lateral ventricle; St, striatum; CC, corpus callosum; GM, grey matter 
Scale bar: A, B, C and D = 100tim 

Figure 3.7 	A proportion of the nestin-labelled cell population was mitotically 
active, as indicated by co-labelling for BrdU or PCNA, in the perilesion tissue 
and SVZ 
Double immunofluorescence labelling for BrdU relative to nestin demonstrated 
proliferating nestin cells in cortical parenchyma (A). Likewise, nestin cells were also 
mitotically active in the SVZ as demonstrated by PCNA-nestin double labelling (B). 
Arrows denote examples of mitotically active nestin-labelled cells. 
Scale bar: A = 50[1m; B = 1001Am 
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to represent cortical interneuron (calretinin and parvalbumin) and pyramidal neuron 
(NF-M and a-internexin) populations. 
Examination of injured tissue from all post-injury time points investigated showed 
that nestin labelling exclusively co-localised with the astrocytic intermediate 
filament protein, GFAP (Figure 3.8A). Cells labelled solely for nestin or GFAP, as 
well as cells demonstrating nestin-GFAP co-localisation, shared similar 
morphological features within perilesion tissue, characterised by an activated 
elongated morphology and parallel cell arrangement, perpendicular to the lesion 
border. Contrary to the widespread co-localisation between nestin and GFAP, nestin 
was not localised within ferritin-positive activated microglia/macrophages (Figure 
3.8B). Furthermore, nestin immunoreactivity was absent from all neuronal 
populations examined within perilesion tissue, including those positive for NF-M, a-
internexin, calretinin and parvalbumin (Figure 3.8C, D, E and F respectively). 
3.3.4 Distribution of DCX-labelled neuroblasts following acute neocortical 
injury 
To determine whether new neurons were generated in the SVZ and perilesion tissue, 
tissue sections were double-labelled for DCX relative to BrdU, nestin and neuron-
specific 13111-tubulin (Figure 3.9). DCX immunoreactive cells were present in the 
SVZ, and occasionally in the subcortical white matter of both non-injured control 
brains (Figure 3.9A) and injured brains (Figure 3.9B). DCX-labelled cells in both 
non-injured and injured brains were mitotically active, as indicated by BrdU 
incorporation (Figure 3.10A), however, these cells rarely, if ever, co-labelled with 
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Figure 3.8 	Nestin was localised to astrocytes, but no microglial/macrophage 
or neuronal populations 
Double immunofluorescence labelling for nestin (green) relative to astrocyte, 
microglial/macrophage and neuronal markers (red) in perilesion tissue at 7 days 
following cortical injury demonstrated nestin labelling exclusively co-localised with 
GFAP (A) and was not present in ferritin positive microglia/macrophages (B), or 
NF-M- (C), a-internexin- (D), calretinin- (E) or parvalbumin- (F) immunoreactive 
neurons. Arrows in A denote examples of co-labelled cells, arrows in B-F denote 
examples of microglia/neurons, arrowheads in B-F denote examples of nestin-
labelled cells. 
Scale bar: 50tim 

Figure 3.9 	Doublecortin-labelled cells were present in the SVZ of both non- 
injured and injured brains, but were absent from both the injury sited of 
injured brains and equivalent region of non-injured brains 
Doublecortin labelling of the SVZ of a non-injured control (A) and injured brain, 7 
days following injury (B). SVZ, subventricular zone; LV, lateral ventricle; CC, 
corpus callosum. 
Scale bar A and B = 100[tm 
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nestin (Figure 3.10B), indicating that they were likely to have surpassed the neural 
progenitor phase of development. Furthermore, a proportion of DCX-labelled cells 
residing in the SVZ co-expressed the early neuronal marker 13III-tubulin (3.10C). 
Observations of DCX labelling were restricted exclusively to the SVZ and DCX 
immunoreactive cells were not observed within perilesion tissue, suggesting that this 
cell population was not recruited in response to injury. These finding were 
confirmed up to 21 days following injury. 
3.3.5 Fate of injury-induced proliferating cells 
As previously demonstrated, cortical injury evoked characteristic alterations in cell 
proliferation, including the generation of nestin-labelled cells. Differentiation of 
newly generated cells into neurons following brain injury has been implicated in 
brain healing. To determine the fate of cells that had incorporated BrdU within the 
first week following injury and whether these cells went on to develop neuronal or 
.glial phenotypes that contributed towards brain healing, brain sections were derived 
from animals perfused at 7, 21 and 42 days following lesion and double-
immunofluorescence labelled for BrdU relative to the same battery of antibodies 
utilised for nestin double labelling studies, including GFAP, ferritin, NF-M, a-
internexin, calretinin and parvalbumin (Figure 3.11). 
Double-labelling 	immunohistochemistry 	demonstrated 	numerous 	GFAP 
immunopositive cells were mitotically active (Figure 3.11A). Likewise ferritin 
positive microglia and macrophages also underwent substantial proliferation in 
response to cortical injury (Figure 3.11B). Strikingly, however, over the course of 
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Figure 3.10 Doublecortin-labelled cells located in the SVZ of non-injured and 
injured brains were mitotically active and expressed the neuronal marker, 
tubulin, but not the early neural marker, nestin 
Double labelling analysis demonstrated that, in both non-injured control and injured 
brains, doublecortin cells were mitotically active (A), but rarely co-labelled with 
nestin (B). Doublecortin cells in the SVZ frequently co-expressed PIII-tubulin. 
Images were taken at 7 days post-injury, but were representative of non-injured 
control brains. Arrows denote examples of co-labelling, arrowheads denote the 
localisation of nestin positive cells. 
Scale bar A, B and C = 50tAm 

Figure 3.11 Injury-induced proliferating cells were identified to be astrocytes 
and microglia/macrophages, but not neurons 
Double immunofluorescence labelling for BrdU (green) relative to astrocytic, 
microglial/macrophage and neuronal markers (red) in cortical perilesion tissue at 7 
days following transient localised injury to the rat cortex. Numerous GFAP labelled 
cells also contained BrdU immunoreactive nuclei (A), Additionally, a proportion of 
ferritin positive microglia/macrophages were also mitotically active following injury 
(B). However, injury-induced proliferating cells had not differentiated into mature 
neuronal phenotypes by 1 (left panels), 3 (middle panels) or 6 (right panels) weeks 
following injury. Labelling is for NF-M- (C-E), a-internexin- (F-H), calretinin- (I-
K) and parvalbumin- (L-N) immunopositive neuronal populations. 
Scale bar: A and B = 351.1m; C-N = 50Rm. 
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42 days following injury, BrdU immunoreactive nuclei were absent from all neuronal 
populations examined, including NF-M- (Figure 3.11C-E) and a-internexin- (Figure 
3.11F-H) immunoreactive pyramidal cells, as well as calretinin- (Figure 3.11I-K) and 
parvalbumin- (Figure 3.11L-N) immunoreactive interneurons. 
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3.4 Discussion 
This chapter investigated the spatio-temporal alterations occurring in proliferating 
and nestin-immunoreactive neural progenitor cells in response to a wound-like 
structural lesion to the rat somatosensory cortex. Compared to other models of 
structural brain injury, including weight-drop, controlled cortical impact and lateral 
fluid percussion (Dixon and Hayes, 1996; Hicks et al., 1997; Hallam et al., 2004; 
Thompson et al., 2005), the injury model utilised in this study is relatively subtle, in 
terms of the extent of injury and specifically creates a lesion in the neocortical grey 
matter. Thus, this lesion paradigm is important for examining degenerative and 
regenerative alterations within the grey matter of the neocortex as well as alterations 
occurring at sites not directly affected by the lesion, which may be implicated in 
brain healing. In this respect, this study demonstrated the recruitment of SVZ-
derived cells in contributing towards brain healing, despite the SVZ not being 
directly damaged by the lesion. 
Overall, acute focal neocortical injury induced early reactive alterations, including 
profuse cell proliferation, as indicated by extensive BrdU incorporation and PCNA 
labelling, as well as microglial/macrophage and astrocyte activation. Proliferating 
cells were identified to be nestin-labelled neural progenitors, DCX-immunoreactive 
neuroblasts, activated microglia/macrophages and astrocytes, but not neurons. 
Nestin-labelled cells were observed within the SVZ and corpus callosum at 1 day 
post-injury and by 7 days following injury nestin immunoreactivity extended up to 
the to injury site. Additionally, double labelling studies indicated co-localisation 
between nestin and the astrocytic marker, GFAP, however nestin was not re- 
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expressed in other neural cell types. Moreover, although DCX cells were abundant 
in the SVZ, these cells did not contribute to re-population of the injured tissue. 
Collectively, these results demonstrate a sequence of changes directed at brain 
healing, involving the recruitment of proliferating and progenitor cells. However, 
this response ultimately culminated in astrogliosis at the wound edge, with an 
absence of neuronal replacement within the injured tissue. 
3.4.1 Acute focal brain lesion induces substantial cell proliferation and 
alterations in endogenous neural progenitor cells 
Similar to previous reports investigating the cellular response to more disruptive 
forms of brain injury, results from this chapter demonstrated that cell proliferation 
was a prominent feature of the post-injury response. In this regard, cell proliferation 
has been demonstrated to occur in a variety of brain lesion paradigms (for example 
Dash et al., 2001; Jin et al., 2001; Kernie et al., 2001; Chirumamilla et al., 2002; 
Parent et al., 2002a, b; Gotts and Chesselet, 2005; Ramaswamy et al., 2005; Tatsumi 
et al., 2005). Importantly, injury-induced proliferating cells may include populations 
of endogenous neural progenitor cells. In this chapter, neural progenitor cells were 
assessed based on immunoreactivity and expression of nestin. 
Both this and other investigations have reported that the basal population of nestin-
labelled cells is relatively small within normal non-compromised mature brain tissue, 
particularly in regions such as the neocortex (Douen et al., 2004), and is generally 
restricted to small populations of endothelial and SVZ cells (Sahin Kaya et al., 
1999). However, various models of brain insult, including physical/mechanical 
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trauma (Holmin et al., 1997; Sahin Kaya et al., 1999; Kernie et al., 2001; 
Chirumamilla et al., 2002; Chen et al., 2003a; Douen et al., 2004), ischemia/stroke 
(Duggal et al., 1997; Li and Chopp, 1999; Arvidsson et al., 2002; Tonchev et al., 
2003), intracerebral haemorrhage (Nakamura et al., 2003), chemical lesions/seizure 
(Clarke et al., 1994) and ionising radiation (Shi et al., 2002), have demonstrated 
prominent spatio-temporal alterations in the neural progenitor cell population, 
including proliferation and lesion-directed migration as well as changes in nestin 
expression, localisation and distribution. 
Results from this chapter demonstrated that nestin-labelled cells, which had 
proliferated within the first post-injury week, were localised to the SVZ and 
perilesion cortical parenchyma. Additionally, nestin immunoreactivity was increased 
within the SVZ and corpus callosum at 1-day post injury, which extended to the 
lesion site by 7 days following injury and thereafter gradually declined, to be 
retained as a remnant within the original lesion tract. This spatio-temporal pattern of 
nestin re-distribution was suggestive of the mobilisation of nestin-labelled cells 
towards the lesion site. Moreover, utilising quantitative real time RT-PCR, 
alterations in nestin immunoreactivity were demonstrated to reflect changes in nestin 
expression, which was significantly elevated within the SVZ, lesion and perilesion 
tissue at 1 day following post-injury and returned to control levels by 28 days post-
lesion. Collectively, these results support those of previous studies implicating 
progenitor cell proliferation and migration in the neural response to injury. The 
onset of alterations in nestin expression/induction has been reported to vary from a 
few days to several weeks post-injury (for example Duggal et al., 1997; Holmin et 
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al., 1997; Li and Chopp, 1999; Sahin Kaya et al., 1999; Chen et al., 2003a; Douen et 
al., 2004). 
3.4.2 Nestin induction and cell proliferation are important makers of neural 
injury and are implicated in brain healing 
Importantly, injury-induced nestin cell production is not the only source of nestin 
expression following injury and previous reports have indicated nestin re-induction 
following brain injury may arise from two potential sources; the proliferation of 
resident nestin progenitors and the embryonic reversion of the mature cytoskeleton 
of reactive astrocytes, oligodendrocytes, microglia, monocytes/macrophages and 
neurons (Clarke et al., 1994; Lin et al., 1995; Duggal et al., 1997; Holmin et al., 
1997; Brewer, 1999; Brook et al., 1999; Li and Chopp, 1999; Sahin Kaya et al., 
1999; Kernie et al., 2001; Kuroda et al., 2002; Nakamura et al., 2003). To determine 
the localisation of nestin to various neural cell types, double-labelling 
immunofluorescence studies were performed. Nestin was not localised within 
microglial/macrophage or neuronal populations. However, nestin and GFAP were 
co-localised in glial-like cells surrounding the lesion site. 
Observations of nestin cell proliferation, distinct spatio-temporal alterations in nestin 
expression and re-distribution between the SVZ and injury site, as well as astrocytic 
proliferation and co-localisation of nestin and GFAP, support roles for both nestin re-
expression in reactive astrocytes and the elaboration of astrocytes from resident 
progenitor and proliferating cells as mechanisms of brain healing following injury. 
Indeed, these mechanisms have been implicated in formation of the glial scar, brain 
86 
Chapter 3 
remodelling and healing (Sahin Kaya et al., 1999; Kernie et al., 2001; Chen et al., 
2003a, b; Douen et al., 2004; Moon et al., 2004; Salman et al., 2004, Tatsumi et al., 
2005). 
3.4.3 Neurogenesis is a potential mechanism of brain healing following injury 
Results from this study suggest that injury-induced proliferating and progenitor cells 
predominantly adopt a glial (astrocytic) phenotype. However, profound alterations 
elicited in endogenous neural progenitor cells following brain 'lesion are particularly 
remarkable as these cells have the capacity to generate astrocytes, oligodendrocytes 
and, importantly, neurons (Von Visger et al., 1994; Taupin and Gage, 2002). Indeed, 
neural progenitor cells residing in germinal regions of the adult brain have been 
shown to generate neurons throughout life (Johansson et al., 1999) in a range of 
mammalian species including rodents (Kuhn et al., 1996; Cameron and McKay, 
2001), primates (Gould et al., 1999; Bernier et al., 2002) and humans (Eriksson et al., 
1998; Bedard and Parent, 2004). Endogenous progenitors may differentiate into 
neurons from pools of cells within the SVZ and the cortical parenchyma (Dayer et 
al., 2005;.  Emsley et al., 2005). 
Importantly, recruitment, differentiation and integration of various stem, precursor, 
progenitor, proliferating and/or migrating cells, into existing neural circuits has 
provoked speculation that these cells may be responsible for contributing to neuronal 
replacement and functional recovery following various forms of experimental brain 
insult (Gu, 2000; Magavi et al., 2000; Kernie et al., 2001; Braun et al., 2002; Rice et 
al., 2003; Chen et al., 2003b). In this regard, several studies have demonstrated 
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evidence of neuronal production in response to experimental brain injury (Kernie et 
al., 2001; Chen et al., 2003b; Rice et al., 2003; Tonchev et al., 2003), providing 
support for neurogenesis as a mechanism of brain repair following TBI (Kernie et al., 
2001; Rice et al., 2003). However, results from this chapter and other investigations 
(Ho1min et al., 1997; Kuroda et al., 2002; Yoshiya et al., 2003; Douen et al., 2004; 
Salman et al., 2004) have not reported neurogenesis as a mechanism of cell 
replacement following brain lesion. 
3.4.4 Why does the potential for neurogenesis differ with injury paradigm? 
The absence of neurogenesis in the present investigation may be due to the location 
and severity of the injury. Many models of cortical lesion generate widespread 
neural damage (Dixon and Hayes, 1996; Hicks et al., 1997; Hallam et al., 2004; 
Thompson et al., 2005), which often directly affects regions associated with high 
plasticity, such as the SVZ or hippocampus, or at least damages cortex more 
extensively. The injury model utilised in this chapter, however, specifically targets 
the grey matter of the neocortex and may not evoke the same signalling mechanisms 
initiated in more disruptive forms of trauma. The absence of constitutive cortical 
neurogenesis has been postulated to result from a lack of appropriate micro-
environmental cues, rather than a limit of the endogenous precursors themselves 
(Emsley et al., 2005), and this deficiency may also account for limited or absent 
neurogenesis following cortical injury in the present study. 
This proposition is supported by findings regarding DCX labelling of migrating 
neuroblasts. Normally, neuroblasts are produced in the SVZ, migrate in the rostra! 
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migratory stream to the olfactory bulb and differentiate into olfactory granule 
interneurons (Lois and Alvarez-Buylla, 1994; Lois et al., 1996; Francis et al., 1999; 
Gleeson et al., 1999; Bedard and Parent, 2004; Yang et al., 2004). It has been 
suggested that these cells may be re-directed to sites of injury, where they contribute 
to neuronal and/or glial replacement (Jin et al., 2003; Goings et al., 2004; Romanko 
et al., 2004; Gotts and Chesselet, 2005; Ramaswamy et al., 2005). However, results 
from this chapter indicate that DCX labelling was absent from perilesion tissue and 
therefore not involved in neuronal replacement in this injury model. This was 
potentially due to a lack of appropriate 'pro-neurogenesis' cues. Conversely, using a 
non-physical brain lesion model that specifically induces apoptotic death in the 
neocortical grey matter Magavi et al. (2000) have demonstrated the long-term 
neuronal replacement capability of lesion-induced proliferating and progenitor cells. 
Thus, although diverse brain lesion paradigms appear capable of inducing the 
generation of new cells, the ultimate neurogenic potential of these cells is likely to be 
dictated by the combined influences of the lesion paradigm, extent of damaged 
created by the lesion and the brain regions directly and indirectly affected the lesion 
(Lie et al., 2004). Importantly, reports of injury-induced cells exhibiting an early, 
robust lesion-directed migratory response highlight a window of opportunity in 
which neuronal fate may be encouraged prior to establishment of scar tissue. 
Although results from this chapter did not report the occurrence of neurogenesis in 
response to cortical injury, they do support the view that the damaged brain instigates 
an adaptive reparative response and emphasise the role of neural progenitor and 
proliferating cells in contributing to this respOnse. 
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3.5 Conclusion 
In summary, this study has demonstrated that cell proliferation and neural progenitor 
cell induction are major reparative mechanisms in the healing response following 
acute focal brain injury. Importantly, this study provides evidence that a lesion 
specific to the grey matter of the neocortex is capable of evoking changes within 
associated parenchymal regions as well as at sites distant to the lesion, that were 
spared from direct injury. In this regard, the results from this chapter suggest that 
brain injury induces a sequence of alterations, involving cell generation and 
activation, which contribute to a wound healing-like response, similar to that 
observed in tissues such as the skin. The differentiation of proliferating and 
progenitor cells, as well as nestin re-expression in reactive astrocytes are important 
mechanisms underlying this healing response and the ultimate formation of a glial 
scar at the wound border. 
Additionally, previous studies have also implicated neurogenesis in this healing 
process. Collectively, reports of injury induced neuro- and glio-genesis and altered 
patterns of cell migration indicate intrinsic repair mechanisms are initiated in the 
damaged brain directed at self-repair (Pluchino et al., 2005). These studies 
emphasise the generally unappreciated level of plasticity and highly adaptive nature 
of the adult mammalian brain. Finally, exogenous manipulation of injury-induced 
proliferating and endogenous neural progenitor cells provides a viable therapeutic 
target for enhancing the brain's response to injury and disease (for recent reviews see 
CaIza et al., 2004; Mitchell et al., 2004; Picard-Riera et al., 2004; Schouten et al., 
2004; Pluchino et al., 2005). 
90 
Chapter 3 
However, whether brain injury evokes an endogenous neurogenic response that 
contributes to functional recovery remains contentious. Indeed, along with increased 
acceptance of adult neurogenesis, scepticism has arisen regarding the existence of 
neurogenesis in non-neurogenic regions, as well as the techniques used to confirm 
such assertions (Kornack and Rakic, 2001, Koketsu et al., 2003). This study has 
highlighted important aspects of the endogenous neural response to injury and 
provided important avenues for future research into brain regeneration. Full 
investigation of these mechanisms will provide important clues as to how 
endogenous brain repair mechanisms can be facilitated. 
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Acute focal brain injury induces a stereotypical sequence 
of reactive and regenerative changes in both neuronal 
and glial cell populations directed at brain healing 
4.1 Introduction 
Significant pessimism has traditionally surrounded the capacity of the adult 
mammalian brain to recover both structurally and, more importantly, functionally 
following TBI. Trauma to the brain causes tissue deformation at the time of injury, 
which may be associated with axonal shearing, contusions, haemorrhages and 
oedema (Finnie and Blumbergs, 2002). Collectively, these perturbations culminate 
in substantial tissue damage, widespread neural disruption and degeneration, 
including both necrotic and apoptotic neuronal death (Newcomb et al., 1999; Liou et 
al., 2003). In addition to degenerative cascades, brain injury also initiates complex 
reactive, cellular, inflammatory, neuro-chemical and metabolic alterations (Maxwell 
et al., 1997; Finnie and Blumbergs, 2002), which affect astrocyte, microglial, 
oligodendrocyte and neuronal cell populations, as well as brain vasculature (Chen et 
al., 2003a). 
Despite the limited recovery generally observed following head trauma, several lines 
of research have demonstrated striking examples of brain plasticity (for example 
Darian-Smith and Gilbert, 1995; Carlen et al., 2002; Englund et al., 2002; Knott et 
al., 2002). Moreover, this phenomenon has been supported by observations of 
spontaneous, though frequently partial, recovery of function following stroke, spinal 
cord injury and human acquired brain injury (Goldberger and Murray, 1988; Wilson, 
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1998; Medana and Esiri, 2003; Constantinidou et al., 2005; Ding et al., 2005). 
Indeed, several studies in animal models of brain trauma suggest that neurons from 
the adult CNS respond to injury with a complex sequence of morphological, 
biochemical and gene expression alterations, directed towards sprouting, 
regeneration, synaptogenesis and even neurogenesis (Christman et al., 1997; Deller 
and Frotscher, 1997; Pastor et al., 2000; Vickers et al., 2000; King et al., 2001; Lie et 
al., 2004). Furthermore, the neuronal response to injury involves potentially 
adaptive alterations, including the re-expression of developmentally important 
proteins and substantial cytoskeletal reorganisation (Christman et al., 1997; Dickson 
et al., 2000; King et al., 2001). 
Additionally, astrocyte, oligodendrocyte, microglial and macrophage populations 
have all been shown to undergo substantial reactive alterations following various 
forms of brain insult (Maxwell et al., 1990; Fujita et al., 1998; King et al., 2001; 
Finnie and Blumbergs, 2002; Tonchev et al., 2003; Chen et al., 2003a; Lee et al., 
2003; Davalos et al., 2005). However, whether these non-neuronal cell populations 
have a primarily facilitative or detrimental contribution to neuronal regeneration 
remains to be elucidated (Ridet et al., 1997; Finnie and Blumbergs, 2002; Batchelor 
et al., 2002). Furthermore, it has been suggested that the ultimate effect of injury-
induced glial activation may depend on the combined influences of injury severity, 
neural disruption, micro-environmental cues and the brain region affected (Ridet et 
al., 1997). Nevertheless, these studies indicate that CNS injury initiates a sequence 
of adaptive alterations, involving all major neural cell populations, directed at tissue 
healing and scar formation (Fawcett and Asher, 1999). In this regard, this response 
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reflects the stereotypical phases of healing, such as coagulation, inflammation, 
proliferation, migration and remodelling, observed in other tissues (Hunt et al., 
2000). However, the culmination of these changes may ultimately impede neuronal 
regeneration (Fawcett, 1997, Fawcett and Asher, 1999). 
The previous chapter demonstrated the rapid induction of cell proliferation and 
neural progenitor cell activation following brain injury and discussed the potential 
role of these cell populations in brain healing. However, brain injury typically 
affects several neural populations, particularly those at the immediate site of damage. 
Therefore, this study investigated the alterations occurring in key neuronal and glial 
cell populations in response to injury and sought to determine which of these 
alterations may be indicative of endogenous brain repair. Immunohistochemical 
techniques and quantitative gene expression analysis were utilised to characterise the 
spatio-temporal co-ordinated neuro-glial response of various cell populations in 
response to focal brain injury. Specifically, alterations in populations of astrocytes, 
microglia, macrophages, oligodendrocytes, perivascular cells and, importantly, 
neurons were examined over a time course of 84 days following localised injury of 
the rat somatosensory cortex. Real-time RT-PCR was utilised to determine whether 
the cellular neuronal response to injury was reflected by changes at the gene 
expression level. Results from this study are discussed in relation to an accumulating 
body of evidence indicating that neuro-glial interactions are fundamental to brain 
healing following trauma. 
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4.2 Experimental procedures 
4.2.1 Immunohistochemistry 
Following transient neocortical injury (as described in Section 2.1.2, Figure 2.1), 
animals were terminally anaesthetised at 1, 7, 14, 21, 42 or 84 days post-injury (n = 3 
per time point). Non-injured, age-matched controls corresponding to the 1, 42 and 
84 days post-injury time points (n=3 per time point) were also perfused. Tissue was 
processed and sectioned for immunohistochemistry as described in Section 2.1.4. 
Tissue sections were labelled with a battery of antibodies directed at various cell 
populations or neuronal compartments as indicated in Table 4.1 (specific antibody 
details are provided in Table 2.1). Neuronal populations and cellular compartments 
were identified based on immunoreactivity for NF-M, parvalbumin, calretinin, 
SMI312, GAP-43 and MAP-2. Astrocytes were identified based on GFAP labelling, 
microglia/macrophages on ferritin labelling and oligodendrocytes were labelled with 
myelin/oligodendrocyte specific protein. Cell proliferation was assessed based on 
BrdU incorporation as described in Section 2.1.3. Specific antibody details are 
provided in Table 2.1. 
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Table 4.1. Antibodies/cell stains utilised to identify different neural cell 
populations 
Cell type/compartment 	 Marker 
Pyramidal neurons 	 NF-M 
Interneurons 	 Calretinin 
Parvalbumin 
Axons 	 SMI312 
GAP-43 
Dendrites 	 MAP-2 
Astrocytes 	 GFAP 
Microglia/macrophages 	 Ferritin 
Oligodendrocytes 	 Oligodendrocyte specific protein 
Proliferating cells 	 BrdU 
Microglia and perivascular cells 	Isolectin 1B4 
4.2.2 Total RNA extraction and quantitative one-step real-time RT-PCR 
Following transient neocortical injury animals were terminally anaesthetised at 1, 7, 
14 and 28 days post-injury (n = 4 per time point). Non-injured, age-matched 
controls corresponding to the 1 and 28 day post-injury time points (n=3 per time 
point) were also perfused. Tissue was dissected from the perilesion region 
immediately lateral and medial to the lesion site, as displayed in Figure 4.1, and 
these two tissue blocks were pooled. Quantitative one-step real-time RT-PCR was 
performed as described in Section 2.1.6, to determine alterations in NF-L, NF-H, 
PIII-tubulin and GAP-43 mRNA following localised neocortical injury, using the 
primer pairs displayed in Table 2.2. Statistical analysis indicated that the two groups 
of control animals were not statistically different and the data for these animals were 
therefore pooled to form one control group (n = 6). 
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Figure 4.1 Diagrammatic representation of sites from 
which tissue was harvested for RNA extraction to be 
assessed by quantitative real time RT-PCR analysis 
Tissue was harvested from regions region immediately 
medial and lateral to the injury site (dotted boxes). These 
2 tissue samples were pooled prior to RNA extraction. 
CC, corpus callosum; SVZ, subventricular zone; St, 
striatum. 
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4.3 Results 
4.3.1 General lesion morphology and histopathology 
Macroscopically, the lesion was initially characterised by tissue cavitation and 
destruction, vascular damage and bleeding. Over the time course examined, these 
alterations resolved and were associated with skull and meningeal repair as well as 
reduced lesion size. Overall, microscopic analysis demonstrated no detectable 
histopathological changes in control brains or in brain regions contralateral to the 
lesion site. However, focal neocortical injury resulted in substantial ipsilateral tissue 
destruction at the site of the lesion as well as in the surrounding perilesion zone, 
including a disruption of glial and neuronal cell populations as well as blood vessels. 
Occasionally a tissue 'plug' was retained within the lesion cavity, consisting of 
degenerating cells and other cell populations that had invaded the injury site. 
4.3.2 The astrocytic response to acute structural brain injury 
The response of the astrocyte population to acute brain injury was determined based 
on immunoreactivity for the cytoskeletal protein GFAP. Examination of astrocytes 
within perilesion tissue demonstrated alterations indicative of rapid activation 
(Figure 4.2). Prior to injury, GFAP immunoreactive astrocytes demonstrated stellate 
morphology and formed a dense network throughout the brain parenchyma, 
particularly in the neocortical grey matter. These cells displayed typically small cell 
bodies and elaborated several slender, tapered processes (Figure 4.2A). GFAP-
labelled cells underwent substantial morphological alterations in response to injury, 
including transformation from a stellate to elongated, morphology (Figure 4.2B). 
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Figure 4.2 	Astrocytes underwent changes indicative of activation in response 
to acute structural neocortical injury, including proliferation, morphological 
alteration and re-distribution 
Astrocytes were assessed based on immunoreactivity for GFAP. In the non-injured 
cortex and at sites distant from neocortical lesion, astrocytes displayed a stellate 
morphology defined by a small soma from which emanated several radially 
extending processes (A, arrows). In response to injury, astrocytes exhibited an 
activated morphology, including elongated somal shape, parallel cell arrangement 
and re-orientation towards the lesion (B, arrows). Additionally, double 
immunofluorescence labelling for GFAP (C) relative to BrdU (D) demonstrated that 
astrocytes proliferated extensively in response to injury (arrows denote examples of 
proliferating astrocytes, see also Figure 3.11A). By 42 days following injury, 
astrocytes had formed a dense plexus at the lesion border, indicative of glial scar 
formation (E, dotted line denotes lesion border, arrows denote scar tissue, see also 
Figure 4.5C). 
Scale bar: A and B = 50mm; C and D = 10[1m; E = 120ium. 
• 
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Furthermore, astrocyte cell bodies underwent hypertrophy, lost their defined 
processes and adopted a streamline morphology and parallel cell arrangement, which 
was directed towards the lesion boarder. Double-labelling immunohistochemistry 
for BrdU demonstrated that a proportion of GFAP immunopositive cells were 
mitotically active following injury (Figure 4.2C and D, see also Figure 3.11A from 
chapter 3). These typically reactive alterations in the astrocyte cell population were 
evoked as early as one day following injury and persisted up to several weeks 
following injury. By 42 days following injury a dense astrocytic plexus, or glial 
scar, had formed lining the lesion border and astrocytes with morphology and GFAP 
content equivalent to pre-injured tissue populated the perilesion zone (Figure 4.2E). 
Interestingly, although astrocytes were shown to be mitotically active within the 
perilesion tissue, as time progressed fewer GFAP-labelled cells contained BrdU 
immunoreactive nuclei and BrdU-labelled nuclei had predominantly localised to the 
injury border. These findings support the view that newly formed astrocytes were 
contributing to the formation of the glial scar. Additionally, astrocytes may have 
been dying, accounting for a decrease in GFAP-BrdU labelled cells. Alternatively, 
astrocytes may have been proliferating excessively, diluting out the concentration of 
BrdU beyond detectable levels. 
4.3.3 The microglial/macrophage response to acute structural brain injury 
In the present study, alterations in microglial and macrophage populations were 
examined based on cellular content of ferritin, an iron binding protein expressed in 
activated microglia and macrophages (Barron, 1995; Zhang and Olsson, 1995; 
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DiPatre and Gelman, 1997). Additionally, tissue sections were also labelled with 
fluorescence-tagged Isolectin IB4, which has been demonstrated to label brain 
microglia (Dailey and Waite, 1999) as well as perivascular cells. Labelling of 
control, non-injured tissue indicated only a very small population of ferritin-labelled 
microglia existed within the brain parenchyma. 
Following injury, a substantial increase in ferritin and Isolectin IB4 cells was 
observed associated with the injured cortical tissue (Figure 4.3 and Figure 4.5). As 
early as one day following injury, numerous ferritin and Isolectin IB4 labelled cells 
were observed within and immediately surrounding the lesion site. Ferritin-labelled 
microglia/macrophages were particularly abundant within and surrounding the lesion 
site by seven days following injury, when labelled cells extended in a large zone 
surrounding the lesion site in the neocortical grey matter and sometimes extending 
into the subcortical white matter (Figure 4.3A). Additionally, numerous cells had 
infiltrated the lesion cavity. Although these cells were a prominent feature of the 
injured tissue, labelling gradually declined over the time course examined with few 
labelled cells remaining by 42-84 days following injury. Double-labelling analysis 
demonstrated that ferritin positive microglia and macrophages underwent substantial 
proliferation in response to cortical injury, as indicated by BrdU incorporation 
(Figure 4.3B, see also Figure 3.11B, Chapter 3). Similar to the astrocytic population, 
the proportion of ferritin-BrdU co-labelled cells (i.e. proliferating 
microglia/macrophages) decreased over time. This may be explained by cell death, 
ongoing proliferation, which diluted the BrdU beyond detectable levels and/or the 
return of some of these cells to circulation. 
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Figure 4.3 	Microglia and macrophages underwent substantial proliferation 
in response to acute structural neocortical injury and infiltrated the lesion site. 
Labelling for activated microglia/macrophages (with ferritin, red and Isolectin IB4, 
green) demonstrated an influx of these cells into injured tissue by 7 days following 
injury (A). Arrows in A denote examples of ferritin-isolectin IB4 labelled microglia, 
arrowheads denote examples of isolectin IB4 labelled blood vessels. Double 
labelling for ferritin (red) relative to BrdU (green) demonstrated that 
microglia/macrophages were highly proliferative within perilesion tissue (B). Dotted 
lines denote the lesion border. 
Scale bar: A = 201.1,m; B = 401..tm 
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Brain microglia underwent marked morphological 'alterations in response to injury, 
which correlated with distance from the lesion site (Figure 4.4A). In non-injured 
control tissue and at sites more distant from the lesion (generally greater that 150- 
200p,m), ferritin labelled-cells demonstrated distinct ramified morphology, whereby 
numerous branched processes emanated from a rounded cell body (Figure 4.4B). In 
the perilesion tissue, close to the injury site (generally within 100[Am of the lesion 
border) ferritin-labelled cells demonstrated both rounded and ramified morphology, 
but were generally rounded, possessing either short stumpy processes or a lack of 
processes, within closer proximity to the lesion cavity (Figure 4.4C). 
4.3.4 Differential distribution of astrocytes and microglia/macrophages within 
injured cortical tissue. 
To determine the interactions between two of the primary injury-related glial cell 
populations, namely astrocytes and microgli a/macrophages, following acute 
structural neocortical injury, brain sections were double labelled for ferritin and 
GFAP (Figure 4.5). These studies showed that astrocytes and 
microglia/macrophages populated discrete regions of the injured cortical tissue. 
Although microglia/macrophages were localised throughout the perilesion tissue, 
they were most abundant within the lesion cavity and by seven days following injury 
had substantially infiltrated this region, whereas astrocytes were activated 
immediately around the lesion border (Figure 4.5A). Interestingly, blood vessels 
were observed within some lesion sites by seven days following injury. Double 
labelling for ferritin and GFAP demonstrated the different distributions of 
microglia/macrophages and astrocytes around vascular structures, for example 
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Figure 4.4 	Brain microglia underwent substantial morphological alteration 
in response to acute structural neocortical injury 
Activated microglia/macrophages were generally absent from the non-injured 
neocortex, as indicted by very few ferritin labelled cells within the cortical 
parenchyma. In response to injury microglia/macrophages infiltrated the lesion site 
and underwent marked morphological alterations (A, dotted line in top right denotes 
lesion border). At sites more distant from the lesion (generally > 150-200w) 
microglia demonstrated distinct ramified morphology, indicated by small cell bodies 
elaborating numerous branched processes (B). With closer proximity to the lesion 
(generally < 1001.tm), microglia/macrophages exhibited an activated morphology, 
characterised by the loss of processes and hypertrophied cell bodies (C). 
Scale bar: A = 301,tm; B and C= 151..tm 
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astrocytes were observed surrounding blood vessels within the perilesion tissue, 
where they potentially contributed to formation of the blood-brain barrier, whereas 
microglia/macrophages were localised around blood vessels within the lesion cavity 
(Figure 4.5A inset). Between 21 and 42 days following injury, activated 
microglia/macrophages were still located within the perilesion tissue, but had 
diminished within the lesion cavity, whereas some extended into the lesion cavity 
(Figure 4.5 B and C). By 42 days following injury, a distinct astrocytic remnant had 
formed within the tract of the initial needle injury and this site was generally free of 
microglia and macrophages (Figure 4.5C). 
4.3.5 Oligodendrocyte/myelin-associated changes following acute structural 
brain injury 
To determine alterations in oligodendrocytes/myelin following acute structural brain 
injury, tissue sections were labelled with an antibody specific for CNS 
myelin/oligodendrocytes (Figure 4.6). As expected, labelling was abundant within 
the white matter tracts of the brain. Additionally, in the non-injured cortex labelling 
was distributed throughout the cortical parenchyma, demonstrating punctate 
distribution which was more abundant in deeper, than superficial cortical laminae 
(Figure 4.6A). By seven days following cortical injury a loss of labelling was 
observed within the immediate perilesion zone, this extended deeper into the cortical 
laminae and myelin degeneration was indicated by granular remnants in the 
immediate perilesion tissue (Figure 4.6B). At 21 and 42 days following injury, 
increased labelling for myelin was observed around the lesion border (Figure 4.6C 
and D). This labelling had a distinct distribution and was localised to filamentous 
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Figure 4.5 	Astrocytes and microglia/macrophages populated different 
regions of the injury site 
Double immunofluorescence labelling for astrocytes (GFAP, green), relative to 
microglial/macrophages (ferritin, red) demonstrated that microglia/macrophages had 
infiltrated the lesion site by 1 week following injury, whereas astrocytes were 
activated at the lesion border (A). Arrowheads and inset in A show a blood vessel 
that has invaded the lesion site and highlights the different localisations of astrocytes 
and microglia around this structure. By 3 weeks post-injury some astrocytes had 
invaded the lesions site and, although still present within the lesion cavity, microglia 
were diminished in number (B). At 6 weeks following injury few microglia 
remained in the lesion cavity (C), however, similar to earlier time points, activated 
microglia were still observed with perilesion tissue. The needle tract had largely 
closed over by 6 weeks following injury, as indicated by an astrocytic remnant 
(arrowheads in C). Dotted line in each image denotes the lesion border. 
Scale bar: 1001,tm 

Figure 4.6 	Acute structural neocortical injury resulted in a loss of labelling 
for oligodendrocytes/myelin within perilesion tissue, followed by increased 
labelling several weeks following injury 
Oligodendrocytes/myelin were visualised by labelling tissue sections with an 
antibody for oligodendrocyte/myelin specific protein, located within the 
oligodendroglial cell membrane. In non-injured tissue, labelling was relatively 
punctate throughout the cortical laminae, with relatively little labelling observed 
within superficial cortical layers (A). By 1 week following injury, labelling within 
perilesion tissue was diminished relative to controls and sometimes this extended 
into the initial lesion tract (arrows in B). At both 3 and 6 weeks following injury, 
increased labelling for oligodendrocyte/myelin specific protein was observed at the 
lesion border (C and D respectively). Inset in C is a high magnification image of 
oligodendrocyte/myelin specific protein labelling at the immediate injury border. 
as 
This labelling was localised,neurite-like structures. Dotted line in each image 
denotes the lesion border. 
Scale bar: A — D = 100ium; inset = 20tim 
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structures within the perilesion zone (Figure 4.6C inset), possibly resembling re-
myelination within this region. Double labelling studies for myelin relative to NF-M 
(Figure 4.7), demonstrated the association of these proteins within the non-injured 
(Figure 4.7A) and injured (Figure 4.7B) neocortex. Numerous axons were co-
labelled throughout the cortical laminae for these proteins. Interestingly, NF-M 
labelled processes within the injury site were often closely associated with 
filamentous structures labelled for oligodendrocyte/myelin specific protein (Figure 
4.7B, inset). 
4.3.6 Changes in brain vasculature in response to brain injury 
In an attempt to identify potential alterations in brain vasculature as a result of 
cortical lesion, tissue sections were labelled with the cellular stain Isolectin IB4 
(Figure 4.8). In non-injured tissue sections, numerous blood vessels were labelled 
with Isolectin IB4. The largest of these vessels were orientated perpendicular to the 
brain surface and were interconnected by numerous smaller vessels (Figure 4.8A). 
At 1 day following injury, limited Isolectin 1B4-labelled blood vessels remained 
immediately surrounding the lesion site (Figure 4.8B). However, by seven days 
post-injury numerous Isolectin 1B4-labelled blood vessels were observed around the 
lesioned region (Figure 4.8C) and by 84 days post-injury vascularisation of the 
cortical tissue appeared relatively normal (Figure 4.8D), indicating the occurrence of 
injury-induced vascular re-modelling. 
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Figure 4.7 	Distribution of oligodendrocyte/myelin specific protein relative to 
NF-M 
Double labelling for oligodendrocyte/myelin specific protein (green), relative to NF-
M (red) demonstrated co-localisation of these markers throughout the cortical 
laminae in the non-injured brain (A). By 7 days following injury (B), NF-M was 
localised to sprout-like protuberances within the lesion cavity and these structures 
were closely associated similar filamentous structures labelled for 
oligodendrocyte/myelin specific protein (B, inset). 
Scale bar: A and B =1001..tm; inset = 2011m 

Figure 4.8 	Acute structural brain injury induced vascular re-modelling 
around the lesion site 
Alterations in cortical vasculature were analysed based on isolectin IB4 labelling. 
Blood vessels in the non-injured cortex were characterised by parallel oriented large 
vessels, interconnected by smaller randomly oriented vessels (A, brain surface lies 
directly above asterisk). Neocortical injury resulted in a substantial loss of blood 
vessels within perilesion tissue (B, injury site lies directly above asterisk). By 7 days 
following injury numerous blood vessels were apparent surrounding the lesion site 
(C, asterisk lies directly left of lesion border) and by 84 days post-injury relatively 
normal vasculature had been restored around the lesion site (D, brain surface lies 
directly above asterisk). Images were taken from equivalent regions of cortical grey 
matter (layers I-IV) at each time point. Images B-D were taken from 
perilesion tissue in the immediate vicinity of the lesion site. 
Scale bar: 201.tm 
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4.3.7 The neuronal response to acute structural brain injury 
Utilising a battery of antibodies directed at different neuronal cell populations and 
compartments, as well as techniques to enable identification of specific alterations in 
neuronal gene expression, the response of neocortical neurons to injury was 
examined. As anticipated, preliminary immunohistochemical analysis confirmed 
that the non-compromised neocortex was comprised of specific neuronal 
populations, including interneurons and pyramidal cells, with distinct columnar and 
laminar organization (Figure 4.9). Pyramidal cells in layers II/III and V of the 
neocortex were labelled for the neurofilament triplet proteins, NF-L, NF-M and NF-
H (Figure 4.9A). The cell bodies and dendrites of pyramidal cells as well as 
numerous other neuronal processes demonstrated labelling for 13111-tubulin (Figure 
4.9B). Calretinin (Figure 4.9C) and parvalbumin (Figure 4.9D) were localised to 
distinct sub-classes of cortical interneurons. MAP-2 was typically localised to the 
apical dendrites of pyramidal cells (Figure 4.9E), whereas phosphorylated 
neurofilaments (as determined by SMI312 labelling) were localised to axons (Figure 
4.9F) and GAP-43 was distributed homogenously throughout the cortical tissue 
(Figure 4.9G). 
Focal neocortical injury evoked a series of reactive and regenerative neuronal 
alterations (Figure 4.10 and Figure 4.11). Following injury, immunohistochemical 
labelling demonstrated substantial alterations in a majority of the neuronal markers 
examined. Initially the lesion boarder was characterised by a range of degenerative 
and reactive changes. These included the abnormal accumulation of phosphorylated 
neurofilament proteins, normally localised to axons (Figure 4.10A), into bulb- and 
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Figure 4.9 	A variety of neuronal markers enabled the various neuronal 
populations and cellular compartments to be visualised with in the rodent 
neocortex 
Low magnification images on left of each panel demonstrate the distribution of each 
marker throughout the cortical laminae, high magnification images on the right of 
each panel show the localisation of each marker within different types of cortical 
neurons. NF-M (A) and f3111-tubulin (B) were largely restricted to cortical pyramidal 
cells as well as numerous neurites within the cortical parenchyma, whereas calretinin 
(C) and parvalbumin (D) were localised to cortical interneuron populations. MAP2 
(E) was generally restricted to the large apical dendrites of cortical pyramidal 
neurites, phosphorylated neurofilaments (F, SMI3 12 labelling) were restricted to 
axons distributed throughout the cortical laminae and GAP-43 was distributed 
homogenously throughout the cortical tissue (G). Arrows in each image denote 
examples of cortical pyramidal/non-pyramidal neurons. 
Scale bar: low magnification = 120t.tm; high magnification = 

Figure 4.10 Cortical injury evoked substantial neuronal degeneration as well 
as a series of reactive cytoskeletal associated alterations 
SMI312, a cocktail of antibodies directed at phosphorylated neurofilaments typically 
localised to axons, was utilised to determine to the axonal response to structural 
injury. SMI312 immunoreactive axons were distributed throughout the non-injured 
cortex, particularly in layer I (A). By 7 days post-injury phosphorylated 
neurofilaments had accumulated into abnormal ring- and bulb-like structures 
(arrowheads in B) and were localised to swollen axons (arrows in B). 
Scale bar: A = 40m; B = 80Rm 
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ring-like structures as well as distinctive neurite swelling (Figure 4.10B). Neurite 
degradation was also a prominent feature of the injury site, manifesting as blebbing 
and beading of neurite structure. These alterations were most abundant between one 
and seven days post-injury and after 14 days post-injury were no longer observed. 
From seven days post-injury onwards, cellular alterations indicative of attempts by 
the injured neurons to regenerate were apparent. Concomitant with the subsidence of 
reactive cytoskeletal alterations was a distinctive neurite sprouting response (Figure 
4.11). Neurite sprouts were elaborated into the injury cavity and were most abundant 
at 7 days post-injury. Although sprouts were also present within the lesion site at 
post-injury intervals of up to 42 days, they were generally not observed beyond 14 
days post-injury. Neurite sprouts were confirmed to be positive for phosphorylated 
neurofilaments (Figure 4.11A) the neurofilament triplet proteins, NF-L, NF-M, NF-
H (Figure 4.11B), 13111-tubulin (Figure 4.11C) and GAP-43 (Figure 4.11D), but not 
MAP-2, suggesting that they were derived from an axonal, rather than dendritic, 
origin. Interestingly, injury-induced sprouts were often closely associated with 
activated microglia/macrophages within the lesion cavity (Figure 4.12). In this 
regard, sprout trajectories often appeared to bend or weave around 
microglia/macrophages, which had infiltrated the lesion site. 
4.3.7.1 Alterations in neuronal gene expression in response to acute structural 
neocortical injury 
To determine whether the injury-induced sprouting response was reflected by 
changes at the gene expression level, real-time RT-PCR was performed to analyse 
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Figure 4.11 Regeneratively sprouting neurites, elaborated into the lesion site 
within a week following injury, were positive for a range of cytoskeletal and 
growth-associated markers, excluding the dendritic protein, MAP2 
By 7 days post-injury numerous sprout-like protuberances had been elaborated into 
the lesion cavity. These processes were immunoreactive for phosphorylated 
neurofilaments (A), NF-M (B), 	 (C) and GAP-43 (D), but not MAP2, 
indicating that they were likely to be of axonal origin. 
Scale bar: 80[tm 

Figure 4.12 Injury-induced axonal sprouts were often closely associated with 
activated microglia/macrophages 
Double immunofluorescence labelling for phosphorylated neurofilaments (SMI312) 
relative to ferritin indicated a close association between sprout-like protuberances 
(arrows in A and B) and activated macrophages and microglia (arrowheads in A and 
B) within the injury cavity. Dotted line denotes injury border. 
Scale bar: 50[1,m 
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potential alterations in the expression of NF-L, NF-H, 13111-tubulin and GAP-43 
between one and 28 days following injury. These investigations demonstrated 
significant alterations in gene expression (Figure 4.13). Although expression of the 
neurofilament triplet proteins NF-L and NF-H were unaltered in response to injury 
(Figure 4.13A), both 13III-tubulin (Figure 4.13B) and GAP-43 mRNA (Figure 4.13C) 
levels were significantly altered. Specifically, 13111-tubulin mRNA levels were 
significantly (p< 0.05) elevated, by approximately 1.4-1.5 fold, between one and 
seven days post-injury, but had returned to normal by 28 days following injury. 
Expression of the growth-associate protein, GAP-43, was significantly (p< 0.05) 
increased at seven and 14 days following injury, by approximately 1.5-1.6 fold, and 
levels had returned to normal by 28 days post-injury. 
4.3.7.2 Brain extrusion was an occasional consequence of acute structural 
neocortical injury 
Occasionally, by several weeks following injury a small macroscopically visible out-
pocketing of brain tissue had formed within or over the injury site. 
Immunofluorescence labelling demonstrated that these structures were continuous 
with the underlying cortical tissue and contained both neuronal and glial cell types 
(Figure 4.14) as well as blood vessels (Figure 4.14B). Indeed, entire cells and/or 
their processes were located within these structures, including both non-pyramidal 
(Figure 4.14C) and pyramidal (Figure 4.14D) neurons, astrocytes (Figure 4.14E) and 
oligodendrocytes/myelin (Figure 4.14F). Features characteristic of injury sites in 
which these structure had not formed, such as residual microglial infiltration, were 
often observed around the margins of the extruded tissue, so it appeared that these 
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Figure 4.13 Acute structural neocortical injury evoked statistically significant 
alterations in important growth- and cytoskeletal-related, but not neurofilament 
triplet, proteins 
Quantitative real-time RT-PCR was utilised to determine the effect of neocortical 
injury on the expression of various neuronal genes at 1, 7, 14 and 28 days post-
injury. The expression of NF-L and NF-H neurofilament triplet genes were 
unaltered in response to cortical injury, however, the expression of 13111-tubulin and 
GAP-43 was significantly elevated. f3111-tubulin mRNA levels were significantly 
increased between 1 and 14 days post-injury, but had returned to control levels by 28 
days post-injury, whereas GAP-43 mRNA levels were significantly increase between 
7 and 14 days post-injury and had returned to control levels by 28 days post-injury. 
P < 0.05. 
A 	Fold alteration in NF-L and NF-H mRNA level following focal structural injury to the rodent neocortex 
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Figure 4.14 Occasionally acute structural neocortical injury resulted in an 
out-pocketing of cortical tissue to form a lump-like structure in the injury site 
The diagrammatic representation in panel A demonstrates the occasional outcome of 
acute structural injury to the neocortex, i.e. the formation of a lump-like structure 
within the injury site by several weeks following injury. Immunofluorescence 
labelling showed that a blood vessels (B) as well as a variety of neural cell types 
were present in this structure, including interneurons (C, labelling for calretinin), 
pyramidal neurons (D, labelling for NF-M), astrocytes (E, labelling for GFAP) and 
oligodendrocytes/myelin (F, labelling for oligodendrocyte/myelin specific protein). 
All images are from a brain at 6 weeks following injury, in which a lump-like 
structure had formed within the lesion site as highlighted by the arrow in A. 
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structures had been formed by an outgrowth from within the centre of the injury site. 
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4.4 Discussion 
In the present investigation, the long-term neural response to acute neocortical lesion 
of the rodent somatosensory cortex was determined, focussing specifically on the co-
ordinated involvement of astrocyte, microglial, macrophage, and neuronal cell 
populations as well as potential vascular and oligodendrocyte/myelin alterations. 
Molecular and cellular alterations were examined at post-injury time points ranging 
from 1 to 84 days. Specifically, immunohistochemistry was utilised to determine the 
cellular alterations occurring in different neural cell populations at 1, 7, 14, 21, 42 
and 84 days post-injury. Quantitative real-time RT-PCR was then utilised to confirm 
whether the cellular alterations in damaged neuronal populations were reflected by 
changes in gene expression of important cytoskeletal and growth-associated genes, 
including PIII-tubulin, NF-L, NF-H and GAP-43, at 1, 7, 14 and 28 days post-injury. 
The injury paradigm utilised in this study was specific to the grey matter of the 
neocortex and produced a discrete wound-like lesion, which directly damaged the 
neocortical laminae but not surrounding or underlying structures. Overall, the neural 
response to acute structural injury was characterised by a progressive sequence of 
reactive and adaptive changes directed at brain healing and the restoration of neural 
cytoarchitecture, which proceeded as a typical tissue-healing response. Importantly, 
astrocyte and microglial activation, as well as reactive and regenerative neuronal 
alterations, myelin re-distribution and re-vascularisation around the lesion site, were 
characteristic aspects of this response and culminated in glial scar formation, brain 
healing and a return to relatively normal cytoarchitecture surrounding the lesion site 
by 84 days post-injury. Figure 4.15 summarises the reactive and adaptive alterations 
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Figure 4.15 Diagrammatic representation of the sequence of cellular 
alterations induced by acute focal injury to the rat neocortex culminating in 
brain healing 
Acute focal injury to the rodent neocortex induced a stereotypical sequence of 
alterations within perilesion brain tissue, involving all major neural cell populations. 
The non-injured rat neocortex was characterised by distinct laminar and columnar 
organisation of both pyramidal and non-pyramidal (interneuron) cells. Large blood 
vessels were oriented perpendicular to the brain surface and were interconnected by 
smaller vessels. 	Astrocytes comprised the prominent glial cell type within 
neocortical grey matter and displayed distinct stellate morphology, although 
resting/ramified microglial were occasionally observed. At 1 day following transient 
needle insertion into the neocortical grey matter, a distinct cavity was formed 
destroying cells residing within the injury site. Activated microglia/macrophages 
and astrocytes were observed within the lesion cavity and at the lesion border, 
respectively. By 7 days following injury, numerous axonal sprouts had been 
elaborated into the lesion sites, concomitant with an influx of activated 
microglia/macrophages within this region. Numerous blood vessels were observed 
within the perilesion tissue and astrocytic activation persisted around the lesion 
border. By 42 days following injury, both astrocyte and microglial/macrophage 
activation had generally subsided, blood vessels had undergone 
pruning/remodelling process (to resemble pre-injury brain vasculature) and a distinct 
glial/astrocytic scar had formed at the lesion margin. 
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in various neural components, contributing to brain healing. 
4.4.1 Damage to the mature brain evokes a wound healing-like response 
involving the orchestrated response of tissue-specific cell populations 
Overall, the molecular and cellular alterations observed in this chapter were 
indicative of an orchestrated interaction between various key neural cell populations, 
and resembled a wound healing-like response involving typical phases of 
inflammation, proliferation/migration and ultimately tissue re-modelling (Maxwell et 
al., 1990; Hunt et al., 2000; King et al., 2001; Yamaguchi and Yoshikawa, 2001; 
Oehminchen, 2004). In this regard, damage to the CNS stimulates the co-ordinated 
activation of glial cell populations, which contribute to the formation of a glial scar 
in the pen-wound region. However, although this response may be adaptive in some 
respects, in conjunction with other inhibitory factors within the adult CNS, it often 
generates a local environment that prevents neuronal regeneration (Fawcett and 
Asher, 1999). Indeed, the specific interactions between damaged and undamaged 
neurons and injury-activated glial cells may determine whether glial cells play a 
predominantly neurotoxic or neurotrophic role during neural repair (reviewed by 
Aschner et al., 1999). 
Utilising a penetrative knife lesion to the cerebrum, Maxwell et al. (1990) 
demonstrated the stereotypical sequence of changes that ultimately culminate in 
wound healing, including acute haemorrhage, necrosis and oedema, followed by glial 
activation, scar formation and wound contraction. In this regard, a study by King et 
al. (2001) also demonstrated similar reactive alterations leading to the borders of the 
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lesion being drawn together. These studies, in combination with findings from the 
present chapter, indicate that the adult brain has a remarkable capacity for repair 
following injury. 
4.4.2 Astrocytes respond rapidly and adaptively to brain injury 
In the non-injured brain, protoplasmic astrocytes of the neocortical grey matter 
provide physical and metabolic support to adjacent neurons (Tacconi, 1998; 
Anderson and Swanson, 2000; Abbott, 2002; Fields and Stevens-Graham, 2002). 
Due to this close association it is, therefore, not surprising that they are activated in 
response to neuronal injury. Astrocytes have been shown to undergo a specific 
stereotypy of reactive alterations in response to injury, including proliferation, 
hypertrophy and increased synthesis of GFAP, a process known as reactive 
astrogliosis (Maxwell et al., 1990; Ridet et al., 1997; Raivich et al., 1999; Kernie et 
al., 2001; McGraw et al., 2001; Chirumamilla et al., 2002; Chen et al., 2003a). 
Overall the present study confirmed these alterations in response to acute cortical 
lesion. 
Reactive astrocytes were observed to contribute to the long term re-modelling of the 
injured tissue through formation of a dense astrocytic plexus, glial scar, and 
restoration of relatively normal astrocyte distribution within close vicinity of the 
lesion site. Indeed, within the first few weeks following CNS injury, reactive 
astrocytes have been shown to create a physical barrier between damaged and non-
damaged tissue, effectively segregating non-damaged tissue from the potentially 
harmful effects of tissue necrosis and blood brain barrier disruption (Fawcett, 1997; 
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Raivich et al., 1999; Chen et al., 2003a). Although this barrier may protect non-
damaged neurons, detrimental consequences of reactive gliosis may ultimately 
impede axonal re-growth (Ridet et al., 1997; Fawcett and Asher, 1999, Batchelor and 
Howells, 2003; Hampton et al., 2004). In this regard, certain extracellular matrix 
molecules are incorporated into the glial scar (McGraw et al., 2001), thus it forms 
both a physical and molecular barrier to neuronal re-growth. Indeed in the present 
study, profuse axonal sprouting was observed between seven and 14 days following 
injury, but was diminished after this time, concomitant with formation of a dense 
astrocyte remnant at the lesion border. 
Interestingly, although astrogliosis and glial scar formation have been viewed as 
inhibitory to axonal growth a selection of studies indicate that astrocytes may in fact 
facilitate axonal sprouting and regeneration following injury. For example, Dusart et 
al. (1999) demonstrated that following a long delay axotomised Purkinje cells were 
able to elaborate new axonal sprouts that were encased in astrocytic sheaths. The 
authors postulate that astrocytes may therefore limit contact between sprouting axons 
and inhibitory molecules and/or express molecules that facilitate axonal re-growth. 
Moreover, astrocytes may secrete cytokines and growth factors that promote neural 
repair, either directly or through the activation of macrophages (Lotan and Schwartz, 
1994). 
4.4.3 Microglia and macrophages invade injured tissue and potentially 
facilitate axonal sprouting 
Microglia and macrophages were assessed regardless of their parenchymal or 
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systemic origin. As such, ferritin labelling for activated microglia in the non-injured 
brain was relatively low and labelled cells were rarely observed. The role of 
microglia in the non-compromised brain has not been fully characterised, but is 
proposed to involve highly dynamic immune-surveillance functions (Nimmerjahn et 
al., 2005). Microglia activation (Aihara et al., 1995) and macrophage infiltration 
(King et al., 2001) are, however, characteristic alterations induced by injury to the 
brain. Indeed, studies by Davalos et al. (2005) have demonstrated that microglia are 
activated within minutes following injury. In response to injury, brain-resident 
microglia proliferate and undergo highly dynamic alterations involving conversion 
into highly mobile macrophages (Ravivich et al., 1999; Stence et al., 2001; 
Chirumamilla et al., 2002; Hampton et al., 2004; Carbonell et al., 2005). However, 
injury-induced mobility is not necessarily lesion-directed (Carbonell et al., 2005). 
Furthermore, recent data indicate that microglia respond rapidly to brain injury by 
extending and coalescing their processes towards sites of injury (Davalos et al., 
2005). Utilising cultured hippocampal tissue slices, Stence et al. (2001) 
demonstrated that that microglial activation proceeds thought a defined sequence of 
morphological alterations; ramified microglia withdraw their dendritic branches and 
elaborate a new set of dynamic protuberances, 'which can be extended and retracted 
to facilitate motility and migration. As confirmed by the present study, overt 
morphological alterations include the transformation from a ramified to 
rounded/amoeboid morphology (Aihara et al., 1995; Stence et al., 2001). The 
morphological transformation of activated microglia has been associated with their 
development into phagocytic macrophages, responsible for clearing tissue debris 
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(Ravivich et al., 1999). Additionally, cells with rounded morphology may also be 
derived from circulating macrophages, extruded into sites of tissue damage (Barron, 
1995; Raivich et al., 1999). 
Although microglial/macrophage activation may result in a prolonged inflammatory 
response and the release of toxic factors resulting in further neuronal destruction 
(Lotan and Schwartz, 1994; Vilhardt, 2005), these cells have also been suggested to 
enhance tissue re-modelling and healing through a variety of integrated processes. 
These processes include inflammation, lipid recycling, secretion of factors that 
promote neural regeneration and neo-vascularisation, phagocytic removal of tissue 
debris as well as other immune functions, such as antigen presentation and 
lymphocyte activation (Thomas, 1992; Lotan and Schwartz, 1994). In this regard, 
microglia may play important roles in limiting the spread of apoptotic stimuli and 
promoting neuronal survival and growth following injury (reviewed by Bruce-Keller, 
1999). 
Microglia and macrophages have also been shown to play important roles in 
facilitating injury-induced axonal sprouting (Prewitt et al., 1997; Batchelor et al., 
1999, 2000, 2002a, b; King et al., 2001), which are supported by observations from 
the present study. Results from the present study indicated that 
microglia/macrophages were abundant following injury, declining in number over 
the time course examined with relatively few, if any, persisting at the longest time 
interval examined. Interestingly, microglia/macrophages were most abundant at 
seven days post-injury, consistent with profuse axonal sprouting at this time. 
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Furthermore, these cells were often observed in close association with sprouting 
axons and it has been suggested that they may release factors facilitative to axonal 
regeneration (King et al., 2001; Batchelor et al., 1999, 2002a, b). 
Indeed, Batchelor et al. (1999, 2002a) demonstrated that injury-induced sprouting 
dopaminergic fibres were intimately associated with activated microglia and 
macrophages as they navigated towards the wound edge. This response was 
correlated with an increasing gradient of brain- and glial- derived neurotrophic 
factors (BDNF and GDNF, respectively), whereas sprouts were unable to penetrate 
into the core of the wound where trophic factors were scarce (Batchelor et al., 1999, 
2000a). However, both observations from this chapter as well as findings by King et 
al. (2001), have demonstrated that sprouting axons were able to penetrate into 
neocortical lesions, infiltrated by microglia and macrophages. Furthermore, mice 
deficient in a variety of macrophage subtypes (osteopetrotic mice) and mice in which 
the expression of BDNF and GDNF were inhibited by antisense oligonucleotides, 
demonstrated decreased periwound sprouting following striatal lesion, relative to 
controls (Batchelor et al., 2000, 2002b). Collectively, these studies strongly support 
a role for microglia and macrophages in facilitating axonal re-growth following 
injury. However, Dusart et al (1999), report that axotomy induced sprouting of 
Purkinje cells is not correlated with the presence of activated macrophages. 
4.4.4 Myelin initially degenerates following injury, but is increased within 
perilesion tissue at later post injury time points 
In this chapter, alterations in oligodendrocytes/myelin were assessed with an 
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antibody specific for the myelin contained within oligodendrocyte membranes. 
Myelin was abundantly distributed throughout the grey matter of the neocortex, in 
association with axons. Although myelin degenerated from perilesion tissue 
following injury, it was observed at the lesion border (forming sprout-like 
protuberances) within a week following injury and was observed in close association 
with sprouting axons. Thus, in this chapter, axons were apparently able to sprout in 
the presence of myelin. However, specific molecules in CNS myelin, including 
Nogo, Myelin-Associated Glycoprotein (MAG) and Oligodendrocyte Myelin 
glycoprotein (0Mgp), as well as other molecules secreted by reactive astrocytes and 
oligodendrocytes, derived from blood or within the extracellular matrix (for example 
tenasin and chondroitin sulphate proteoglycans as well as many other molecules) 
have generally been viewed as inhibitory to axonal re-growth (reviewed by Fawcett 
and Asher, 1999; Bandtlow and Schwab, 2000; Goldberg and Barres, 2000; Qiu et 
al., 2000; Watkins and Barres, 2002; McGee and Strittmatter, 2003; Domeniconi and 
Filbin, 2005). Interestingly, these molecules share a common receptor, NgR, which 
has been implicated in this process (Watkins and Barres, 2002; McGee and 
Strittmatter, 2003). The re-appearance of myelin at the lesion border, in addition to 
the formation of a dense astrocytic plexus, may have contributed to the decrease in 
axonal sprouting, observed several weeks following injury. Thus, although myelin 
may have been associated with sprouting axons initially, formation of the glial scar 
effectively prevented this sprouting response in the long term. 
4.4.5 Brain injury induces vascular remodelling and restoration 
Structural brain injury frequently results in deformation or tearing of blood vessels. 
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In the present investigation, blood vessels immediately surrounding the lesion were 
largely destroyed, as indicated by an absence of staining with Isolectin IB4. From 
seven days onwards, labelled blood vessels were again observed in and around the 
lesion site. Although this investigation did not quantify the alterations in brain 
vasculature following injury, studies by Chen et al. (2003a) have demonstrated a 
degree of vascular remodelling following focal brain injury, including decreased 
blood vessel density and increased diameter, which eventually returned to control 
values. A recent review by Dvorak (2005), indicates the involvement of 
angiogenesis, the formation of new blood vessels, as a mechanism of wound healing 
as well as aberrant growth, such as tumour formation. However, the author refers to 
this form of angiogenesis, compared to that normally occurring during development 
of the vascular system, as proceeding abnormally and resulting in the formation of 
vessels that are irregularly branched and distributed. In this chapter, vascular 
remodelling contributed to restoration of relatively normal vasculature within close 
proximity of the lesion. These finding suggest that vascular growth and re-modelling 
are an important feature of brain repair following injury. 
4.4.6 Neurons undergo early reactive cytoskeletal alterations in response to 
brain injury 
Brain injury results in significant neuronal degeneration and death. Consistent with 
previous investigations, this manifested as frank neuronal loss at the injury site, as 
well as degenerative alterations including neurite beading and disconnection (Chen et 
al., 2003a). Degenerative neuronal changes were generally restricted to a region 
immediately surrounding the lesion cavity. The reactive axonal, and particularly 
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cytoskeletal, changes observed in the present study are consistent with previous 
investigations and have been described as an evolving pathology potentially 
involving altered ionic concentrations, abnormal enzyme activation, altered 
neurofilament phosphorylation, impeded axonal transport, axonal swelling and 
eventual axonal disconnection, resulting in the formation of terminal axon bulbs 
incorporating abnormally compacted or accumulated cytoskeletal elements 
(Schalaepfer, 1987; Adams, 1992; Egeler-Peerdeman, 1993; Jafari et al., 1997, 1998; 
Maxwell et al., 1997; Povlishock et al., 1997; Fitzpatrick et al., 1998; Graham et al., 
2000; King et al., 2000a, b, 2001; Smith and Meaney, 2000; Postmantur et al., 2000; 
Vickers et al., 2000; Chen et al., 2003a; Hamberger et al., 2003). 
Interestingly, although abnormal neurofilament accumulation is often reported as 
characteristic of neuronal damage, some studies have reported a reduction in 
neurofilaments at sites of injury (Hoffman et al., 1984, 1985; Maxwell and Graham, 
1997) and, contrary to the present investigation in which neurofilament triplet 
expression was found to be unaltered in response to injury, some data indicate: 
diminished neurofilament expression in response to injury (Hoffman et al., 1987, 
1993; Goldstein et al., 1988, Hoffman and Cleveland 1988; Muma et al., 1990; 
Nixon and Shea, 1992). However, Gervasi et al. (2003) report an increase in 
peripherin and NF-M mRNA, associated with increases in protein, following optic 
nerve injury. These discrepancies potentially reflect the use of a variety of injury 
paradigms involving different CNS and PNS regions (Gervasi et al., 2003). 
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4.4.7 Injury-induced adaptive neuronal alterations include sprouting and re-
expression of important growth related proteins 
Neurons have been shown to undergo a variety of molecular and cellular alterations 
in response to injury. Indeed, the present investigation provides data supporting an 
attempt by mature cortical neurons to regenerate following injury. Alterations 
associated with attempted regeneration included substantial axonal sprouting in 
addition to significant re-expression of the developmentally important growth-
associated protein, GAP-43, and significantly increased expression of the 
cytoskeletal protein, 13111-tubulin. Alterations in gene expression, including an 
increase in developmentally important growth and cytoskeletal genes, have been 
reported following injury to both the PNS (reviewed by Gillen et al., 1997) and CNS 
(reviewed by Emery et al., 2000, 2003) and support the view that neurons undergo 
adaptive changes following injury, directed at brain repair. In general, regenerative 
changes following injury to the PNS, which are typically much more successful than 
those occurring following CNS injury, include increased synthesis of actin, tubulin 
and GAP-43 and decreased neurofilament expression (Bisby and Tetzlaff, 1992). 
Although findings from the CNS are less clear, the increases in 13111-tubulin and 
GAP-43 reported in the present study indicate that CNS neurons undergo at least a 
transient attempt at regeneration following injury. 
Although the mechanisms underlying the axonal response to injury are not fully 
understood, several reports suggest that damaged axons undergo a stereotypic 
sequence of reactive and regenerative alteration, which are associated with 
cytoskeletal reorganisation and up-regulation of growth associated protein 
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(Povlishock and Becker, 1985; Christman et al., 1997; King et al., 2001). Indeed 
axons undergo an early swelling response, which may be associated with 
degenerative or regenerative alterations. For example, Povlishock and Becker (1985) 
and King et al. (2001) have shown that reactive axonal swellings may elaborate 
sprout-like protuberances. Furthermore, sprouts may have unusual features 
including club-like endings and partial myelination (King et al., 2001) or dystrophic 
growth cones (Tom et al., 2004). Interestingly, evidence of axonal sprouting has also 
been reported to occur following both stroke and spinal cord injury (reviewed by 
Carmichael, 2003a, b). However, the development of abnormal growth cones at the 
proximal tips of sprouting CNS neuron axons is postulated to account for 
regenerative failure in the CNS (Tom et al., 2004; Verma et al., 2005). 
Notably, both the axonal sprouting response and concomitant gene expression 
alterations were generally not maintained past approximately 14 days post-injury, a 
time when the glial scar is likely to form (reviewed by Raivich et al., 1999). Indeed, 
expression of both GAP-43 and 13111-tubulin had returned to control levels by 28 days 
I following injury and axonal sprouts were rarely observed after this time.*  Although 
the glial scar is, therefore, likely to be impeding axonal regrowth it has been 
suggested that the incapacity for re-establishment of neuronal connections following 
injury may be a means of protection, ensuring that sprouting axons do not integrate 
maladaptively into neural architecture (Lamer, 1995; McKinney et al., 1999; 
Ravivich et al., 1999; Jacobs et al., 2000). These findings provide interesting 
avenues for future research, particularly regarding the opportunistic window in 
which appropriate axonal sprouting may be facilitated. 
- - 
1* sprouting axons appear to require a substrate upon which to grow. Microglia/macrophages, which have 
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, infiltrated the injury site, are likely to provide this substrate and, additionally, may produce molecules that prothote 
' axonal growth. As the glial scar develops and microglia/macrophages disperse from the injury site it is plausible 
that axonal sprouts alter their growth paths, are retracted, degenerate and/or are incorporated into the glial scar. 
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4.5 Conclusion 
Consistent with previous investigations, this study demonstrates substantial 
alterations in key neural cell populations and components, including astrocytes, 
microglia/macrophages and neurons as well as oligodendrocytes/myelin and brain 
vasculature in response to acute focal brain injury. Importantly, astrocyte and 
microglia/macrophage cell populations underwent a stereotypical activation response 
following injury, which was associated with substantial alterations in the damaged 
neuronal population. Neurons underwent alterations indicative of attempted 
regeneration, including reactive sprouting and significant increases in the expression 
of important cytoskeletal and growth-associated genes. Collectively, the reactive and 
adaptive alterations observed in the present study, involving the co-ordinated 
response of both neuronal and glial cell populations, are indicative of substantial 
neural and vascular re-modelling. 
These changes presumably reflect the extent of endogenous brain repair possible 
following acute focal brain injury and demonstrate an adaptive and sustained attempt 
at re-establishment of brain cytoarchitecture. Importantly, the neuro-glial alterations 
observed in this study reflect, to a large extent, the stereotypical wound-healing 
response, seen in tissues such as the skin, following physical trauma. In this regard, 
brain healing may be viewed as a general response, involving tissue-specific cell 
populations, incorporating phases of coagulation, inflammation, proliferation and re-
modelling, resulting in the formation of a glial scar. 
Although this investigation did not extend to measuring the functional outcome of 
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the cellular, morphological and molecular outcomes observed, it does suggest that 
the damaged brain re-models to the best of its ability. Brain injury generally 
proceeds as an evolving sequence of alterations, involving both primary and delayed 
secondary changes, which may be adaptive or deleterious in nature. Importantly, the 
timing of degenerative and regenerative phases may afford windows of opportunity, 
in which deleterious reactions can be inhibited and adaptive changes promoted. In 
this regard, this study highlights several aspects of the neural response to injury that 
may be therapeutically targeted to promote effective recovery, including both the 
promotion of neuronal/axonal re-growth as well as therapies aimed at enhancing the 
potentially facilitative influences glial cell populations may play in this response. 
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Axotomy of cortical neurons grown in vitro evokes 
cytoskeletal and morphological alterations directed at 
intrinsic axonal sprouting 
5.1 Introduction 
TBI in humans and experimental animal models frequently results in widespread 
axonal disruption, or DAI, in the absence of other brain parenchymal alterations 
(Povlishock and Becker, 1985; Christman et al., 1997; Maxwell et al., 1997; Graham 
et al., 2000; Smith and Meaney, 2003; Povlishock and Katz, 2005). In this regard, 
axons are damaged when the brain undergoes rapid acceleration/deceleration or 
rotational forces resulting in axonal severing, shearing or stretching (Smith and 
Meaney, 2000). Axotomy, or axonal disconnection, may occur by primary or 
delayed mechanisms; axons may be torn at the time of injury or, more commonly, 
the axonal cytostructure is damaged by injury-induced alterations in the local internal 
and/or external environment that evoke a complex cascade of detrimental alterations, 
ultimately disrupting the axonal cytoskeleton, impeding axonal transport and 
culminating in axonal swelling and disconnection (Schalaepfer, 1987; Adams 1992; 
Yamaguchi and Povlishock, 1992; Egeler-Peerdeman, 1993; Povlishock and Jenkins, 
1995; Jafari et al., 1997; 1998, Maxwell et al., 1997; Povlishock et al., 1997; 
Fitzpatrick et al., 1998; Postmantur et al., 2000; Smith and Meaney, 2003; Chung et 
al., 2005) — events which may or may not result from disturbances in the axonal 
membrane and subsequent abnormal enzyme activation (Maxwell et al., 1997; Chung 
et al., 2005). These changes may result in neuronal death, atrophy, or an attempt at 
regeneration (Tuszynski and Gage, 1995; Singleton et al., 2002; Selzer, 2003). 
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Although injury to the CNS is associated with poor axonal regenerative ability 
(Fawcett and Asher, 1999; Schwartz et al., 1999; Domeniconi and Filbin, 2005), 
several studies have demonstrated striking examples of axonal plasticity and 
sprouting following injury and indicate that these changes involve substantial 
cytoskeletal reorganisation (Povlishock and Becker, 1985; Kristt, 1987; McHale et 
al., 1995; Dusart et al., 1999; Christman et al., 1997; Deller and Frotscher, 1997; 
McKinney et al., 1997; Dickson et al., 2000; King et al., 2001; Tom et al., 2004; 
Kerschensteiner et al., 2005). However, injury-induced sprouting in the mature CNS 
has generally been viewed as a transient abortive process and, in instances where 
functional injury-induced sprouting has been observed, this has largely been 
attributed to collateral sprouting from local undamaged axons (Deller and Frostcher, 
1997). Thus, whether an injured axon can sprout from its surviving proximal tip 
remains to be fully elucidated. In this regard, complex interactions between 
components of the neuronal cytoskeleton, are crucial for axonal outgrowth, 
branching and pathfinding during neuronal development and maturation (Tanaka and 
Sabry, 1995; Brandt, 1998; Szebenyi et al., 1998; Dent et al., 1999; Gallo and 
Letourneau, 2000; Kalil et al., 2000; Korey and VanVactor, 2000; Suter and 
Forscher, 2000; Dent and Kalil, 2001, 2003; Dent et al., 2003). However, it is 
unknown whether similar cytoskeletal mechanisms underlie axonal sprouting. 
Promoting and enhancing post-injury axonal sprouting is the primary goal of many 
therapeutic repair strategies (Selzer, 2003). However, uncontrolled axonal growth 
and aberrant synapse formation may ultimately be maladaptive and has been 
implicated in the development of epileptiform activity following brain injury 
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(Lamer, 1995; Salin et al., 1995; McKinney et al., 1997) and the pathogenesis of 
Alzheimer's disease (Masliah et al., 1991, 1992; Vickers et al., 2000; Arendt, 2001). 
In this regard, it may not always be appropriate to promote post-injury axonal growth 
and synaptic re-establishment unless the precise and correct targets of newly growing 
axons can be defined and growing axons can effectively reach these targets. 
Due to the inherent complexity and relative inaccessibility of the adult mammalian 
brain it is difficult to assess the reaction of damaged axons, particularly in the 
presence of confounding glial factors. In vitro experimental models are, therefore, 
important for assessing neuronal responses to trauma as well as providing a platform 
for assessing potential therapeutic agents (Dickson et al., 2000; Fayz and Tator, 
2000; Chung et al., 2005) and, despite their simplified nature, are capable of 
reproducing important aspects of in vivo brain injury (Morrison et al., 1998). As 
discussed above, axonal injury is a frequent universal consequence of TBI. To 
assess the response of individual axons to injury, this chapter utilised an in vitro 
model of axotomy, in which axons of relatively mature neurons were directly 
transected (Dickson et al., 2000). This study explored the intrinsic regenerative 
potential of CNS axons and whether this response recapitulates developmental 
patterns of axonal growth. Agents that disrupt specific cytoskeletal components 
were utilised to determine whether similar cytoskeletal mechanisms underlie axonal 
growth and regeneration and determine if cytoskeletal disruption is a viable therapy 
for preventing maladaptive axonal sprouting responses. 
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5.2 Experimental procedures 
5.2.1 Primary dissociated neocortical neuron culture preparation and in vitro 
axonal injury 
Primary dissociated neocortical neuron cultures were prepared and axonal injuries 
were performed as described in sections 2.2.2 and 2.2.3, respectively. Neuronal 
cultures were fixed during development at 3-5 days in vitro (DIV) or at 4, 14 and 24 
hours following axonal injury at 21 DIV. 
5.2.2 Assay of in vitro cell proliferation 
To determine the approximate birth dates of cortical neurons in vitro, cultures were 
incubated with lORM of BrdU, for 72 hours at either 7 or 17 DIV. Cultures 
underwent a complete media change to remove any unincorporated BrdU and were 
grown to 21 DIV. Following fixation in 4% PFA/0.001M PBS, DNA denaturation 
was performed by incubating cultures in 2M HCI for 1 hour at 37°C. Dividing cells 
were visualised by immunolabelling with an antibody against BrdU (Sigma, Table 
2.1). 
5.2.3 Analysis of Cell Death 
The nucleic acid-binding vital dye, propridium iodide (PI), was used to analyse cell 
death. -PI is excluded from cells with intact cell membranes, however, is able to 
penetrate the cell membrane and label the nuclei of dead and dying (late apoptotic 
and necrotic) cells, where membrane integrity is compromised. A volume of 1011I of 
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PI (at 501.4,g/m1) was added to cultures and they were gently agitated to evenly 
distribute the PI and examined under a Leica DM IRB inverted microscope. 
5.2.4 Administration of cytoskeletal disrupting agents 
To determine the effects of cytoskeletal disruption during neurite development and 
post-injury events, cytoskeletal agents that disrupt the dynamic properties of the most 
motile cytoskeletal components, namely microtubules and microfilaments, were 
utilised. Specifically, taxol (Amersham Biosciences, San Francisco, CA, USA) was 
used to stabilise microtubules and promote microtubule formation and bundling, 
nocodazole (Sigma, St. Louis, MO, USA) was utilised to cause microtubule 
destabilisation and dissolution and latrunculin A (Molecular Probes, Eugene, 
Oregon, USA) was utilised as an actin depolymerising agent. Taxol was 
reconstituted in sterile 0.01M PBS and added to the subsequent media of cultures at a 
concentration of lOttg/ml. Nocodazole was reconstituted in sterile 12% 
DMSO/0.01M PBS and added to cultures at a final concentration of 1 t.tg/ml. 
Latrunculin A was reconstituted in sterile 10% DMSO/0.01M PBS and added to 
cultures at a final concentration of l[ig/ml. Vehicle-treated cultures were processed 
concurrently to serve as controls. 
To determine the effect of taxol-induced microtubule stabilisation, nocodazole-
induced microtubule destabilisation and latrunculin A-induced actin 
depolymerisation during neurite development, cultures were incubated in the 
presence of each agent for 48 hours between three and five DIV. Additionally, to 
determine the effect of cytoskeletal disruption during injury-induced axonal 
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sprouting events, cytoskeletal disrupting agents were administered to the subsequent 
media of cultures immediately following localised axotomy at 21 DIV and cultures 
were re-incubated for 4, 14 or 24 hours post-injury. Studies to determine whether the 
effects of taxol were reversible were performed using 11.1g/m1 taxol (as higher 
concentrations caused substantial cell death with prolonged exposure). To 
investigate the permanency of taxol-induced microtubule stabilisation, taxol was 
washed out of developing cultures at 5 DIV and cultures were maintained as normal 
for up to 21 DIV and compared to vehicle-treated cultures as well as cultures which 
were constantly exposed to taxol. To determine whether the effects of taxol could be 
reversed following axonal injury, taxol was washed out of injured cultures after four 
hours and cultures were allowed to recover for a further 20 hours prior to fixation. 
5.2.5 Live cell digital imaging 
Time-lapse digital imaging was utilised to investigate the effect of taxol on growth 
cone motility and morphology, as well as the dynamic response of neurons to 
localised axotomy. At 1 day prior to imaging, cultured monolayers, growing on 
glass coverslips were transferred to individual 35mm glass petri dishes. The 
Neurobasal Tm media, in which the neurons were growing, was gradually replaced 
with "imaging buffer" (mM: NaCI, 124; KC1, 5; CaCl2, 0.2; MgCl2, 1; dextrose, 30; 
HEPES, 25; pH 7.3, Zhang and Benson, 2001) over a time course of 1 hour prior to 
imaging, to promote neuronal survival when imaging over several hours. Using 
differential interference contrast (`Normaskr) microscopy, a time series of images 
were captured from a Leica DM IRB inverted microscope, equipped with a heated 
stage (37°C). 
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5.2.6 Transmission and scanning electron microscopy 
For scanning electron microscopy studies, cultures growing on glass coverslips were 
fixed with 2.5% glutaraldehyde in 0.1M phosphate buffer (pH 7.4) for 20 minutes at 
room temperature, post-fixed with 0.1% osmium tetraoxide in phosphate buffer, at 
room temperature for 15 minutes and dehydrated through a graded ethanol series. 
Specimens were critical point dried with CO 2, mounted onto copper stubs and sputter 
coated with gold for observation with a JEOL JSM-840 scanning electron 
microscope. For transmission electron microscopy studies, cortical cultures were 
fixed in 2.5% glutaraldehyde in 0.1M phosphate buffer, at 37°C for 10 minutes. 
Cultures were post-fixed in 1.5% osmium tetroxide in 0.1M phosphate buffer at 
room temperature for 30 minutes, followed by incubation in 2% uranyl acetate in 
70% ethanol for 5 minutes. Cultures were then dehydrated through a graded ethanol 
series and embedded in 100% epon. Specimens were sectioned at 70nm, stained 
with 5% uranyl acetate (10 minutes) and Reynolds lead citrate (10 minutes) and 
examined on a Philips EM-410 transmission electron microscope. 
5.2.7 Immunocytoochemistry and staining of cultured neocortical cells 
Following fixation in 4% PFA/0.01M PBS, indirect immunofluorescence labelling 
was utilised to visualise the distribution of specific components (see table 5.1), 
including f3111-tubulin, tau and phosphorylated neurofilaments, in developing neurites 
and injured sprouting axons, as described in section 2.2.3. Additionally, to label for 
filamentous actin, cultures were incubated with AlexaFluor 488 phalloidin 
(Molecular Probes, Eugene, OR, USA, dilution 1:200), for 30 minutes following 
immunohistochemistry. Cultures were also labelled for a range of markers indicative 
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of neuronal maturity (see Table 5.1). Specific antibody details are provided in Table 
2.1. 
Table 5.1. Antibodies used to identify different neuronal compartments 
Cellular compartment 	 Marker 
Neurons 	 NSE 
Neurites 	 NF-M 
Axons 	 5M1312 
Tau 
Dendrites 	 MAP-2 
Synapses 	 Synaptophysin 
Post-mitotic neuronal nuclei 	NeuN 
Proliferating cells 	 BrdU 
5.2.8 Quantitative and statistical analysis 
The effect of taxol on neurite development was quantitatively analysed by 
determining the proportion of neurites tipped by a growth cone. A growth cone was 
defined as a fan-shaped structure at the tip of a neurite, with a width three times 
greater than its neurite of origin. The effect of taxol treatment on neurite length was 
also determined. Digital images of immunofluorescence labelled specimens were 
captured pre-treatment and post-vehicle or post-taxol treatment, and the lengths of 
100 neurites from each category were measured. 
The effect of taxol on post-injury axonal sprouting was determined in terms of sprout 
number and sprout length, four hours after injury. Cultures injured by axonal 
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transection were incubated in taxol or vehicle for four hours immediately following 
injury, followed by PFA fixation and immunofluorescence labelling. Digital images 
of several individual injury sites were captured. To quantitate the effect of taxol on 
sprout elongation, the length of 100 post-injury axonal sprouts were measured from 
vehicle- and taxol-treated fellow cultures. Additionally, to determine the effect of 
taxol on sprout elaboration, the number of post-injury axonal sprouts was calculated 
from 15 individual transection injury sites from vehicle- and taxol-treated fellow 
cultures. This value was expressed as the number of sprouts per 100ium of cut site 
length. 
For quantitation, taxol-related experiments were repeated five times (i.e. on cultures 
derived form five individual litters) and studies were performed by an investigator 
blind to the treatment of the cultures under investigation. NIH Image (version 1.61) 
software was used to capture digital images and perform measurements. Statistical 
analysis was performed using StatView (version 5.0) software. As appropriate, 
paired t-tests or ANOVA were performed on quantitative data. postl-h—o 
comparisons (Fisher's test) were performed following ANOVA. 
Preliminary investigations to determine the effects of nocodazole-induced 
microtubule destabilisation and latrunculin A-induced actin depolymerisation during 
neurite development and regeneration were qualitatively assessed. 
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5.3 Results 
5.3.1 In vitro cortical neuron development 
In the days following plating, dissociated cortical neurons formed aggregates, 
adhered to the coverslip substrate and elaborated several slender neurites. Analysis 
of the morphological and cytoskeletal characteristics of developing cortical neurons 
was performed at three DIV. Figure 5.1 illustrates the localisation of specific 
cytoskeletal components in developing neurites at three DIV. Both 13111-tubulin and 
tau were localised throughout entire neurons, extending into the tapered extremities 
of dendrites and splayed extremities of axons, as well as the growth cone remnants 
(Szbenyi et al., 1998; Kalil et al., 2000), spikes and small branches located along the 
lengths of some neurites (Figure 5.1A and B). Both f3111-tubulin and tau were more 
abundant in neurite shafts and the central growth cone domain than in the proximal 
domain of growth cones. Filamentous actin was distributed unevenly throughout 
developmental neurites, but was particularly enriched within growth cones and 
extended into filopodia and lamellipodia (Figure 5.1C). Phosphorylated 
neurofilaments were, however, only localised in a sub-set of neurites and labelling 
was absent in growth cones (Figure 5.1D). 
5.3.2 Cytoskeletal disruption during neurite development 
The effects of cytoskeletal disruption were examined by exposing developing 
cultures to the microtubule stabilising and destabilising agents, taxol and nocodazole, 
respectively as well as the actin depolymerising agent, latrunculin A. To determine 
the effect of microtubule stabilisation on neuronal development, developing cultures 
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Figure 5.1 	Cytoskeletal components demonstrated specific distribution in 
developing neurites 
Developing neurites were characterised by a slender neurite shaft tipped by an 
expanded fan-shaped structure, the growth cone. Components of the microtubule 
cytoskeleton, such as 13111-tubulin (A) and tau (B), were distributed throughout 
neurite shafts, extending into the proximal and sometimes distal regions of 
developmental growth cones (arrows denote examples). Filamentous actin (as 
visualised by phalloidin labelling) was predominantly localised to typically motile 
structures such as developmental growth cones and the spikes and small branches 
extending from neurite shafts (C, arrows denote examples). Phosphorylated 
neurofilaments were generally restricted to neurite shafts and rarely extended into 
growth cones or small neurite branches (D, arrow denotes examples). All images 
were taken at 3DIV. 
Scale bar: A and B = 10[tm; C and D = 20[tm 
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were exposed to taxol and examined for morphological and cytoskeletal alterations. 
Initially, neurites were tipped by characteristically splayed growth cones, however, 
in the presence of taxol the neurites rapidly formed bulbous end-structures, many of 
which lacked the filopodial protrusions characteristic of growth cones (Figure 5.2). 
Developing cultures, incubated in taxol between three and five DIV demonstrated 
substantially altered morphology compared to vehicle treated controls (Figure 5.3). 
Vehicle-treated neuronal aggregates elaborated numerous slender neurites, which 
extended radially and often in defined bundles. These neurite bundles splayed out 
distally into individual neurites, many of which were tipped by a growth cone 
(Figure 5.3A). In contrast, the neurites of taxol-treated neurons remained localised 
around their neuronal aggregates, often curling and looping back towards the 
aggregates from which they originated (Figure 5.3B). Scanning electron microscopy 
demonstrated that compared to vehicle-treated neurites, which demonstrated 
elaborate growth cones at their distal tips (Figure 5.4A), taxol-treated neurites were 
thickened, often swollen into bulbous structures at their distal tips and lacked 
elaborate morphological structure. Furthermore, some neurites retained aberrant 
growth cones with filopodial-like protrusions distally, while others completely 
lacked protuberances at their distal tips (Figure 5.4B and C respectively). 
Neuron specific 13111-tubulin was distributed throughout neurite shafts, but was also 
localised to club- and loop-like structures in the distal tips of taxol-treated neurites 
(Figure 5.5A), whereas tau (Figure 5.5B) was evenly distributed throughout the 
distended neurites. Filamentous actin was most abundant in neurite tips, where it 
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Figure 5.2 	Disruption of microtubule dynamics with taxol resulted in growth 
cone collapse and inhibition of neurite growth 
Live cell imaging, utilising differential interference contrast (Normaski) optics, 
demonstrated that taxol-induced microtubule stabilisation lead to the rapid formation 
of bulbous structures at neurite tips and cessation of neurite growth (arrows denote 
examples). 
Scale bar: 20[tm 

Figure 5.3 	Disruption of microtubule dynamics with taxol caused neurite 
distension and altered neurite path-finding 
By 5 DIV, developing cortical neurons had aggregated and elaborated numerous 
radially extending fasiculated neurite bundles (A, arrow denotes example). In 
contrast, taxol-induced microtubule disruption between 3 and 5 DIV (B) resulted in 
the formation of swollen neurites (arrowhead), which predominantly curled and 
looped back upon themselves (arrow). 
Scale bar: 601um 

Figure 5.4 Microtubule disruption induced marked morphological 
alterations in the growth cones of developing neurites 
Scanning electron microscopy was utilised to demonstrate alterations surface 
morphology in response to taxol-induced microtubule disruption relative to vehicle-
treated controls. Vehicle-treated developing neuronal cultures exhibited growth 
cones with distinct 3-dimensional morphological complexity (A). Taxol-induced 
microtubule disruption, however, resulted in a loss of morphological complexity, 
defined by growth cone collapse and near (B) or complete (C) loss of filopodia and 
I amellipodi a. 
Scale bar: 21.im 
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often formed ball-like accumulations and defined filopodia could no longer be 
distinguished (Figure 5.5C). Additionally phosphorylated neurofilaments, although 
uniformly distributed in neurite shafts, were often accumulated into bulb- and ring-
like structures at neurite tips (Figure 5.5D). Filamentous actin, 13111-tubulin and tau 
were distributed throughout the filopodial-like structures emanating from the swollen 
tips of some taxol-treated neurites; presumably these structures correspond to growth 
cones, in which normal morphology has been disrupted by microtubule stabilisation. 
Quantitative analysis demonstrated that taxol significantly (p < 0.05) reduced the 
proportion of neurites tipped by a growth cone from 53.2% ± 7.8 (SE) in vehicle-
treated controls, to 18.2% ±3.7 (SE) following taxol treatment (Figure 5.6A). 
Additionally, taxol inhibited neurite elongation between three and five DIV (Figure 
5.6B). At three DIV, mean neurite length for untreated cultures was 64.0m ± 3.9 
(SE). By five DIV, vehicle-treated neurites had elongated significantly (p < 0.05) to 
90.91.tm ±2.1 (SE), however, taxol-treated neurites did not extend significantly (p > 
0.05) from pre-treatment and were significantly shorter (p < 0.05) than vehicle-
treated controls, with a mean neurite length of 59.8m ± 1.4 (SE). 
Taxol washout demonstrated that the effects of taxol were long lasting, with stunted 
neuronal morphology persistent at 21 DIV. However, the effects of taxol were 
partially reversible as increased neurite growth was observed in cultures from which 
taxol was removed, as compared to cultures grown in the continued presence of taxol 
(cell death was high in the latter cultures). Moreover, some of the neurites from 
which taxol was removed regained their growth cones (Figure 5.7). 
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Figure 5.5 	Cytoskeletal components were abnormally distributed within 
taxol-treated neurites 
Although 13111-tubulin was distributed relatively uniformly throughout the distended 
neurite shafts and bulbous neurite tips of taxol-treated cultures (A, arrow), it was also 
localised to abnormal loop-like structures in some neurite tips (A, arrowheads). Tau 
was also distributed uniformly throughout distended taxol-treated neurite shafts, but 
also occasionally extended into their filopodial extremities (B, arrow). Unlike the 
elaborate and extensive labelling of developmental growth cones for filamentous 
actin, phalloidin labelling of taxol-treated growth cones demonstrated bulb-like actin 
accumulations within neurite tips (C, arrows). As observed in vehicle-treated 
cultures, phosphorylated neurofilaments were localised to neurite shafts, but also 
extended into the distended end structures of taxol-treated neurites (D, arrow) and 
were localised to abnormal bulb- and loop-like structures within neurite tips (D, 
arrowheads). 
Scale bar: 2011m 

Figure 5.6 	Quantitative analysis demonstrated that taxol-induced 
microtubule stabilisation resulted in a statistically significant reduction in the 
number of neurites tipped by growth cones and inhibition of neu rite growth 
Quantitative analysis demonstrated that taxol-treatment between 3 and 5 DIV 
resulted in a substantial reduction in growth cone number relative to vehicle-treated 
controls (A). Likewise, quantitation of neurite length at 3 DIV and following 48 
hours of either vehicle- or taxol-treatment demonstrated vehicle-treated cultures 
underwent statistically significant neurite growth between 3 and 5 DIV, relative to 
baseline measurement, whereas taxol-treatment significantly inhibited neurite growth 
(B). 
* p < 0.05. Error bars are standard error of the mean 
A 	Effect of microtubule stabilisation on 
growth cone number 
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Figure 5.7 	The effects of taxol-induced microtubule disruption were partially 
reversible during neurite development 
Following taxol-treatment between 3 and 5 DIV, taxol was removed from the media 
and cultures re-incubated for several days prior to double immunofluorescence 
labelling for 13111-tubulin (green) relative to filamentous actin (red, phalloidin 
labelling). Although the effects of taxol were relatively long lasting, indicated by 
prolonged neurite distension, expanded growth cone-like structures were restored at 
the tips of several neurites (arrows denote examples). 
Scale bar: 201.4m 
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Preliminary investigations were carried out with nocodazole (Figure 5.8) and 
latrunculin A (Figure 5.9) to determine the effects of microtubule destabilisation and 
actin depolymerisation during neurite development. Both nocodazole and latrunculin 
A exposure for 48 hours between three and five DIV resulted in profound 
morphological alterations and aberrant cytoskeletal arrangement compared to control 
cultures. Nocodazole-induced microtubule destabilisation resulted in stunted neurite 
growth. Additionally, these cultures exhibited neuronal cell bodies and neurites that 
were often bordered by sections of lamellipodial-like membrane, which were not 
observed in vehicle-treated cultures by this stage of development, while many 
growth cones lacked obvious lamellipodia. The presence of abnormally abundant 
filopodial-like structures was confirmed with labelling for 13111-tubulin, tau, 
filamentous actin and phosphorylated neurofilaments (Figure 5.8A, B, C and D 
respectively). Alternatively, latrunculin A-induced actin depolymerisation resulted 
in a marked loss of growth cone-like structures at neurite tips. Furthermore, other 
typically actin-rich structures such as the spikes and small branches emanating from 
neurite shafts were also absent from latrunculin A treated cultures. Again these 
finding were confirmed by labelling for 13111-tubulin, •tau, filamentous actin and 
phosphorylated neurofilaments (Figure 5.9A, B, C and D respectively). 
5.3.3 Characterisation of neuronal maturity by 21 DIV 
A main aim of these investigations was to determine the role of the neuronal 
cytoskeleton in the reactive and regenerative events characterising the response of 
mature neocortical neurons to injury. Thus, the degree of neuronal maturity of 
neurons grown in vitro for several weeks was determined. By 21 DIV, cultures were 
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Figure 5.8 	Nocodazole-induced microtubule disruption resulted in an 
abundance of filopodia and lack of lamellipodia on developmental growth cones 
Nocodazole treatment of developing neuronal cultures between 3 and 5 DIV, 
followed by labelling for f3111-tubulin (A), tau (B), filamentous actin (C, phalloidin) 
and phosphorylated neurofilaments (D, SMI3 12), resulted in a loss of lamellipodia 
from developmental growth cones, revealing a distinctly filopodial morphology 
(arrows in A-C denote examples). Moreover, spikes and filopodial-like structures 
were abundant along neurite shafts (arrowheads in A-C denote examples). Similar to 
vehicle-treatment, phosphorylated neurofilaments were restricted to neurite shafts 
(arrows in D). 
Scale bar: A = 5[Am; B = 20[1,m; C and D = 101am 

Figure 5.9 	Latrunculin A-induced actin depolymerisation resulted in a loss 
of growth cones and other typically motile structures from developing neurites 
Cultures treated with latrunculin A between 3 and 5 DIV had vastly reduced growth 
cone numbers and lacked spikes and small branches along neurite shafts, as indicated 
by labelling for 13111-tubulin (A), tau (B), filamentous actin (C) and phosphorylated 
neurofilaments (D) (arrows denote examples). 
Scale bar: 20t.tm 
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characterised by large, multi-cellular aggregates (Figure 5.10A), from which 
elaborate networks and bundles of neuronal processes extended, forming 
interconnections with other aggregates (Figure 5.10B). BrdU was administered to 
cultures at seven (Figure 5.11A) or 17 DIV (Figure 5.11B) to determine whether any 
neurons were actively proliferating. The nuclei of all neurons lacked 
immunoreactivity for BrdU and neuronal nuclei were positive for NeuN, a marker of 
post-mitotic neurons (Figure 5.11C). 
By 21 DIV, neurons were immunoreactive for a range of markers indicative of 
neuronal maturity. Specifically, neuronal populations or cellular compartments were 
found to be immunoreactive for neurofilament triplet proteins (Figure 5.12A, B), 
MAP-2 (Figure 5.12C) and tau (Figure 5.12D). Extensive tau and phosphorylated 
neurofilament labelling demonstrated the abundance of axons within the neurite 
bundles interconnecting neuronal aggregates (MAP-2 labelled dendrites were rarely 
localised within these neurite bundles). Moreover, both pyramidal neuron and non-
pyramidal/interneuron populations were present within cultures, as indicated by 
positive labelling for markers of these different neuronal types, such as 
neurofilament and calretinin, respectively. Calretinin labelling demonstrated the 
presence of a subpopulation of cortical interneurons (Figure 5.12E). The extensive 
presence of synaptic contacts was demonstrated by labelling for the pre-synaptic 
marker, synaptophysin (Figure 5.12F). Transmission electron microscopy (Figure 
5.13) confirmed the presence of synapses (Figure 5.13A) and demonstrated that 
axons within axonal bundles were not myelinated (Figure 5.13B). Collectively, 
morphological and immunohistochemical studies demonstrated that embryonically- 
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Figure 5.10 By 21 DIV neocortical neuron cultures were characterised by the 
formation of multi-cellular aggregates interconnected by radially extending 
bundles and networks of neuronal processes 
Scanning electron microscope images demonstrating the morphological makeup of 
neocortical cultures by 21DIV. On initial plating, cells were rounded and lacked 
processes. Over the course of 21 days in culture, cells aggregated to form large 
multi-cellular clusters (A, arrows), which elaborated numerous neurites neurite 
bundles (B, arrows). 
Scale bar: A and B = 20[tm 

Figure 5.11 Dissociated neurons grown in culture for 21 days were no longer 
mitotically active 
Neocortical neuronal cultures were incubated in the presence of BrdU for 3 days at 
either 7 (A) or 17 (B) DIV. Cultures were grown to 21 DIV and double labelled with 
neuron specific enolase (NSE, red). Double labelling demonstrated that neurons had 
not incorporated BrdU (green) and were therefore not mitotically active. Arrows in 
A and B denote examples of neurons labelled for NSE, arrowheads denote examples 
of BrdU-labelled nuclei, at no stage were these markers localised to the same cells. 
The post mitotic state of cultured neocortical neurons was confirmed by positive 
labelling for the post-mitotic neuronal nuclei marker, NeuN (green), relative to tau 
(red) and numerous NeuN-labelled nuclei were located throughout neuronal 
aggregates by 21 DIV (C, arrows denote examples). 
Scale bar: A, B and C = 301tm 

Figure 5.12 Dissociated neurons grown in culture for 21 days demonstrated 
labelling for a variety of markers indicative of mature neuronal phenotypes 
By 21 DIV, cultured cortical cultures contained both pyramidal and non-pyramidal 
neurons and neurons were positive for a range of maturity-related markers including 
phosphorylated neurofilaments (as indicated by SMI312 labelling, A), NF-M (B), 
MAP2 (C), tau (D) and calretinin (E). Neurons had also made numerous synaptic 
contacts as indicated by extensive labelling for synaptophysin (F). 
Scale bar: 40[tm 

Figure 5.13 Dissociated neurons grown in culture for 21 days made synaptic 
contacts and were not myelinated 
Transmission electron microscopy confirmed the presence of synaptic contacts 
within neocortical cultures (A, arrowheads denote an example of a synapse) and 
demonstrated the absence of axonal myelination by oligodendrocytes (B, arrowheads 
denote an example of an unmyelinated axon). 
Scale bar: A and B = 21.im 
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derived neocortical neuron cultures, grown for 21 days, developed neurochemically 
defined sub-populations of neurons, which established polarity, were post-mitotic, 
formed synapses and possessed a range of markers indicative of neuronal maturity. 
Furthermore these cells were growing in relative isolation, free of their normal 
myelin sheaths and supporting astrocytic network. Collectively, these findings 
indicated that culturing embryonic neocortical cells for 21 days is adequate to 
achieve a mature neuronal phenotype. 
5.3.4 Characterisation of the response of mature cortical neurons to localised 
axonal transection 
Cultured cortical neurons were injured by localised neurite transection at 21 DIV, 
when they had reached relative maturity (as discussed in Section 5.3.3). Time-lapse 
digital imaging demonstrated that neurons respond to transection with a specific, 
highly dynamic sequence of changes (Figure 5.14). Immediately following injury, 
neuronal processes began to retract away from the site of injury (Figure 5.14A). This 
retraction response persisted for up to 4-6 hours after injury. Within 2-6 hours 
following injury, an extensive axonal sprouting response was initiated, manifested by 
the elaboration of fine protrusions into the injury site from the lesion boarder (Figure 
5.14B). Live cell imaging demonstrated that these sprouting processes were 
extremely dynamic and grew both directly across the lesion site as well as back 
towards the transected axonal bundle from which they originated. Post-injury axonal 
sprouts were generally characterised by slender sprout shafts tipped by expanded 
growth cone- or club-like end structures (Figure 5.15), although some sprouts 
tapered distally. 
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Figure 5.14 Axonal transection injuries induced a dynamic response including 
neurite retraction and sprouting 
Axonal injury at 21 DIV evoked a rapid and highly dynamic sequence of alterations 
within the proximal segment of severed neurites, characterised by an early phase of 
retraction away from the injury border (A), followed by the elaboration of fine 
sprout-like protuberances into the lesion site within several hours following injury 
(B). 
Scale bar: 40[tm 

Figure 5.15 Post-injury axonal sprouts were characterised by slender sprout 
shafts and expanded distal tips, a similar morphology to developmental growth 
cones 
Scanning electron microscopy of injury sites at 4 hours following axonal transection 
demonstrated that injury-induced sprouts exhibited similar morphological features to 
those observed in developing neurites, including prominent filopodial-like structures 
(arrow). Other sprout morphologies were also observed, including sprouts with 
bulbous end structures, which extended filopodial-like structures. 
Scale bar: 5[tm 
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Immunofluorescent labelling was utilised to determine the distribution of 
cytoskeletal components in post-injury neurite sprouts at 4, 14 and 24 hours 
following injury (Figure 5.16). Post-injury analysis demonstrated that the alterations 
occurring in response to axonal transection were consistent across all cultures at each 
time point investigated. Double labelling studies demonstrated that MAP-2 labelled 
processes (dendrites) only extended short distances from the neuronal aggregates and 
were rarely transected during neuronal injury. A prominent feature marking the 
injury site border was the accumulation of neurofilament triplet proteins into ring-
and bulb-like structures (Figure 5.16) as has been described previously in both in 
vivo and in vitro models of neuronal injury (King et al., 1997, 2001; Dickson et al., 
2000) as well as the previous investigations in this thesis. Ring and bulb-like 
structures were apparent at all time points examined, existing either in isolation or as 
a continuum of the severed axonal tips. 
13III-tubulin (Figure 5.17A) and tau (Figure 5.17B) were consistently distributed 
throughout post-injury axonal sprouts at all time points investigated. At four hours 
post-injury, numerous axonal sprouts had extended into the injury site. By 14 hours 
post-injury, sprouts had continued to elongate, with net extension towards the 
opposite side of the injury site from their origin. At 24 hours following injury, 
sprouting was extensive and many sprouts katl —crossed—the— injury—site. 
Phosphorylated neurofilaments became distributed in post-injury axonal sprouts by 
14 hours post-injury, as opposed to either 13111-tubulin or tau, which were distributed 
throughout sprouts at all post-injury time points examined (Figure 5.17C). Both 
f3111-tubulin and tau were uniformly distributed throughout sprout shafts and their 
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Figure 5.16 Axonal transection induced the abnormal accumulation of 
neurofilament triplet proteins into bulb- and ring-likes structures 
A prominent characteristic of the injury site, following axonal transection, was the 
aberrant accumulation of neurofilament triplet proteins. 	Neurofilaments 
accumulated into bulb-like structures (small arrows) as well as ring-likes structures, 
which were either continuous with (large arrows), or in isolation of (arrowheads), 
severed axonal tips. These structures were immunoreactive for all neurofilament 
triplet sub-units, as well as phosphorylated neurofilaments. Labelling is for NF-M. 
Scale bar: 100ium 

Figure 5.17 f3111-tubulin and tau were localised to axonal sprouts at all time 
points examined, whereas neurofilament triplet proteins were expressed later in 
the sprouting response 
Analysis of injured neuronal cultures at 4, 14 and 24 hours post-injury demonstrated 
that the injury-induced sprouting response was progressive and sustained resulting in 
extensive re-growth across the lesion site by 24 hours following injury. Sprouts were 
immunopositive for the microtubule related markers (3III-tubulin (A) and tau (B) and 
were labelled for NF-M by 14 hours following injury (C). Arrows in each image 
denote examples of injury-induced sprouts. 
Scale bar: 120[tm 
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splayed end-structures (Figure 5.18A and B). Filamentous actin was abundant in 
sprout growth cones (Figure 5.18C), however phosphorylated neurofilaments were 
restricted to the sprout shafts (Figure 5.18D). 
5.3.5 Cytoskeletal disruption during attempted axonal regrowth 
The effect of microtubule stabilisation on post-injury axonal sprouting was 
investigated by exposing cultures, grown for 21 DIV, to taxol immediately following 
axonal transection. Taxol exposure had a substantial effect on post-injury axonal 
sprouting (Figure 5.19). In vehicle-treated cultures the degree of sprouting increased 
as time progressed resulting in extensive sprout growth across the injury sites by 24 
hours post-injury (Figure 5.19A). However, post-injury axonal sprouting was 
comparably limited in taxol-treated cultures (Figure 5.19B). In addition, taxol 
exposure resulted in substantial alteration in sprout morphology (Figure 5.20). 
Injured, vehicle-treated cultures elaborated sprouts that were generally tipped by 
expanded growth cone-like structures (Figure 5.20A). Conversely, injured taxol-
treated cultures elaborated sprouts tipped by bulbous end-structures (Figure 5.20B). 
Taxol wash-out at least partially reversed the inhibitory effects of microtubule 
stabilisation on sprout growth, with increased sprouting observed in cultures in 
which taxol had been removed as compared to those continually exposed to taxol 
following injury at - 21 DIV. Additionally, some sprouts regained growth cone-like 
structures at their tips following taxol washout (Figure 5.20C). 
Quantitative analysis demonstrated that taxol substantially influenced sprout 
outgrowth and elongation (Figure 5.21). Sprout outgrowth was significantly (p < 
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Figure 5.18 Cytoskeletal components demonstrated specific distribution 
within sprouting axons 
Similar to developing neurites, injury-induced axonal sprouts expressed 13111-tubulin 
(A) and tau (B) throughout the sprout shaft and expanded distal tip (arrows) whereas 
filamentous actin was primarily localised to growth cone-like structures at sprout tips 
(C, arrow) and phosphorylated neurofilaments were restricted to sprout shafts (D, 
arrows). 
Scale bar: 20tim 

Figure 5.19 Taxol-induced cytoskeletal stabilisation resulted in fewer sprouts 
crossing injury sites by 24 hours post-injury 
When mature injured cultures were exposed to taxol, the sprouting response was 
substantially altered and, relative to vehicle-treated cultures (A), few sprouts were 
observed to have crossed injury sites by 24 hours post-injury (B). Arrows denote 
examples of sprouts. 
Scale bar: 601Ltm 

Figure 5.20 Taxol-induced microtubule stabilisation resulted in substantially 
altered sprout morphology, but these effects were partially reversible 
Although the sprouts of injured vehicle-treated cultures demonstrated expanded 
growth cone-like structures at their distal tips (A), the distal tips of neurites from 
taxol-treated cultures displayed bulb-like morphology (B). Taxol washout from 
injured sprouting cultures resulted in the restoration of lamellipodial like structures 
on growth cone-like structures at sprout tips, but sprouts remained distended (C). 
Arrows denote examples of sprouts. Dotted lines define injury site borders in each 
image. 
Scale bar: A and B = 20t.tm; C = lOtkm 
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0.05) inhibited by taxol, with vehicle-treated cultures elaborating an average of 14.7 
± 1.6 (S.E) sprouts per 10011m of cut site length compared to taxol-treated cultures, 
which had elaborated on average only 6.6 ± 1.5 (S.E) sprouts per 100Rm of cut site 
length, four hours following injury (Figure 5.21A). Similarly, statistical analysis 
indicated a significant (p < 0.05) difference between mean sprout length in injured, 
taxol-treated (21.61Am ± 0.8 (S.E)) and vehicle-treated (42.61Am ± 0.5 (S.E)) cultures 
at four hours post-injury, demonstrating that taxol profoundly inhibited sprout 
elongation (Figure 5.21B). Cell death analysis, using the vital dye propridium 
iodide, demonstrated the localisation of dead and dying cells along injury site 
boarders. Taxol exposure did not affect the level of cell death up to 24 hours 
following axotomy. However, increased cell death was observed when cultures were 
exposed to taxol for greater than 72 hours. 
Injured sprouting cultures were also exposed to the nocodazole and latrunculin A. 
Nocodazole exposure substantially inhibited post-injury axonal sprouting, with little 
evidence of sprouting observed by four hours post-injury (Figure 5.22A). 
Moreover, when present these sprouts were often tipped by growth cones elaborating 
numerous filopodial-like protrusions, which lacked obvious lamellipodia, similar to 
the growth cones observed following nocodazole treatment of developing neuronal 
cultures (Figure 5.22B). Interestingly, latrunculin A treatment of injured cultures 
had no obvious affect on the axonal sprouting response and cuts sites were often 
repopulated by numerous new sprouts several hours following injury (Figure 5.23A). 
However, these sprouts often lacked obvious growth cone-like structures observed in 
vehicle-treated cultures (Figure 5.23B). 
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Figure 5.21 Quantitative analysis indicated that taxol-induced microtubule 
stabilisation significantly reduced sprout outgrowth and elongation 
Quantitation of sprout number/100tim cut site length demonstrated a significant 
reduction in injury-induced sprouts between vehicle- and taxol-treated cultures (A). 
Additionally, sprout length was significantly reduced in response to taxol-treatment 
relative to vehicle-treated controls (B). 
* p < 0.05. Error bars are standard error of the mean 
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Figure 5.22 Nocodazole-induced microtubule disruption substantially reduced 
post-injury axonal sprouting 
By 4 hours following injury, cultures exposed to nocodazole exhibited relatively few 
sprouts per injury site (A, dotted line denotes injury border). Moreover, the growth 
cone-like structures at sprout tips elaborated numerous defined filopodia, but lacked 
lamellipodia (B, arrow). 
Scale bar: A = 301Am, B = 10pm 

Figure 5.23 Latrunculin A-induced actin disruption altered sprout growth-
cone morphology 
Although axonal sprouting was profuse in the presence of the actin depolymerising 
agent, latrunculin A (A, dotted line denotes injury border), the expanded end-
structures frequently observed on neurite tips in control cultures, were abolished in 
latrunculin A-treated cultures (B, arrows denote examples of sprouts lacking growth 
cones). 
Scale bar: A = 30[.tm, B = 15txm 
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5.4 Discussion 
The previous chapters in this thesis have demonstrated that a variety of adaptive 
alterations are evoked in the mature injured brain including the extensive induction 
of neural progenitor cells, adaptive changes in various glial populations and 
substantial axonal sprouting, associated with adaptive alterations in gene expression. 
Importantly, the intrinsic mechanisms underlying the potential for axons of mature 
central neurons to regrow in response to injury are not fully understood and are 
difficult to appreciate in the complexity of the CNS milieu and confounding glial 
respcinses. This study has, therefore, utilised live digital imaging, scanning electron 
microscopy and immunofluorescence-labelling techniques to investigate the intrinsic 
axonal sprouting response exhibited by relatively mature neurons in a simplified 
axonal injury model, in which neurons are grown in isolation. Furthermore injury-
induced axonal sprouting was compared to initial neurite development to determine 
whether similar dynamic cellular and cytoskeletal events underlie these processes. 
Importantly, comparing how axons attempt to regenerate following injury with initial 
axonal development will provide important clues regarding the mechanisms 
employed by regenerating axons and allow therapeutic strategies to more effectively 
target specific aspects of the regenerative response. 
In this study, a substantial regenerative attempt was indicated by the elaboration of 
sprout-like protuberances into injury sites. The overall morphology, motility and 
cytoskeletal composition of these injury-induced axonal sprouts was highly 
homologous with developing neurites. This was further highlighted by the 
demonstration that exposure to microtubule disrupting agents had similar effects on 
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initial neurite growth and injury-induced axonal sprouting. Additionally, disruption 
of the cytoskeleton substantially affected the morphology and cytoskeletal makeup of 
the growth cone-like structures tipping both developmental and regeneratively 
sprouting axons. Collectively, these results indicate that similar cytoskeletal 
dynamics may underlie both developmental and regenerative growth and contribute 
to clarifying the dynamic cytoskeletal mechanisms utilised by regeneratively 
sprouting axons. 
5.4.1 In vitro experimental models of neuronal/axonal injury are important for 
determining intrinsic degenerative and regenerative responses 
Although much research on neural repair is currently directed at understanding the 
mechanisms of degeneration and regeneration utilising in vivo models of 
experimental brain injury, which aim to simulate numerous aspects of human brain 
trauma, it is often difficult to gauge the response of individual neurons/axons to 
injury and separate intrinsic neuronal responses from confounding glial factors. In 
this regard, the poor regenerative ability of the adult brain, and CNS in general, has 
been attributed to a variety of factors encompassing a non-permissive environment as 
well as an intrinsic inability of neurons to re-initiate growth (Fawcett, 1992, 1997). 
This study was, therefore, designed to assess the potential for intrinsic axonal 
regeneration, utilising a culture system in which neurons can be grown to maturity in 
relative isolation (Dickson et al., 2000). 
Importantly, a frequent consequence of TBI is diffuse axonal injury and subsequent 
widespread axonal disconnection (Maxwell et al., 1997). This disruption typically 
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occurs in central white matter and includes both myelinated and unmyelinated axons 
(Reeves et al., 2005). A variety of in vitro experimental models have been 
developed to determine the effects of mechanical injury on cultured neuronal 
populations and although these models are able to replicate many aspects of brain 
injury (reviewed by Morrison et al., 1998), few are able to specifically injure axons. 
Moreover, specifically analysing the axons of CNS neurons utilising in vitro systems 
has been particularly difficult due to the challenges involved in culturing CNS 
neurons, relative to PNS neurons, and in examining the axonal component 
independent of the somato-dendritic component (Taylor et al., 2005). 
In this regard, specialised culture chambers have been developed in which axonal 
and somato-dendritic neuronal compartments can be assessed individually. These 
chambers, known as compartmentalised, or Campenot, chambers utilise growth 
factors to direct axonal growth to specific regions of the chamber (for example 
Campenot, 1982; Eng et al., 1999). However, this system has predominantly been 
used for investigating PNS neurons and is less useful for investigating CNS neurons, 
which differ in their growth requirements and do not efficiently grow under such 
conditions (Taylor et al., 2005). The neuronal culture system utilised in the present 
chapter resulted in the formation of discrete axonal bundles, interconnecting 
neuronal aggregates, which could be focally injured (for example transected or 
stretched) to determine the potential for intrinsic axonal regeneration in the absence 
of confounding glial factors. In this regard, individual bundles of axons were injured 
and immediately manipulated and/or imaged or examined by scanning electron 
microscopy and cytochemical techniques. 
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A similar culture system has previously been utilised, in which axonal bundles were 
transiently stretched by pressurised fluid deflection (Chung et al., 2005). However, 
this system produced a delayed axotomy response and, although useful for 
elucidating the evolving pathology of axonal disconnection, was less appropriate for 
examining potential regenerative events. Importantly, studies utilising defined 
axonal transection models (for example Dickson et al., 2000; Chung et al., 2002; 
Haas et al., 2004), similar to that utilised in the present investigation, have 
demonstrated the usefulness of this model system in examining axonal regeneration 
and determining the effects of inhibitory and facilitative molecules during 
regenerative attempts. Moreover, these studies were also able to compare neurite 
developmental and post-injury sprouting events. Recently, Taylor et al. (2005), have 
developed a specialised microfluidic culture system in which hydrostatic pressure is 
utilised to fluidically isolate axonal from somato-dendritic compartments. 
Importantly, this system is amenable to direct axonal manipulation. 
Collectively, these studies highlight the role of in vitro neuronal injury models as 
economical, accessible systems, which can be easily controlled to study the intrinsic 
response of neurons to various forms of extrinsic chemical, molecular and/or 
mechanical manipulation. In vitro axonal injury models are useful for understanding 
the similarities and discrepancies occurring between axonal development and 
regeneration and provide a solid platform for the initial testing phase of agents that 
may translate into potential clinical therapies. As such, the following discussion 
compares injury-induced axonal sprouting events with initial axonal development 
and examines the role of the axonal cytoskeleton in these processes. 
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5.4.2 Cytoskeletal disruption during neuronal development highlights the 
importance of cytoskeletal dynamics during neurite elongation 
To determine the role of the cytoskeleton during neurite growth and regenerative 
sprouting, the distribution of various cytoskeletal components was firstly confirmed 
by immunohistochemistry. As has been described extensively by other investigators, 
typical distribution of cytoskeletal components was observed in developing neurites 
in the current study. Notably, filamentous actin was localised to the most motile 
periphery of developmental growth cones, tubulin and microtubule-associated 
proteins such as tau were predominantly distributed within neurite shafts and growth 
cone central domains, occasionally extending into filopodia, and neurofilaments 
were restricted to neurite shafts and excluded from growth cones. The relative 
localisation of these cytoskeletal components may reflect their relative importance in 
axonal growth. For instance, microtubules have been demonstrated to be essential in 
axonal outgrowth (Okabe and Hirokawa, 1990; Walker, 2001), whilst axonal growth 
can proceed in the absence of neurofilaments (Jiang et al., 1996; Zhu et al., 1997; 
Levasseur et al., 1999), albeit at a slower rate (Walker, 2001). Importantly, neuronal 
intermediate filament expression has been associated with periods of rapid growth, 
particularly in axons where neurofilament triplet proteins become highly 
phosphorylated (Benson et al., 1996) 
As described above, the culture system utilised in this study was particularly useful 
for studying exclusively neuronal alterations in response to extrinsic manipulation 
and was therefore amenable investigating the effect of bath-applied cytoskeletal 
disrupting agents. In this regard, early stage cultures (three DIV) were exposed to 
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taxol to investigate the effects of microtubule stabilisation on neurite development. 
Taxol, widely used in the treatment of various cancers, promotes the polymerisation 
of tubulin monomers and the formation of stable, non-functional microtubules 
(Gotaskie and Andreassi, 1994). The microtubule network is a particularly motile 
component of the axonal cytoskeleton within developing neurites (for reviews see 
Brandt, 1998; Kalil et al., 2000; Kalil and Dent, 2005). Exposure of cortical neurons 
to taxol in the current study resulted in neurite distension, cessation of neurite 
elongation and a significant reduction in growth cone formation. Similar effects of 
taxol have been observed in cultured chick sensory neurons (Letourneau and Ressler, 
1984; George et al., 1988). 
These studies also demonstrated that, following taxol treatment, loops of tubulin 
immunoreactivity were localised within the deformed end-structures that replaced 
developmental growth cones at neurite tips, with ring- and bulb-like accumulations 
of phosphorylated neurofilaments often observed within the central core of the 
microtubule loops. The segregation of microtubules and neurofilaments is unusual 
as these cytoskeletal components are normally intermixed (Letourneau and Ressler, 
1984). The dilated bulbous structures that formed at neurite tips following taxol 
exposure frequently lacked filopodia and lamellipodia, and thus probably lacked the 
ability to effectively transduce guidance cues - a factor likely to account for the 
curling and looping of neurites around their aggregates of origin. 
Abnormalities occurring after taxol exposure are likely to reflect the bundling and 
proliferation of microtubules within neurites as well as altered microtubule spacing 
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and interaction with microtubule associated proteins (Black, 1987). Taxol-promoted 
microtubule proliferation may exhaust the local pool of tubulin monomers available 
for utilisation in neurite elongation and presumably causes steric hindrance of axonal 
transport, which may prevent the delivery of constituents necessary for neurite 
extension. Indeed, Theiss and MeIler (2000) demonstrated that taxol inhibits 
anterograde axonal transport. Furthermore, although results from this chapter 
demonstrated that some taxol-treated neurites regained growth cones and neurite 
growth increased following taxol washout, many neurites remained distended, 
indicating that taxol induced microtubule stabilisation is relatively permanent. 
Although nocodazole 	pecifically acts on microtubules, its affects oppose those 
of taxol; nocodazole binds to tubulin and causes microtubule depolymerisation 
(Dinter and Berger, 1998). Preliminary investigations demonstrated that exposure of 
developing cortical cultures to nocodazole inhibited neurite growth and caused 
substantial morphological reorganisation, which differed from the morphological 
aberrations induced by taxol exposure. Nocodazole-exposed neurites developed 
growth cones that lacked lamellipodia, as reported previously by Gallo (1998). 
Additionally, a proportion neurons were bordered by a lamellipodial-like fringe, 
structures that were not observed in taxol-treated cultures. Collectively, studies 
involving microtubule disruption (both stabilisation and destabilisation) highlight the 
importance of this cytoskeletal component in developmental neurite growth, as 
illustrated by severely misdirected aberrant growth or growth inhibition in the 
presence of such agents. In this regard, studies recently reviewed by Kalil and Dent. 
(2005) indicate that microtubules may play a. more predominant role in 
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developmental axon guidance than previously appreciated, a process in which actin 
filaments were believed to be primarily responsible for. 
Nevertheless, the complex interplay between microtubules and actin filaments was 
indicated in the present study, where disruption of the actin cytoskeleton also 
resulted in inhibited neurite growth as well as a loss of actin-rich structures, such as 
growth cone filopodia and lamellipodia. Each cytoskeletal disrupting agent had a 
dose dependant effect on neurite growth and was utilised at a sub-lethal 
concentration. Interestingly, each agent also disrupted a specific aspect of 
cytoskeletal dynamics, but ultimately prevented neurite growth, with differing effects 
on growth cone morphology. Collectively, these studies emphasise the significance 
of dynamic interactions between the various cytoskeletal components for successful 
neurite growth. 
5.4.3 Axons undergo rapid, highly dynamic alterations in response to physical 
injury indicative of attempted regeneration 
Numerous studies, in both in vitro and in vivo injury models as well as human brain 
injury cases, have documented the deleterious effects of brain and neuronal injury on 
the neuronal cytoskeleton, including cytoskeletal misalignment, abnormal 
accumulation or loss of cytoskeletal elements and cytoskeletal dissolution (reviewed 
by Povlishock and Christman, 1995; Maxwell et al., 1997; Fitzpatrick et al., 1998; 
Smith and Meaney, 2000; Povlishock and Katz, 2005). Thus, injury-induced 
alterations in the cytoskeleton of mature CNS neurons are implicated in resultant 
neuronal degeneration. Importantly, axotomy of neurons in the developing nervous 
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system, peripheral nervous system or nervous system of lower vertebrates and 
invertebrates is often followed by a robust and relatively successful or complete 
attempt at regeneration, whereas axonal injury in the mature CNS is met with a 
limited capacity for repair. As discussed, this may be due to non-permissive 
elements in the mature CNS environment as well as endogenous neuronal 
mechanisms, including factors such as a developmental loss of growth capacity 
(Fischer et al., 2004) and inability to rapidly seal damaged axonal membranes 
(Ahmed et al., 2001). 
However, accumulating data now indicate that neurons from the adult brain have 
the capacity to mount a regenerative attempt following injury. Many of these studies 
indicate that these regenerative attempts are associated with cytoskeletal 
rearrangement and manifest as the elaboration of fine sprout-like protuberances into 
the vicinity of lesion sites (for example Foerster, 1982; Kristt, 1987; Satin et al., 
1995; Christman et al., 1997; Dickson et al., 2000; Pastor et al., 2000; King et al., 
2001; Chung et al., 2002; Haas et al., 2004). Importantly, the mechanisms 
underlying attempted axonal regenerative attempts are not fully understood and, 
whilst collateral sprouting from undamaged axons has been the largely accepted 
mode of axonal re-growth following axotomy, few studies have directly investigated 
the potential for mature CNS neurons to sprout from disconnected axonal proximal 
tips following axotomy. In this regard, growth cone formation at severed axonal tips 
has been postulated as a key mechanism in successful axonal regeneration (Ziv and 
Spira, 1997; Verma et al,. 2005), although these structures may differ significantly 
between axotomy in the PNS and CNS and in invertebrates as opposed to vertebrates 
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(as discussed below). Interestingly, the formation of dystrophic, or abnormal, 
growth cones at severed tips of CNS axons has been attributed to the inability of 
these neurons to effectively re-grow their axons following injury (Tom et al., 2004). 
This study attempted to specifically investigate the response of mature mammalian 
CNS neuron axons to transection. Thus, utilising an in vitro model of axonal injury 
capable of eliciting a substantial axonal sprouting response (Dickson et al., 2000), 
this study demonstrated that axonal transection induced a characteristic and highly 
dynamic response, which included both reactive and regenerative sprouting events. 
Time-lapse imaging verified that axons retract away from injury sites immediately 
following, and up to several hours after, transection. Post-injury axonal retraction 
has been reported previously following lamprey spinal cord transection (McHale, 
1995). The retraction response was accompanied by other reactive alterations, 
including swelling in the distal region of severed axons and the accumulation of 
neurofilaments into ring- and bulb-like structures, as reported previously (Povlishock 
and Becker, 1985; MeIler, 1993: Dickson et al., 2000; King et al., 2001). 
Results from this chapter demonstrated that extensive neurite sprouting was initiated 
within four to six hours of injury. By 24 hours post-injury, several sprouts had 
traversed the lesion sites and many exhibited small growth cone-like structures at 
their tips, suggesting that this is a guided response and not simple elongation along 
random pathways. Importantly, this response was maintained beyond 24 hours 
following injury, indicating that cortical neurons not only possess an intrinsic 
capacity to sprout following injury, but also an ability to sustain this response. 
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Moreover, although sprouting in the mature CNS has been largely viewed as an 
abortive response, attributed to both a non-permissive environment as well as 
intrinsic neuronal factors, the finding that mature neurons are able to sustain a 
regenerative attempt free of their normal glial matrix suggests that the poor 
regenerative ability of the adult brain may be more attributable to compounding glial 
factors, than an incapacity of the neurons themselves. Notably, the defined media 
utilised in this study lack a range of growth factors that might support regeneration, 
although it does contain insulin (Brewer et al., 1993; Brewer, 1995). 
Analysis of the morphology, cytoskeletal composition and dynamic properties of 
post-injury sprouts indicated some notable similarities with developing neurites. For 
instance, developing neurites and sprouting axons were motile, slender structures. 
Additionally, a majority of sprouts were tipped by expanded growth cone-like 
structures, which exhibited immunoreactivity for tubulin, tau and filamentous actin, 
but not neurofilaments. However, putative regeneration-associated growth cones 
were generally smaller and less elaborate than developmental growth cones. 
Importantly, injury-induced axonal sprouts are not always tipped by growth cone like 
structures. For example, the 'sprouting bulbs' reported by King et al. (2001) and 
Povlishock and Becker (1985) elaborated finger-like protrusions, lacking defined 
end-structures. Moreover, studies by Jacobs et al. (1997), involving injury to 
lamprey spinal axons showed that, contrary to normal growth cones in the 
developing nervous system, the growth cones of regenerating axons lacked filopodia 
and lamellipodia and were filled with neurofilaments. 
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Interestingly, Hall et al. (1997) have demonstrated that axotomy close to the soma of 
neurons from the lamprey CNS results in the formation of ectopic axonal sprouts 
from dendrites, whereas axotomy at more distal sites results in sprouting from the 
proximal stump. Moreover, utilising cultured Aplysia neurons, Spira et al. (1996, 
2001, 2003) demonstrated that axotomy resulted in the formation of a motile growth 
cone at the proximal axonal tip, which was associated with substantial reorganisation 
of cytoskeletal proteins as well as other organelles within this region and is likely to 
involve calcium activated processes (Gitler and Spira, 1998; Spira et al., 2001). 
Similarly, Goldberg and Burmeister. (1992) showed that filopodial-like structures are 
rapidly elaborated from transected Aplysia axons. Overall, these studies demonstrate 
that axons undergo a stereotypical sequence of changes in response to transection, 
including initial retraction, proximal tip swelling, with normal axonal diameter 
maintained up-stream from this, and finally the transformation of the swollen tip into 
a dynamic growth cone (reviewed by Spira et al., 2003). Stone et al. (2001), 
however, note that axonal injury does not culminate in swelling in all axons, with 
smaller calibre axons undergoing relatively little change over time. Nevertheless, 
similar stereotypical reactive alterations have been observed following axotomy of 
mammalian CNS neurons, however, the full repertoire of responses may be lacking, 
potentially accounting for the poorer regenerative ability of the mammalian CNS 
relative to lower vertebrates, invertebrates, the PNS and the developing nervous 
system. 
Results from this study indicate that in both developing and regeneratively sprouting 
axons, neurofilaments are established at later time points than either microtubules or 
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microfilaments. These results suggest that neurofilaments are not required for initial 
sprout outgrowth. For instance, Zhu et al. (1997) and Levavasseur et al. (1999) have 
demonstrated that neurite outgrowth proceeds in the absence of neurofilaments. 
Neurofilaments, however, may play an important role in sprout elongation. In this 
regard, reduced regenerative ability of the peripheral nervous system has been 
reported in neurofilament deficient animals (Jiang et al., 1996; Zhu et al., 1997). 
Further, Meller (1993) speculates that neurofilaments may provide the propulsive 
force underlying sprout growth. 
5.4.4 Inhibition of injury-induced axonal sprouting with taxol or nocodazole 
highlights the importance of microtubule dynamics in axonal 
regeneration 
Administration of taxol immediately following axonal transection at 21 DIV resulted 
in distinct morphological changes, similar to those observed in developing taxol-
treated developing neurites. Taxol exposure substantially inhibited post-injury 
axonal sprouting, causing a significant reduction in sprout length and number at four 
hours post-injury. Post-injury sprouting was not completely abolished by taxol, 
suggesting that mechanisms other than microtubule dynamics may be responsible for 
sprout formation and growth. For instance, the actin and microtubule cytoskeletons 
may act in a co-ordinated manner to dictate the cytoskeletal response underlying 
sprout growth, as is the case during neurite development (Letoumeau et al., 1987), 
with disruption of one component affecting the dynamics of the other (Dent and 
Kalil, 2001). Similar to taxol, nocodazole also substantially inhibited axonal 
sprouting. Interestingly, disruption of actin did not obviously inhibit injury-induced 
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axonal sprouting as numerous axonal sprouts had crossed the lesion site of 
latrunculin A-treated cultures several hours after injury. However, sprouts in 
latrunculin A-treated cultures generally lacked distal growth cone-like. 
Collectively, these results indicate some of the notable similarities between 
developing and sprouting axons, and verify that the dynamic properties of 
microtubules are fundamental to the processes of sprout outgrowth and elongation. 
However, discrepancies are also highlighted in the relative importance of actin 
filaments in axonal development compared to regeneration, in that actin 
depolymerisation inhibited developmental, but not regenerative, growth. These 
findings also highlight the relative importance of the growth cone during axonal 
regenerative attempts. For example, although regenerative sprouting axons lacking 
obvious growth cones were able to undergo substantial growth, this may have been 
misdirected. 
5.4.5 Cytoskeletal disruption as a therapeutic strategy to prevent aberrant 
axonal sprouting following brain injury and in Alzheimer's disease 
The results from this chapter, as well as numerous other investigations, indicate that 
cytoskeletal disruption may be an effective therapy for targeting several postulated 
maladaptive cytoskeletal alterations induced by both physical injury and as part of 
the evolving pathology of certain neurodegenerative diseases. For example, using an 
in vivo model of brain trauma, Adlard et al. (2000) demonstrated that taxol inhibits 
microtubule loss and neurofilament accumulation, alterations that are viewed as 
pathological following neuronal injury. Furthermore, injury-induced axonal 
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sprouting has been implicated in the development of hyper-excitable circuitry, 
aberrant synapse formation and post-traumatic epilepsy following head trauma 
(Lamer, 1995; McKinney et al., 1997; Prince, 1997; Prince et al., 1997; Jacobs et al., 
2000; Santhakumar et al., 2001). Post-traumatic epilepsy is a common consequence 
of TBI, occurring months to years after the initial injury. Notably, abnormal 
epileptiform activity can result from both hippocampal and cortical injury/lesion, 
however, post-traumatic epilepsy is particularly common following penetrating 
wounds of the neocortex (Prince, 1997). Results from this chapter indicate that 
microtubule disruption effectively prevents injury-induced axonal sprouting in vitro. 
Therefore, agents such as taxol and nocodazole may have important therapeutic 
implications in preventing maladaptive sprouting responses following brain trauma. 
Importantly, the present investigation has demonstrated that the effects of taxol were 
at least partially reversible, an important feature should this agent be used 
therapeutically in the treatment of neuronal injury. 
Interestingly, disrupted neural circuitry (Phinney et al., 1999), including aberrant 
axonal sprouting (Arendt, 2001; Masliah et al:, 1991, 1992) has been demonstrated in 
Alzheimer's disease, where axonal sprouts have been localised around B-amyloid 
plaques. Importantly, many of the cytoskeletal abnormalities observed in both 
human and experimental models of brain injury are replicated in cases of 
Alzheimer's disease (King et al., 2000; Vickers et al., 2000; Woodhouse et al., 
2005). This has led to the proposal that B-amyloid deposition may cause chronic 
physical injury to surrounding axons, physically compressing and potentially 
severing them, which results in an attempt by the afflicted axon to regenerate 
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(reviewed by Vickers et al., 2000; Woodhouse et al., 2005). Thus, the formation of 
aberrant, or dystrophic neurites, has also been interpreted as a mechanism of 
regenerative failure (DeWitt and Silver, 1996), in which plaques induce a 'mass-
effect' on surrounding neurites causing them to attempt to regenerate, but this is 
ultimately compounded by the chronic, evolving nature of B-amyloid plaque 
formation (Vickers et al., 2000; Woodhouse et al., 2005). 
Cytoskeletal-stabilising agents such as taxol may have important implications in 
curbing cytoskeletal abnormalities and aberrant sprouting associated with the 
evolving pathology of Alzheimer's disease as well as associated disorders (reviewed 
by Trojanowski et al., 2005). For instance, taxol has been demonstrated to reduce B-
amyloid toxicity in Alzheimer's disease (Michaelis et al., 1998, 2005) as well as 
inhibit detrimental alterations in intracellular calcium levels that may result in 
neuronal death (Burke et al., 1994), aberrant changes in tau antigenicity (Mattson, 
1992) and excitotoxicity (Furukawa and Mattson, 1995). At low doses taxol has also 
been shown to promote recovery of function following spinal cord injury (Perez-
Espejo et al., 1996). However, Figueroa-Masot et al. (2001) have reported that taxol 
potently induces apoptosis in cultured cortical neurons in a dose and exposure-time 
dependent manner. Accordingly, the present study recorded relatively little cell 
death following taxol exposure for 24 hours, but cell death was substantially 
■ 
increased following 72 hours of taxol treatment. Trojanowski et al. (2005) review 
work indicating that, utilised as a therapy for Alzheimer's disease and related 
conditions, taxol may be used at much lower doses and different dose regimes than 
when used as a chemotherapeutic agent, to prevent toxicity. 
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5.5 Conclusion 
The inability of axons to successfully regenerate following brain trauma has been 
attributed to several factors within the CNS milieu as well as an intrinsic incapacity 
for regeneration by damaged neurons themselves (Berry et al., 1994; Fawcett, 1997; 
Bandtlow and Schwab, 2000; Golberg and Barres, 2000; Qui et al., 2000; Batchelor 
and Howells, 2003; Rhodes and Fawcett, 2004). The current study demonstrates that 
mature CNS cortical neurons can respond rapidly to injury by sprouting. 
Importantly, the microtubule disrupting agents, taxol and nocodazole, inhibited both 
initial neurite development and injury-induced axonal sprouting, indicating that 
common mechanisms of microtubule dynamics are likely to underlie both processes. 
Although taxol and nocodazole have opposing effects on microtubule structure 
(polymerisation and depolymerisation, respectively), both agents essentially act to 
suppress microtubule dynamics, which are crucial to normal neurite growth and post-
injury axonal sprouting. Interestingly, disruption of microfilaments had differential 
effects on developing and regeneratively sprouting axons, indicating the relative 
importance of the different cytoskeletal components in these processes. Collectively, 
this study has highlighted the remarkable intrinsic capacity of relatively mature 
cortical neurons to undergo a sustained axonal sprouting response after injury. These 
finding therefore suggest that the poor regenerative ability of central axons in vivo is 
likely to be more attributable to the non-permissive environment of the CNS rather 
than an intrinsic incapacity of the neurons themselves. 
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Finally, conditions such as the development of post-traumatic epilepsy following 
acquired brain injury (Lamer, 1995; Prince, 1997; Prince et al., 1997; Jacobs et al., 
2001) as well as the evolving pathology of Alzheimer's disease and other 
neurodegenerative disorders (Trojanowski et al., 2005) may include episodes of 
abnormal reactive neurite sprouting and detrimental cytoskeletal changes. Thus, 
agents that specifically target particular cytoskeletal components may be of 
therapeutic use in curbing the pathological evolution of these conditions. 
Importantly, the study of axonal degeneration and regeneration in vitro will be useful 
for studying the mechanisms underlying these processes as well as testing and 
developing therapeutic agents to prevent detrimental alterations and enhance 
adaptive alterations following brain injury and in various neurodegenerative 
disorders. 
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a-internexin undergoes identical reactive alterations 
following physical injury and in the evolving pathology 
of Alzheimer's disease 
6.1 Introduction 
Abnormalities in the neuronal cytoskeleton are common to physical injury and a 
variety of neurodegenerative diseases (Lariviere and Julien, 2004). In this regard, 
the neurofilament triplet proteins, unique to neurons, undergo striking alterations in 
response to physical injury and the evolving pathology of Alzheimer's disease (AD) 
(King et al., 1997, 2000a, b; Vickers et al., 2000; Woodhouse et al., 2005). Indeed, 
abnormalities in neurofilament triplet proteins are a key hallmark of neuronal trauma 
(Hoffman et al., 1984, 1985, Maxwell and Graham, 1997; Jafari et al., 1997, 1998; 
Maxwell et al., 1997; Povlishock 1997; Nixon, 1998; Dickson et al., 2000; King et 
al., 2000a, b, 2001; Zhang et al., 2000), where they accumulate into bulb- and ring-
like formations at sites of axonal damage and/or become localised to regenerative 
axonal sprouts in both in vitro (Dickson et al., 2000) and in vivo (King et al., 2001) 
models of experimental neuronal injury. 
Intriguingly, abnormal accumulations of neurofilament triplet proteins and aberrantly 
sprouting neurites, bearing striking morphological and neurochemical resemblance to 
physically injured neurons undergoing reactive and regenerative events, have been 
observed in AD (King et al., 1997, 2000a, b; Vickers et al., 1997, 2000; Woodhouse 
et al., 2005). AD is a chronic neurodegenerative disorder in which a specific pattern 
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of pathological changes result in extensive synapse loss and neuronal death, 
culminating in memory decline, impaired cognitive ability and profound dementia 
(Vickers et al., 2000; Morrison and Hof, 2002; Spires and Hyman, 2004). 
Pathological hallmarks of AD include the extracellular presence of B-amyloid 
plaques and associated intracellular neurofibrillary pathology (Vickers et al., 2000; 
Woodhouse et al., 2005). However, the mechanism linking B-amyloid deposition 
with neuronal abnormalities remains elusive. Interestingly, a sub-set of cortico-
cortical projection, neurofilament triplet-rich pyramidal neurons demonstrates 
selective vulnerability to AD pathology, whereas interneurons usually remain un-
altered (Hof et al., 1990; Hof and Morrison, 1990; Vickers et al., 1992, 1994, 2000; 
Vickers, 1997; Sampson et al., 1997; Morrison et al., 1998; Morrison and Hof, 2002; 
Bussiere et al., 2003). 
AD is a progressive disorder and develops through a defined sequence of stages 
involving a specific distribution of pathological alterations (Braak and Braak, 1991). 
In end-stage AD, both tau and neurofilament triplet proteins accumulate within 
neuronal cell bodies and dendrites to form neurofibrillary tangles (NFTs) and 
neuropil threads, respectively. Additionally, dystrophic neurites (DNs) are 
associated with a sub-population of 13-amyloid plaques, termed neuritic plaques. 
DNs encompass neurites that have undergone a variety of morphological and/or 
neurochemical alterations. The pathological changes contributing to end-stage AD 
pathology may be initiated in the brain many years before the clinical symptoms are 
apparent. Thus, a preclinical stage of AD is also recognised, characterised by minor 
cognitive impairments and a lack of tau-labelled neurofibrillary pathology, but 
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presence of plaques, in neocortical areas (Braak and Braak, 1991; Morris et al., 1996; 
Vickers et al., 2000). Changes in neuronal intermediate filament proteins may, 
therefore, constitute the initial cytoskeletal disruption in DNs in preclinical cases of 
AD, preceding classical NFT formation, tau pathology and overt dementia (Masliah 
et al., 1993; Vickers et al., 1994; Su et al., 1996, 1998; Nakamura et al., 1997; 
Dickson et al., 1999). In this respect, neurofilament triplet immunopositive ring- and 
bulb-like structures, particularly associated with dense fibrillar B-amyloid plaques, 
are the first cytoskeletal alteration observed in preclinical AD cases (Dickson et al., 
1999; Vickers et al., 1996). Analysis of the distribution of these cellular alterations 
across aged-control, preclinical and end-stage AD cases provides an opportunity to 
investigate the development of AD pathology as a continuum. 
As discussed above, the neurofilament triplet proteins have been widely studied, both 
in the neuronal response to injury and the evolving pathology of AD. Conversely, a-
internexin, also a member of the neuronal intermediate filament family of proteins, 
has largely been regarded as an important developmental protein (Kaplan et al., 
1990; Fleigner et al., 1994). Accordingly, few studies have investigated the normal 
distribution of a-internexin throughout neuronal development and within the adult 
brain. Furthermore, a-internexin has received little attention with regard to neuro-
degenerative and neuro-regenerative research, although recent studies indicate that 
this protein may indeed be involved in such events (for example McGraw et al., 
2002). Moreover, with respect to AD, the discrete localisation of neurofilament 
triplet containing neurons suggests that they alone cannot account for all the cell loss 
occurring throughout the disease process. In this regard, Shepherd et al. (2001) 
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demonstrated that neurons containing neurofilament triplet proteins are spared in 
AD. Additionally, recent studies regarding neuronal intermediate filament inclusion 
disease (NIFID) have indicated that abnormalities in a-internexin are a major feature 
of the disease pathogenesis (Cairns et al., 2004a, b, c; Momeni et al., 2005; Mosaheb 
et al., 2005). Thus, intermediate filament proteins, such as a-internexin, may be 
implicated in the evolving pathology of the AD. 
Chapters 4 and 5 of this thesis have highlighted the cytoskeletal alterations 
characteristic of neurons undergoing reactive and regenerative events following 
injury, particularly the early formation of reactive neurofilament triplet protein bulb-
and ring-like structures, which are also characteristically associated with B-amyloid 
plaques in early AD. Utilising in vitro and in vivo experimental neuronal injury 
models, as well as brain tissue from individuals in preclinical and end-stages of AD, 
this study was designed to determine the developmental localisation of a-internexin, 
as well as the distribution of this protein within the adult brain. Additionally, to 
further elucidate the cytoskeletal alterations characterising neuronal injury relative to 
the evolving pathology of AD, this study also comparatively analysed the 
involvement of a-internexin in injury-induced neuronal alterations and the neuritic 
changes associated with 13-amyloid plaque formation in AD. Results from this study 
are discussed with regard to the 'mass-effect' variant of the Amyloid Cascade 
hypothesis, proposing that B-amyloid deposition in AD causes physical damage to 
surrounding neurons (reviewed by Vickers et al., 2000; Woodhouse et al., 2005). 
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6.2 Experimental procedures 
6.2.1 Primary dissociated neocortical neuron culture, axonal transection 
injuries and immunohistochemistry 
Primary dissociated neocortical neuron cultures were prepared as described in 
section 2.2.1. To determine the developmental distribution of a-internexin, cultures 
were fixed between 1 and 21 DIV. The effect of physical injury on a-internexin 
distribution was assessed following axonal transection injuries performed on cultured 
neocortical cells at 21 DIV, as described in Section 2.2.2. Injured cultures were 
fixed at 6 or 12 hours following injury as well as at 1, 2, 3, 4, or 5 days post-injury. 
Cultures were labelled with antibodies directed against a-internexin relative to either 
NF-M or tau as illustrated in Table 6.1 (full antibody details are provided in Table 
2.1). 
As described in Chapter 5 and the introduction above, aberrant accumulation of 
neurofilament triplet proteins into ring-like formation, characterises an early reactive 
changed following axonal injury. The proportion of a-internexin, relative to NF-M 
ring-like structures was calculated at various time points following axonal injury. 
For quantitation of a-internexin ring-like structures, at least 100 rings were counted 
across several injury sites of cultures derived from three separate litters. From this, 
the proportion of a-internexin only rings, NF-M only rings and co-localisation 
within ring-like structures was calculated. 
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6.2.2 In vivo structural brain injuries 
6.2.2.1 Immunohistochemistry 
In vivo structural brain injuries were performed as described in Section 2.1.2, Figure 
2.1. Animals were transcardially perfused at 1, 7, 14, 21, 42 and 84 days following 
injury. Non-injured, age-matched controls corresponding to the 1, 42 and 84 days 
post-injury time points were also perfused. Tissue was processed and sectioned for 
immunohistochemistry, as described in Section 2.1.4, utilising antibodies directed 
against a-internexin relative to either NF-M, parvalbumin or calretinin as indicated 
in table 6.1 (full antibody details are provided in Table 2.1). 
Table 6.1. Antibodies used to identify cell populations/compartments/structures 
within physically injured neurons as well as preclinical and end-stage AD cases 
Cell type/structure 	 Marker 
Pyramidal neurons/triplet protein 	NF-M 
Interneurons 	 Calretinin 
Parvalbumin 
Neuronal intermediate filament 	a-internexin 
Axons 	 . Tau 
B-amyloid plaques 	 B-amyloid* 
*See antibody description in section 6.2.3.3 above 
6.2.2.2 Quantitative one-step reverse transcriptase RT-PCR for mRNA analysis 
To determine potential alterations in a-internexin gene expression in response to 
injury, tissue immediately medial and lateral to the lesion site, or equivalent regions 
from non-injured brains, was harvested and processed from post-injury time intervals 
as described in Section 3.1.2. Quantitative one-step real-time RT-PCR was 
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performed, as described in Section 2.1.6, using the a-internexin and GAPDH primer 
pairs displayed in Table 2.2. Statistical analysis indicated that the two groups of 
control animals were not statistically different and the data for these animals was 
therefore pooled to form one control group (n = 6). 
6.2.3 Human brain tissue samples 
To determine the similarities and discrepancies induced in a-internexin in response 
to experimental models of physical injury and AD pathology, brain tissue was 
sourced and processed from end-stage AD cases, in addition to preclinical 
(pathologically aged) and control cases. The end-stage of AD is characterised by 
profound dementia and the accumulation of 13-amyloid plaques, tau-rich NET 
formation as well as extensive but selective neuronal death in the hippocampus and 
cortex. Whereas, the preclinical phase of AD is defined by the presence of B-
amyloid plaques, but not tau-immunoreactive neurofibrillary pathology in 
neocortical areas and may be associated with minor cognitive deficits (Braak and 
Braak, 1991; Mirra et al., 1991; Morris, 1996; Vickers et al., 2000; Morrison and 
Hof, 2002). 
6.2.3.1 Tissue categorisation 
Brain tissue samples included seven end-stage AD cases, confirming to the CERAD 
criteria (Mirra et al., 1991) with Braak stages V and VI distribution of hallmarks 
(Braak and Braak, 1991), seven preclinical AD cases and four control cases (Table 
6.2). Preclinical cases were defined by the presence of widespread B-amyloid 
immunoreactive plaques in the neocortex, with the distinction that these plaques 
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could not be defined as "neuritic" based on thioflavine S staining or immunolabelling 
with PHF-tau antibodies (Saunders et al., 1998; Vickers et al., 1996). Theses cases, 
therefore, do not conform to the CERAD criteria for diagnosis of clinical AD (Mirra 
et al., 1991) and are classified, pathologically, as Braak stage III (Braak and Braak, 
1991). Control cases demonstrated no AD-associated pathology, but were of similar 
ages and post-mortem interval to preclinical and end-stage AD cases. 
6.2.3.2 Tissue sourcing 
Human brain tissue was obtained from multiple sources including the Institute of 
Biogerontology Research (USA), the National Health and Medical Research Council 
Brain Bank (Adelaide, Australia), and the Department of Pathology, University of 
Sydney (Australia). Brains had been either perfusion-fixed with 2% picric acid/4% 
PFA, or blocks of cerebral cortex were immersion-fixed in 4% PFA. 
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Table 6.2. Tissue sources for human control preclinical and end-stage AD cases 
Type Age Gender Post-mortem Pathological diagnosis 
(yrs) interval (hrs) 
AD 65 M 3 AD 
AD 66 M 2.8 AD 
AD 72 F 4 AD/Pneumonia 
AD 74 F 2 Pneumonia 
AD 76 F 26 AD 
AD 84 F 3 AD 
AD 88 M 7 Dementia 
Preclinical AD 62 M 20 Thrombosed coronary artery 
Preclinical AD 71 M 32.5 Cardiac arrhythmia 
Preclinical AD 78 M 2.25 Post-operative 
Preclinical AD 81 F 3 Cardiac arrest 
Preclinical AD 84 M 3 Cardiopulmonary arrest 
Preclinical AD 90 M 2.16 Respiratory arrest 
Preclinical AD 91 M 3 Cardiac failure 
Control 58 F 28 Coronary Disease 
Control 65 M 16 Cardiac infarction 
Control 67 M 32 Cardiac infarction 
Control 83 F 8.5 Bowel disease 
6.2.3.3 Tissue processing 
Samples of inferior temporal gyrus and superior frontal gyrus from all case types 
were sectioned on a cryostat at 40-501Am and tissue sections were immunolabelled 
for a-internexin relative to tau, NF-M, parvalbumin or calretinin as shown in table 
6.1 (specific antibody details are provide in Table 2.1, excluding anti-B-amyloid 
antibody, as detailed subsequently). The antibody utilised in the current study, 
directed against 13-amyloid, was a rabbit antibody recognising all B-amyloid peptides 
(1:500, QCB, Hopkinton, MA, USA). For the quantitation of co-localisation 
between a-internexin and NF-M, 100 ring-like DNs were counted across seven 
preclinical cases. No differences were observed in the immunolabelling profile for 
the various antibodies across varying post-mortem to fixation intervals or different 
fixation protocols. 
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6.3 Results 
6.3.1 a-internexin distribution during development 
To determine the developmental cellular localisation of a-internexin relative to NF-
M, rat neocortical cultures were fixed at a range of time points between 1 and 21 
DIV (Figure 6.1). At early time points (1-8 DIV), NF-M immunoreactivity was 
more abundant than a-internexin both in terms of number of labelled cells and 
distribution within individual cells (Figure 6.1A). In this regard, a-internexin 
immunoreactivity was generally not observed independent of NF-M. Additionally, 
NF-M immunopositive cells often lacked a-internexin immunoreactivity even at 
time points as early as 1 to 2 DIV. 
In older cultures (14-21 DIV), a-internexin immunoreactivity was more abundant 
than at earlier time points and was generally co-localised with NF-M (Figure 6.1B). 
In these cultures, a-internexin was located within particular neuronal types, but was 
variably distributed within these cells. In some cells, a-internexin was distributed in 
the form of slender filaments surrounding the nuclei and emanating along the 
neurites (Figure 6.1C). Alternatively, in other cells, labelling was uniformly 
distributed within the neurites and demonstrated polarised distribution within the 
soma (Figure 6.1D). Interestingly, after 14 DIV, a distinct population of small cells 
was observed, which labelled for a-internexin independent of NF-M (Figure 6.1E). 
This class of a-internexin immunopositive cells generally extended two to four 
neurites and a-internexin was distributed more abundantly on one side of the cell 
body than the other. 
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Figure 6.1 	a-internexin is expressed throughout the development of 
neocortical neurons grown in vitro, and is localised to specific cell types 
At time points as early as 1-2 DIV a-internexin (A, green) was not observed to 
precede the appearance of NF-M (A, red), and NF-M labelling was more abundant 
than a-internexin, both in terms of proportion of cells labelled and distribution 
within individual neurons (A, small arrowheads denote neurite more extensively 
labelled for NF-M than a-internexin, large arrowheads denote NF-M only labelled 
neurons, arrow denotes neuron co-labelled for a-internexin and NF-M). As neuronal 
cultures matured (14-21 DIV), a-internexin (B, green) became more abundant, but 
was generally co-located with NF-M (B, red). Arrows in B denote examples of cell 
bodies co-labelled for a-internexin and NF-M, arrowheads denote examples of 
neurites demonstrating co-labelling for these markers. Within individual neurons a-
internexin demonstrated variable distribution. 	In cells with pyramidal-like 
morphology, a-internexin localised as discrete segments around the nuclei and along 
the neurites (C, arrow). In other cells, a-internexin was distributed relatively 
uniformly throughout the neurites and demonstrated polarised distribution within the 
cell body (D, arrow). From 14 DIV onwards, cultures were characterised by the 
appearance of a new population of neurons labelled exclusively for a-internexin (E, 
green), which had an immature phenotype, extended few short neurites (arrows 
denote examples) and did not co-label for NF-M (E, red). Arrows in E denote 
examples of cells labelled for a-internexin and not NF-M. 
Scale bar: A — F = 40iim; G, H = 801Am 
' 
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6.3.2 Alterations in a-internexin associated with the reactive and regenerative 
changes resulting from localised axonal injury in vitro 
In vitro axonal transection injuries were performed to determine the localisation of 
a-internexin relative to the reactive and regenerative responses of physically injured 
axons at 6 and 12 hours following injury as well as at 1, 2, 3, 4 and 5 days following 
injury. Axonal transection injuries were performed at 21 DIV, when neocortical 
cultures had reached relative maturity (as described in Chapter 5). Within one day 
following injury, a variety of reactive and regenerative cellular alterations were 
observed in and immediately surrounding the lesion sites (Figure 6.2 and Figure 6.3). 
Axonal transection elicited the prominent accumulation of both a-internexin and NF-
M into abnormal ring- and bulb-like formations. Ring-like structures demonstrated 
three neurochemical constitutions based on their immunolabelling profile; a-
internexin-only, NF-M-only and co-localisation for a-internexin and NF-M (Figure 
6.2). Analysis of the presence of ring-like structures demonstrated an absence of 
rings after four days post-injury with the proportion of all three ring types remaining 
relatively constant at all time points prior to this. Specifically, of the total ring-like 
structures observed, 28.8± 3.21% (SE) were labelled for a-internexin only, 
35.3±2.19% (SE) were labelled for NF-M only and 35.91±3.38% (SE) were labelled 
for both a-internexin and NF-M. Importantly, the reactive alterations observed in 
transected axons were followed by the elaboration of a-internexin immunoreactive 
neurites into the lesion site (Figure 6.3). These sprout-like processes emanated from 
the lesion border and were evident as early as 12 hours following injury, persisting 
until the latest post-injury time point examined. 
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Figure 6.2 	a-internexin and NF-M underwent similar reactive alterations in 
response to axonal transection in vitro 
Within 6 hours following axonal transection injuries, reactive cytoskeletal alterations 
were observed at the lesion border. These alterations included the formation of ring-
like structures, labelled for a-internexin (green) and/or NF-M (red), which were 
present either independently or as a continuum of damaged axons. Double 
immunofluorescence labelling demonstrated 3 labelling patterns of ring-like 
structures; a-internexin only (small arrowhead), NF-M only (arrow), co-labelling for 
a-internexin and NF-M (large arrowhead). 
Scale bar: 30[Im 

Figure 6.3 	a-internexin contributed to the reactive and regenerative changes 
elicited by axonal transection injury 
At 6 hours following axonal transection injury a-internexin had abnormally 
accumulated into ring-like structures at severed axonal tips (arrows in A denote 
examples) and was also localised to the swollen tips of severed neurites (arrowhead 
in A denotes an example). By 12 hours following injury numerous a-internexin 
positive ring-like structures littered the injury site and a-internexin was also 
localised to sprout-like structure within the injury site (arrowheads B denote 
examples). By 24 hours post-injury a-internexin-labelled axons had crossed the 
injury site (arrowheads in C denote an example). 
Scale bar: A, B and C = 40t.tm 
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6.3.3 a-internexin distribution in the adult rat neocortex 
Utilising double labelling immunohistochemistry, the normal cellular localisation 
and laminar distribution of a-internexin relative to NF-M was determined in the 
adult rodent neocortex. Double labelling of brain sections from adult control non-
injured rats demonstrated a distinct laminar labelling pattern of a-internexin and NF-
M (Figure 6.4). Specifically, layer I revealed comparable labelling patterns for both 
intermediate filament types, with fine processes distributed throughout the layer. 
Strikingly, layer II/III contained a distinct and previously undescribed band of a-
internexin positive cells (Figure 6.4A). Within individual cells, a-internexin was 
distributed evenly throughout the soma. Moreover, the orientation and morphology 
of these cells was indicative of a subclass of pyramidal neurons, in that they each• 
possessed a pyramidal-shaped soma, clearly defined apical dendrite directed to the 
pial surface and laterally extending basal dendrites. Although a proportion of a-
internexin immunoreactive cells were co-labelled for NF-M (Figure 6.4B), the great 
majority were exclusively labelled for a-internexin. 
Layer V of the rat neocortex predominantly contained larger NF-M immunoreactive 
pyramidal cells, however, some a-internexin-labelled cells, similar to those observed 
in layer II/III were also contained within this layer. Double labelling for a-
internexin relative to the markers calretinin (Figure 6.4C) and parvalbumin (Figure 
6.4D), confirmed that a-internexin was not localised to the cell body of processes of 
interneurons. Collectively, these findings confirmed that a-internexin is localised to 
a distinct subclass of pyramidal neurons in the adult rat neocortex, with only partial 
overlap with neurofi lament triplet containing pyramidal neurons. 
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Figure 6.4 	a-internexin was primarily localised to a population of layer 
II/III cortical pyramidal neurons in the normal rodent cortex 
Immunofluorescence labelling revealed that a-internexin was localised to a distinct 
population of neurons within layer II/III of the adult rodent cortex, which 
demonstrated pyramidal-like morphology (A). 	Double immunofluorescence 
labelling demonstrated that a-internexin immunoreactive neurons were likely to be a 
distinct class of cortical pyramidal neurons. For instance, cells in the a a-internexin-
labelled population displayed distinctly pyramidal neuron morphological features. 
Moreover, a majority of these neurons labelled for a-internexin (green, small arrows 
in B) independently of NF-M (red, arrowhead in B), although co-localisation was 
demonstrated in a small portion of these cells (large arrow in B). Additionally, in all 
cortical laminae, a-internexin cells (green) were not immunoreactive for the 
interneuron calcium-binding proteins, calretinin (C) or parvalbumin (D). Similarly, 
calretinin and parvalbumin-labelled cells did not contain a-internexin labelling. 
Arrows in C and D denote examples of a-internexin-labelled cells and arrowheads 
denote examples of calretinin and parvalbumin cells, respectively. 
Scale bar: A = 10011m; B = 45p,m; C and D = 30[tm 
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6.3.4 Alterations in a-internexin associated with the reactive and regenerative 
changes resulting from in vivo structural brain injury 
To compare and contrast the reactive and regenerative alterations occurring in the in 
vitro axonal injury model with those occurring in vivo, adult rats underwent acute 
structural neocortical injuries and brain tissue was examined at a range of post-injury 
time intervals. Consistent with observations from the in vitro model of axonal 
injury, ring-like structures were a prominent feature of the lesion site and 
demonstrated three labelling profiles (a-internexin only, 18.0-± 9.0% (SE), NF-M 
only, 22.5±-4.5% (SE), co-labelling for a-internexin and NF-M, 59.5±4.5% (SE)) 
(Figure 6.5). Injury to the rat neocortex resulted in the formation of a distinct cavity 
that, between 1-7 days post injury, was surrounded by abnormal ring- and bulb-like 
accumulations of a-internexin (Figure 6.6A). By seven days post-injury, ring-like 
structures were still present but a substantial increase in the number of bulb-like 
structures was also observed (Figure 6.6B). However, from 14 days post-injury 
onwards both ring and bulb-like structures were absent from the lesion border. 
Importantly, concomitant with the resolution of abnormal accumulations of a-
internexin, alterations characteristic of attempted regeneration were demonstrated 
within the injured tissue from seven days post injury onwards. Notably, these 
alterations included a substantial number of neurites, with similar morphology to the 
sprouting neurites observed following both in vitro axonal injury (Section 6.3.2 this 
chapter and Chapter 5) and in vivo structural brain injury (Chapter 4), elaborated into 
the lesion cavity (Figure 6.6C). Sprouting neurites were either co-labelled for both 
a-internexin and NF-M or labelled independently for these intermediate filament 
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Figure 6.5 	a-internexin and NF-M underwent similar reactive alterations in 
response to acute structural brain injury 
Within a week following structural injury to the rat neocortex, abnormal 
accumulations of a-internexin (green) and NF-M (red) were observed surrounding 
the lesion site. Similar to the alterations observed following in vitro axonal injury, 
these alterations included the formation of ring-like structures, which demonstrated 3 
labelling patterns; a-internexin only (small arrowhead), NF-M only (arrow) and co-
labelling for a-internexin and NF-M (large arrowhead). 
Scale bar: 201.tm. 
I 

Figure 6.6 	a-internexin was involved in both the reactive and regenerative 
changes evoked by acute structural neocortical injury 
Focal injury to the rat cortex resulted in substantial destruction of layers I-IV and 
evoked a stereotypical sequence of reactive responses involving aberrant 
accumulation of a-internexin into ring- and bulb-like structures between 1 and 14 
days post-injury. At 7 days post-injury, a-internexin-labelled ring-like structures 
were abundant in injured cortical tissue (arrows in A), whereas a-internexin-labelled 
bulb-like structures became more predominant by 14 days post-injury (arrows in B 
denote a-internexin ring-like structures, arrowheads denote a-internexin bulb-like 
structures). By 7 days post-injury distinct a-internexin-labelled sprout-like 
structures were observed within the injury site (arrowheads in C denote an example), 
and by 84 days following injury bulb- and ring-like pathology had resolved, axonal 
sprouts generally rarely observed within the injury site and relatively normal 
cytoarchitecture was restored surrounding the lesion border (arrowheads in D denote 
examples of a-internexin-labelled cells within close proximity to the lesion border). 
Dotted lines in C and D denote the lesion border. 
Scale bar: A, B and C = 60[tm; D = 80[A.m 
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proteins. Further tissue healing was indicated by the restoration of relatively normal 
tissue architecture by 84 days post-injury, as indicated by the presence of non- , 
compromised a-internexin-labelled cells within close proximity of the lesion border 
(Figure 6.6D). 
In addition to immunohistochemical analysis, quantitative real-time RT-PCR was 
utilised to examine whether any of the alterations in a-internexin distribution, 
particularly those related to regenerative events, such as injury-induced sprouting, 
were reflected by changes in a-internexin gene expression following injury. Indeed, 
quantitative mRNA analysis at 1, 7, 14 and 28 days post-injury indicated significant 
(p< 0.05) increases in a-internexin mRNA levels at 14 days post-injury, which had 
returned to control levels by 28 days following injury (Figure 6.7). 
6.3.5 a-internexin distribution in the adult human neocortex 
Interestingly, immunolabelling demonstrated the same distribution pattern of a-
internexin in all human cases compared to that in the rat neocortex (Figure 6.8). 
Consistent with the rat neocortex, a prominent band of a-internexin-labelled cells 
populated layer II/III of the human neocortex, with orientation and morphology 
indicative of pyramidal cells (Figure 6.8A). Double labelling confirmed that these 
a-internexin-labelled cells constituted a distinct class of pyramidal neurons, which 
did not demonstrate immunoreactivity for NF-M (Figure 6.8B), or interneuron 
markers, parvalbumin and calretinin (Figure 6.8C). NF-M and a-internexin were co-
localised within a small proportion of cortical pyramidal cells. Layer V of the 
human neocortex was more prominent than in the rat neocortex and was comprised 
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Figure 6.7 	a-internexin expression was significantly increased in response to 
acute structural neocortical injury 
Quantitative real-time RT-PCR was performed to determine alterations in a-
internexin gene expression in response to cortical injury at 1, 7, 14 and 28 days 
following injury. a-internexin mRNA levels were significantly elevated at 14 days 
post-injury, but returned to control levels by 28 days post-injury. 
P < 0.05 
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Figure 6.8 	a-internexin was localised to a distinct subclass of pyramidal 
neurons in the human neocortex 
Similar to the rat neocortex, a-internexin was localised to a population of pyramidal-
like neurons in layer II/III of the human neocortex (A). Double labelling 
demonstrated that these cells labelled for a-internexin (arrows in B denote examples) 
independently of NF-M (arrowhead denotes example). Furthermore, a-internexin 
immunopositive cells (arrow in C) were a discrete class of pyramidal neurons and a-
internexin was not localised to interneuron populations (arrowhead in C denotes an 
example of a parvalbumin-labelled cell). In addition to the distinct band of layer 
II/III a-internexin-labelled pyramidal neurons, a-internexin was also localised to an 
array of irregularly orientated cells within layer VI of the human cortex (arrows in D 
denote examples). Images were taken from the inferior temporal gyrus of a 65-year-
old control case. 
Scale bar: A = 140pm; B = 60ttm; C = 30m; D = 50tim 
Images are courtesy of Dr Tracey Dickson. 
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predominantly of large NF-M-labelled pyramidal neurons. Within layer VI of the 
human cortex, similar a-internexin immunopositive neurons to those described for 
layer II/III were observed. Occasionally these pyramidal-shaped cells exhibited 
irregular orientation (Figure 6.8D). 
6.3.6 a-internexin alterations in end-stage AD cases 
Previous investigations have demonstrated a close association between neurofilament 
triplet protein aberrations and B-amyloid plaques in AD (see introduction). Double 
labelling for a-internexin relative to B-amyloid and tau was performed to determine 
whether abnormalities in a-internexin distribution were associated with B-amyloid 
plaques and tau DNs (Figure 6.9). Indeed, clusters of a-internexin immunoreactive 
DNs were frequently associated with 13-amyloid plaques (Figure 6.9A). Moreover, 
bulb-like a-internexin-labelled DNs were occasionally observed to have a tau-
immunoreactive core (Figure 6.9B). 
6.3.7 a-internexin alterations in preclinical AD cases 
Immunolabelling of preclinical AD cases demonstrated that, in addition to the 
previously described neurofi lament triplet immunoreactive dystrophic/abnormal 
neurites associated with B-amyloid plaques in the neocortical grey matter, abnormal 
accumulations of a-internexin were also localised within B-amyloid plaques. 
Consistent with NF-M, a-internexin was localised to a variety of dystrophic neurite 
subtypes, including bulb-like and ring-like dystrophic neurite morphological forms. 
Additionally, the ring-like DNs displayed morphology identical to the ring-like 
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Figure 6.9 	a-internexin aberrations were associated with B-amyloid plaques 
and tau dystrophic neurites in end stage AD 
Double labelling for a-internexin (A, green) relative to 13-amyloid (A, red), 
demonstrated that clusters of abnormal a-internexin-labelled neurites (arrows) were 
localised to regions occupied by fibrillar 13-amyloid deposits located within the 
inferior temporal gyrus and superior frontal gyms. Classical tau elongated and 
fusiform abnormal neurites (B, large arrowhead) were observed within a-internexin 
dystrophic neurite clusters. Occasionally, tau cores (B, small arrowhead) were 
present within bulb-like a-internexin-labelled dystrophic neurites (B, arrow). 
Images were taken from the inferior temporal gyms from a 74-year-old female AD 
case. 
Scale bar: A and B = 30Rm 
Images are courtesy of Dr Tracey Dickson. 
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accumulations of a-internexin observed in experimental models of physical injury 
(Figure 6.10A). 
Plaque-associated, a-internexin-labelled ring-like structures showed variable patterns 
of co-localisation with NF-M. Of the ring-like structures examined, 48.5±5.9% (SE) 
were only labelled for a-internexin, whereas only 10±-2.2% (SE) were exclusively 
labelled for NF-M. Co-localisation of NF-M and a-internexin occurred in 41.4 
±-5.9% (SE) of rings. These patterns of localisation were independent of the laminar 
location of the plaque with which the ring-like structures were associated. 
Additionally, the majority of plaques contained accumulations of both NF-M- and a-
internexin-labelled filaments. 
6.3.8 Abnormal ring-like accumulations of a-internexin, but not NF-M, were 
present in end-stage AD cases 
Although immunolabelling demonstrated the presence of both NF-M and a-
internexin immunolabelling in DNs associated with B-amyloid plaques in preclinical 
Alzheimer's disease cases, end-stage cases were defined by a distinct lack of NF-M 
immunoreactive ring-like DNs, with the continuing presence of a-internexin ring-
like structures (Figure 6.10B). Identical to preclinical AD cases, these a-internexin-
labelled ring-like structures were located within the plaque-associated clusters of 
DNs. 
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Figure 6.10 a -internexin was involved in the evolving cytoskeletal pathology 
associated with AD 
Aberrant a-internexin immunoreactive ring-like structures were characteristic of 
preclinical (A) and end-stage (B) AD. Double immunofluorescence labelling for a-
internexin (green) relative to NF-M (red) demonstrated distinct similarities and 
notable differences between preclinical and end-stage AD. In preclinical AD 3 
distinct labelling patterns of ring-like structures were observed; a-internexin only, 
NF-M only and a-internexin-NF-M co-labelled ring-like structures (denoted by 
small arrowhead, arrow and large arrowhead in A). In end-stage AD, ring-like 
structures were exclusively labelled for a-internexin and were never observed to be 
immunoreactive for NF-M (small arrowheads in B). Asterisk in B denotes a 
spherical bulb-like dystrophic neurite co-labelled for a-internexin and NF-M. 
Images in panel A were taken from the inferior temporal gyrus of an 84-year-old 
male. Images in panel B were taken from the inferior temporal gyrus of a 72-year-
old male-. 
Scale bar: A = 201..tm; B = 30pm 
Images are courtesy of Dr Tracey Dickson. 
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6.4 Discussion 
Although substantial alterations in neurofilament triplet proteins have been reported 
to occur in response to a variety of experimental neuronal injury paradigms as well 
as the evolving pathology of certain neurodegenerative diseases (reviewed by 
Maxwell et al., 1997; Vickers et al., 2000; Lariviere and Julien, 2004), a-internexin 
by comparison has received relatively little attention with regard to injury-related 
alterations and involvement in the pathogenesis of AD. However, recent —SW-dies 
have indicated that aggregations of a-internexin form a major hallmark pathological 
alteration in NIFID (Cairns et al., 2004a, b, c; Momeni et al., 2005; Mosaheb et al., 
2005). 
In general, a-internexin has largely been regarded as a predominantly developmental 
protein. In this respect, a-internexin has been reported as the major intermediate 
filament component of the neuronal cytoskeleton in early brain development, prior to 
the bulk expression of the neurofilament triplet proteins (Pachter and Liem, 1985; 
Fliegner et al., 1990, 1994; Kaplan et al., 1990; Shaw, 1991; Giasson and 
Mushynski, 1997). Whereas in the mature CNS, neurofilament triplet proteins are 
the most abundantly expressed neuronal intermediate filament proteins (Shaw, 1991; 
Hall et al., 2000; Lariviere and Julien, 2004) and are restricted to specific neuronal 
subclasses, including the large pyramidal cells of the neocortex (Hayes and Lewis 
1992; Hof and Nimchinsky, 1992; Hof et al., 2000; van der Gucht et al., 2001; 
Kirkcaldie et al., 2002). 
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A recent investigation has, however, reported substantial alterations in a-internexin 
in response to physical injury in both CNS- and PNS-derived neurons (McGraw et 
al., 2002), suggesting that the normal expression and role of a-internexin may not be 
restricted to developmental periods (Julien, 1999; Lariviere and Julien, 2004) and 
that a-internexin may indeed be involved in neurodegenerative and 
neuroregenerative events in injury and disease. This chapter, therefore, aimed to re-
examine the normal cellular distribution of a-internexin during the development of 
cortical neurons as well as in response to neocortical injury and the evolving 
pathology of AD, with the view that B-amyloid deposition structurally injures 
surrounding neocortical neurons (reviewed by Vickers et al., 2000; Woodhouse et 
al., 2005). 
Overall, a-internexin was widely expressed in both the rodent and human neocortex, 
where it was specifically localised to a sub-set of pyramidal neurons. In response to 
physical damage, a-internexin underwent distinctive changes in expression and 
cellular distribution and these alterations were demonstrated in both in vitro and in 
vivo experimental neuronal injury models. Notably, these abnormalities were 
identical to alterations in the neurofilament triplet proteins in response to injury and 
included the formation of ring- and bulb-like structures and the elaboration sprout-
like structures into injury sites. 
Immunohistochemical analysis demonstrated morphologically and neurochemically 
identical alterations in a-internexin in human brain tissue from preclinical and end- 
stage AD cases. Moreover, the neuronal intermediate filament composition of DNs 
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associated with neuritic B-amyloid plaques differed between preclinical and end-
stage AD cases. Notably, a-internexin immunoreactive ring-like DNs, localised to 
B-amyloid,plaques, represent a previously undescribed pathological alteration in the 
evolving Pathology of AD. This finding implicates the specific neuronal 
intermediate filament complement of a neuron in contributing to its relative 
vulnerability to AD pathology. Furthermore, the similarities between the reactive 
alterations in a-internexin in models of experimental neuronal injury and AD 
provide further evidence that13-amyloid plaques may structurally injure neurons. 
6.4.1 The cellular distribution of a-internexin differs from that of NF-M 
during neuronal development in vitro 
Similar to the neurofilament triplet proteins, a-internexin demonstrated distinct 
cellular distribution in developing neocortical cells. However, contrary to reports of 
a-internexin preceding the expression of neurofilament triplet proteins (Fliegner et 
al:, 1990; Kaplan et al., 1990; Giasson and Mushynski, 1997), relatively young 
neurons often lacked a-internexin immunoreactivity, but contained NF-M. This 
suggests that a-internexin may not be performing a scaffolding function for future 
triplet protein construction in these cells and that, at least in cortical neurons, a-
internexin may not have as large a role in neurite development as previously thought 
(Shea and Beermann, 1999). Similar to findings from the present study, Benson et 
al. (1996) reported the presence of a-internexin immunoreactivity in hippocampal 
neurons at all developmental stages, where it was distributed as long filaments and 
short fragments in axons and dendrites respectively. Importantly, studies by Benson 
175 
Chapter 6 
et al. (1996) and Suzuki et al. (1997) demonstrated that a-internexin was localised to 
dendritic spines and post-synaptic densities, implicating it in the formation and 
maintenance of these structures (Benson et al., 1996; Suzuki et al., 1997). 
Additionally, Levavasseur et al. (1999) demonstrated that a-internexin is not 
required for axonal growth during development. Collectively these studies 
demonstrate that a-internexin may have a variety of roles within developing neurons, 
including those not typically ascribed to neurofilament triplet proteins. 
6.4.2 Injury-induced a-internexin alterations resemble those occurring in NF-
M in both in vitro and in vivo models of experimental neuronal injury 
Collectively, results from both the in vitro and in vivo injury paradigms demonstrated 
that a-internexin underwent a distinct stereotypy of reactive alterations following 
neuronal injury, which has been previously described to occur in neurofilament 
triplet proteins (Dickson et al., 2000; King et al., 2001). These changes included the 
early predominance of a-internexin-labelled ring-like structures as well as the 
localisation of a-internexin in swollen neurites surrounding the lesion site and later 
predominance of a-internexin-labelled bulb-like structures. These alterations 
resolved over time, reflecting the acute nature of the injury paradigms and indicating 
that these alterations may comprise a transitory phase in preparation for regeneration 
(Dickson et al., 2000; King et al., 2001). 
Compared to the robust regenerative response of axons in the developing nervous 
system and PNS, axons in the mature mammalian brain are generally unable to 
mount a sustained attempt at regeneration in vivo (as discussed in Chapter 5). The 
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present investigation, therefore, aimed to determine the role of a-internexin in 
potential axonal regenerative attempts utilising in vitro and in vivo experimental 
models of neuronal injury capable of eliciting a neurite sprouting response (as 
demonstrated in Chapters 4 and 5). Immunohistochemical analysis demonstrated 
that both injury paradigms were capable of inducing the elaboration of numerous a-
internexin—labelled sprouts into lesion sites. Moreover, a-internexin expression was 
significantly elevated following injury, returning to control levels by 28 post-lesion. 
McGraw et al. (2002) have also recently demonstrated similar alterations in a-
internexin in axonal regenerative attempts in both PNS and CNS neurons. 
Collectively these findings highlight the involvement of a-internexin in neuronal 
regenerative attempts and emphasise that formation of the glial scar may perturb this 
response (as discussed in Chapter 4). The increase in a-internexin expression may 
indicate a final regenerative attempt by a sub-set of neurons prior to establishment of 
the glial scar. The expression of the neurofilament triplet proteins remained 
unaltered in response to injury (see Chapter 4), this may reflect the different 
contributions of neuronal intermediate filament proteins in neuronal regenerative 
attempts. 
6.4.3 a-internexin-labelled DNs represent an additional hallmark pathology 
associated with neuritic B-amyloid plaques in preclinical and end-stage 
AD 
An array of cytoskeletal, synaptic, apoptotic and regenerative markers are localised 
to plaque-associated DNs and these alterations correlate with disease stage (Masliah 
et al., 1993; Wang and Munoz, 1995; Saunders et al., 1998; Dickson et al., 1999; 
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Arendt, 2001). Importantly, the presence of B-amyloid plaques associated with 
neuronal intermediate filament-immunoreactive DNs and a lack of tau neurofibrillary 
pathology have been proposed to represent a preclinical, or very early, phase of AD 
in which only minor cognitive impairment is apparent and end-stage cortical 
pathology is absent (Braak and Braak, 1991; Morris et al., 1996). In this regard, 
plaque-associated alterations in neurofilament triplet proteins are proposed to 
represent the very first cytoskeletal aberration that may predict subsequent 
development of end-stage AD pathology, including extensive tau-immunoreactive 
neurofibrillary pathology (Masliah et al., 1993; Vickers et al., 1994, 1996; Su et al., 
1996, 1998; Nakamura et al., 1997; Dickson et al., 1999). 
An important feature of end-stage AD is the distinct absence of neurofilament triplet 
immunopositive ring-like DNs, (Vickers et al., 2000; Woodhouse et al., 2005). In 
this regard, Vickers et al. (1996) and Dickson et al. (1999) have described DNs as 
developing through 4 distinct phases from preclinical to end-stage AD: (I) the initial 
formation of neurofilament triplet rings; (II) continued neurofilament triplet 
accumulation to form bulb-like structures; (III) the appearance of tau cores within 
neurofilament triplet immunoreactive bulb-like DNs; (IV) DN maturation into 
predominantly tau/paired helical filament containing structures. Thus, phases I and 
II are characteristic of preclinical AD, whereas in end-stage AD, phase III and IV 
DNs have developed (Masliah et al., 1993; Vickers et al., 1994). 
Findings from this chapter have demonstrated that a-internexin DNs were a 
characteristic feature of both preclinical and end-stage AD. In this regard, a- 
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internexin was localised to ring-like, and bulbous DNs and a proportion of these 
demonstrated tau cores in end stage cases. However, contrary to the neurofilament 
triplet proteins, a-internexin-labelled ring-like DNs were present in both preclinical 
and end-stages of AD, whereas NF-M ring-like DNs were exclusively restricted to 
the preclinical phase of the disease. 
6.4.4 How are B-amyloid deposition and DN formation linked? 
Importantly, the mechanisms linking plaque formation with the earliest stages of 
neurofibrillary pathology remain to be fully elucidated. The presence of a-
internexin ring-like DNs in end-stage AD implicates a-internexin-containing 
neurons as being vulnerable to the earliest stages of DN formation in this advanced 
stage of the disease. In this regard, the neuronal intermediate filament complement 
of neuronal populations may contribute to differential neuronal vulnerability to AD 
pathology. 
The pervading view regarding neurodegeneration in AD is explained by the 
"amyloid cascade hypothesis" (Selkoe, 1994), which asserts that B-amyloid 
deposition results in neuronal death by evoking neurotoxic, biochemical and 
metabolic pathways (Hashimoto and Masliah, 2003). Intriguingly, the specific 
neurofilament triplet and a-internexin DNs observed in preclinical and end-stage AD 
were morphologically and neurochemically identical to the reactive cytoskeletal 
ring- and bulb-like accumulations characteristic of axonal damage in both of the 
structural neuronal injury paradigms investigated (Dickson et al., 2000; King et al., 
1997, 2001). 
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The neuronal response to axotomy follows a stereotypical sequence of events, 
including degeneration of the distal axonal segment and reactive alterations in the 
surviving proximal axon, which remains attached to the cell body, as well a 
subsequent retrograde, or cell body, reaction (Smith and Meaney, 2000). 
Neurofilament triplet proteins may accumulate into bulb-like structures in the 
severed proximal stump and into ring-like structures within distal axonal terminals (a 
location from which they are normally excluded) (Maxwell et al., 1997). 
Thus, aberrant ring- and bulb-like DNs observed in preclinical and end-stage AD 
may represent a 'reactive' response of axons, which have undergone some form of 
physical injury. In this regard, a 'mass-effect' variant of the amyloid cascade 
hypothesis postulates that continued deposition of B-amyloid generates space-
consuming lesions within the brain, which progressively compress and constrict 
surrounding neurons and/or block axonal transport to ultimately cause axotomy-like 
injuries to surrounding neurons (Vickers et al., 1996; King et al., 1997; Dickson et 
al., 1999; Vickers et al., 2000; Dickson and Vickers, 2001; Woodhouse et al., 2005). 
6.4.5 B-amyloid plaques may physically disrupt surrounding neurons and 
their processes 
The complement of neuronal changes occurring in AD pathogenesis may be 
explained by physical injury exerted by B-amyloid plaques (Vickers et al., 1997, 
2000). For instance, aberrations in dendritic structure and density are associated with 
B-amyloid plaques in both human AD cases and transgenic animal models. Plaque 
associated dendritic changes include decreased density, abnormal geometry (Le et 
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al., 2001), dendritic spine loss and atrophy (Tsai et al., 2004) and loss of the dendritic 
protein MAP-2 within fibrillar plaques (Adlard and Vickers, 2002). Moreover, 
plaque-associated axonal alterations may include axonal varicosities, swelling, 
disconnection and loss (Benes et al., 1991; Tsai et al., 2004). Interestingly, these 
features are also common to traumatically injured axons (Maxwell et al., 1997). 
Furthermore, neurons surrounding plaques often demonstrate distorted 
morphologies, whereby they are bent around the plaque and this abnormality can be 
reversed by treatment with B-amyloid antibody (Lombardo et al., 2003). 
Collectively, these studies provide evidence that B-amyloid plaques may physically 
displace and/or injure neurons. 
Moreover, physical injury in experimental models of neuronal trauma is typically 
transient, however, B-amyloid plaques may develop over many years and thus 
generate chronic lesions that continually activate attempts by the affected neurons to 
regenerate (Vickers et al., 2000). In this regard, aberrant axonal sprouting and 
dystrophic boutons, immunoreactive for GAP-43, have also been associated with B-
amyloid plaques (Masliah et al., 1993; Phinney et al., 1999). It has been postulated 
that B-amyloid plaque formation may induce a neurotrophic effect on surrounding 
neurites (Phinney et al., 1999). Conversely, chronic activation of aberrant 
regenerative attempts, including alterations in the neuronal cell body (the retrograde 
reaction), may ultimately culminate in the neurofibrillary pathology that contributes 
to neurodegeneration and neuronal loss (Vickers et al., 2000). 
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6.5 Conclusion 
This study has shown that cortical neurons differ in their complement of 
neurofilament triplet and a-internexin intermediate filament proteins and has 
identified a distinct class of pyramidal neurons in both the rodent and human adult 
brain, which exclusively contain a-internexin. Furthermore this study highlights 
some of the distinct similarities and discrepancies that exist between these two 
protein classes during development, in response to injury and during the progressive 
cytoskeletal pathology associated with AD. Strikingly, both neurofilament triplet 
proteins and a-internexin were involved in the reactive and regenerative response of 
structurally injured neurons. Specifically, identical to the neurofilament triplet 
proteins, a-internexin abnormally accumulated into ring- and bulb-like formations 
and was localised to sprouting axons. The eventual resolution of triplet protein and 
a-internexin ring-and bulb-like accumulations in models of experimental neuronal 
injury suggests that this phase of the neuronal response to injury is like to be 
transient and associated with a subsequent phase of regeneration, indicated by the 
elaboration of axonal sprouts. 
Identical reactive alterations in a-internexin were shown to be associated with 
neuritic plaques in both preclinical and end-stage AD cases. These findings provide 
support for the hypothesis that B-amyloid deposition in AD causes structural injury 
and displacement of surrounding neurons and their neurites. The discovery of a-
internexin ring-like DNs represents a novel hallmark pathology of AD. Furthermore, 
the persistence of early indicators of neuronal damage, namely a-internexin ring-like 
DNs, in end-stage AD highlights the differential vulnerability of neuronal 
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intermediate filament-containing pyramidal neurons in the different stages of AD and 
the ongoing ability of B-amyloid plaques to induce structural injury throughout the 
disease process and into advanced stages of the disease. 
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General Summary and Discussion 
7.1 Background 
The inability of the adult brain to undergo full structural and functional restoration 
following physical injury is evidenced by the fact that acquired brain injury 
frequently results in prolonged or permanent mental and/or physical deficits. 
Intriguingly, however, episodes of mild to moderate TBI are often associated with 
some degree of functional recovery (Goldberger and Murray, 1988; Wilson, 1998; 
Medana and Esiri, 2003; Constantinidou et al., 2005; Ding et al., 2005; Povlishock 
and Katz, 2005). This response may be due to an initial subsidence of various 
inflammatory reactions and other responses such as diaschisis, where un-injured 
neurons undergo temporary loss of function (Duff, 2001). Post-injury recovery may 
also be attributed to long-term plasticity and compensation by undamaged brain 
regions, possibly including frank replacement of degenerated neurons (Kruger and 
Morrison, 2002; Emsley et al., 2005) and/or lost neuronal connections (Kristt, 1987; 
McHale et al., 1995; Dusart et al., 1999; Christman et al., 1997, Deller and Frotscher, 
1997; McKinney et al., 1997). 
An accumulating body of literature has demonstrated striking examples of adult 
brain plasticity, adaptability, repair and regeneration in response to CNS injury. 
Indeed, the adult CNS undergoes a transient increase in plasticity following injury, 
which is thought to recapitulate changes observed during development and PNS 
regeneration (Emery et al., 2003). The intrinsic repair mechanisms utilised by the 
• adult brain, in addition to experimental repair strategies aimed at enhancing these 
responses, have demonstrated that the adult brain is much more adaptable than was 
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historically appreciated. However, although the endogenous adaptive response may 
be enhanced by various rehabilitative therapies (Wilson, 1998; Tillerson and Miller, 
2002; Nudo, 2003), no surgical or pharmacological treatment currently exists to fully 
restore pre-injury neural integrity following trauma to the human brain (Smith and 
Meaney, 2000). Additionally, it is likely that no single therapy will adequately 
overcome all consequences of brain degeneration following injury and instead 
several combined and interactive approaches will probably be required. 
The inability of the adult brain to undergo effective repair following injury revolves 
around several factors including the combined influences of an inhibitory CNS 
milieu, an intrinsic inability of mature neurons to initiate adaptive growth processes 
and a limited capacity for neurogenesis within the adult brain (Fawcett and Asher, 
1999; Schwartz et al., 1999; Domeniconi and Filbin, 2005). Contemporary research 
is directed at understanding the molecular and cellular factors that inhibit neural 
regeneration as well as potential adaptive endogenous responses that may be 
extrinsically manipulated to facilitate effective repair mechanisms (Selzer, 2003). A 
large literature now exists supporting various experimental approaches aimed at 
either evoking neurogenesis or promoting axonal regeneration and synaptogenesis in 
the injured brain. In general, these methods either directly target damaged axons or 
endeavour to promote a neurogenic response. Alternatively, indirect strategies have 
been developed to block inhibitory factors associated with the post-injury sequela, 
such as inhibitory molecules in CNS myelin and the glial scar as well as toxic factors 
associated with glial activation, cell degeneration and blood-brain barrier breakdown, 
thus allowing endogenous neuronal responses to be revealed. 
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Importantly, although many strategies to promote neural repair have been successful 
in experimental settings, many of these therapies have fallen short in translating to 
cases of human head trauma. Largely, this lack of transplantation may be attributed 
to limitations in experimental models simulating all aspects of human head traumas 
as well as representing only a fraction of the vast variation in the combination of 
influences associated with the human population, such as age, gender, genetic back 
ground and environment (Statler et al., 2001). However, experimental models of 
neuronal/brain injury have proven invaluable in understanding the molecular and 
cellular mechanisms underlying neurodegeneration and regeneration following 
injury. 
For endogenous reparative attempts to be effective, damaged neurons must survive 
the initial insult as well as confounding factors, such as glial activation and damage 
due to breeches in the blood brain barrier. Neurons must subsequently have the 
capacity to correctly navigate their processes to pre-injury targets. Additionally or 
alternatively, a traumatic event may induce the elaboration of new neurons from 
endogenous neural progenitor populations, which subsequently differentiate and 
integrate into the damaged neural circuitry. In the brain, these changes must occur 
appropriately within a background of confounding glial responses. Thus, the 
capacity for endogenous neurogenesis and axonal regeneration following TBI remain 
contentious and are widely accepted to be significantly influenced by extra-neuronal 
factors. 
It is imperative to note that although many neuro-repair strategies are focussed upon 
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promoting axonal regeneration and neurogenesis, the intrinsic capacity the damaged 
brain possesses to evoke these responses remains incompletely understood. It will be 
crucial to determine the capacity for endogenous brain repair prior to developing 
therapies that can effectively target intrinsic and potentially latent responses. For 
instance, the inextricably complex nature of the adult CNS may have evolved poor 
regenerative capacity for good reason and promoting axonal growth or neurogenesis 
in an unregulated manner may have dire consequences. This thesis investigated the 
endogenous mechanisms underlying axonal regenerative attempts and brain repair 
following structural injury. The following discussion reviews the aims and major 
findings of this thesis and discusses the relevance of these findings in relation to 
current understanding of endogenous brain repair mechanisms and methods that are 
being developed to enhance this response. 
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7.2 Review of general thesis aims and main findings 
This thesis primarily sought to investigate the endogenous capacity for repair 
following structural injury to the adult mammalian brain and the intrinsic potential 
for regeneration of axotomised mature central neurons. Collectively, findings from 
this thesis contribute to understanding the molecular and cellular events responsible 
for endogenous neuronal regenerative attempts and brain healing following structural 
injury and highlight important aspects of the neuro-glial response to injury that may 
be therapeutically targeted to enhance brain repair and neuronal regeneration. The 
major findings from this thesis are as follows: 
7.2.1 The adult mammalian brain possesses the capacity to recruit 
proliferating and progenitor cells to sites of injury to bring about brain 
healing 
Aim 1: 
The initial aim of this thesis was to determine the fate of injury-induced proliferating 
and progenitor cells and determine whether structural brain injury evokes a 
neurogenic response capable of producing neurons that replace those lost by injury. 
Finding 1: 
Acute structural brain injury evoked extensive cell proliferation and induction of 
neural progenitor cells. Importantly, the primary germinal region of the adult brain, 
the SVZ, was involved in this process and was likely to elaborate a proportion of the 
cells, which congregated at the lesion margin and contributed to brain healing by 
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formation of a glial scar. Ultimately, proliferating and progenitor cells associated 
with the injury site were identified to be newly generated glial cells or reactive 
astrocytes, and not neurons. Thus an acute focal lesion to the rodent neocortex did 
not evoke a neurogenic response or neuronal replacement within damaged cortical 
tissue. 
7.2.2 Co-ordinated and adaptive responses involving all major neural cell 
populations contribute to brain healing following structural injury 
Aim 2 
A second goal of this thesis was to investigate the molecular and cellular 
mechanisms directed at endogenous brain repair, therefore, determining the co-
ordinated short- and long-term interactive responses between astrocytes, 
microglia/macrophages, oligodendrocytes/myelin, neurons and brain vasculature in 
contributing to brain healing. 
Finding 2 
Acute structural brain injury elicited an adaptive and co-ordinated neuro-glial 
response involving microglial activation, astrogliosis and regenerative neuronal 
alterations, including axonal sprouting and altered gene expression. Although 
astrogliotic changes may have ultimately hindered axonal regrowth within the injury 
site, these changes contributed to a brain healing response that resulted in the 
restoration of relatively normal neural cytoarchitecture within close proximity of the 
lesion site. Importantly, molecular changes occurring during neuronal regenerative, 
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or sprouting, events (including up-regulation of the developmentally important 
genes, GAP-34 and 13111-tubulin) were similar to the genetic alterations 
characterising early neurite development. 
7.2.3 Adult central neurons possess a remarkable capacity to attempt 
regeneration following axotomy that, in some respects, reflects 
developmental axonal growth 
Aim 3 
Thirdly, the response of relatively mature axotomised neurons was investigated in an 
in vitro model of axonal injury to enable the intrinsic reaction of damaged axons to 
be studied, free of confounding glial factors such as myelination, astrogliosis and 
inflammation. Specifically, the cytoskeletal mechanisms underlying axonal re-
growth following injury and during development were compared to determine 
whether axonal regenerative growth recapitulates initial neurite development. 
Finding 3 
Following axonal injury in vitro, relatively mature axotomised neocortical neurons 
demonstrated a remarkable intrinsic capacity for regeneration. This response was 
characterised by the rapid and sustained elaboration of axonal sprouts into lesion 
sites. Interestingly, injury-induced axonal sprouts demonstrated microtubule 
dynamics, morphological features and neurochemical composition, but not actin 
dynamics, which were similar to developing neurites. These findings indicate that 
poor axonal regeneration in the adult CNS may be more attributable to inhibitory 
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factors in the CNS environment than an intrinsic incapacity of injured neurons to re-
initiate growth. 
7.2.4 The neuronal intermediate filament protein, a-internexin, undergoes 
identical morphological and neurochemical alterations following 
physical injury relative to preclinical and end-stage AD 
Aim 4 
Much of the work covered in this thesis focussed on investigating the role of the 
neuronal cytoskeleton in injury-induced axonal degeneration and regeneration. 
Recent studies have drawn important parallels between the reactive cytoskeletal 
alterations that result from neuronal injury and the early cytoskeletal pathology of 13- 
amyloid plaque-associated DNs in preclinical and end-stage AD cases. For instance, 
bulb- and ring-like accumulations of neurofilaments following physical injury are 
morphologically and neurochemically identical to a sub-class of DNs in AD. 
Additionally, AD is associated with an aberrant 13-amyloid plaque-associated axonal 
sprouting response. Collectively, these findings implicate plaque-induced physical 
injury as a mechanism of neurodegeneration in AD. Thus, a final sub-aim of this 
thesis was to explore the evolution of DN formation utilising brain tissue from non-
AD, preclinical and end-stage AD cases, relative to the reactive events that 
characterise the neuronal response to physical injury to further elucidate the 
similarities between plaque-associated DNs and physically injured axons Particular 
emphasis was placed on examining alterations in the neuronal intermediate filament 
protein a-internexin, which, unlike the neurofilament triplet proteins has received 
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relatively little attention in studies of neuronal injury and AD. 
Finding 4: 
The neuronal intermediate filament protein, a-internexin, undergoes similar 
alterations to neurofilament triplet proteins in the reactive and regenerative events 
that characterise the neuronal response to injury. In this regard, both a-internexin 
and neurofilament proteins abnormally accumulate into ring- and bulb-like 
formations within injured axons and are subsequently localised to injury-induced 
axonal sprouts. Intriguingly, morphologically and neurochemically identical DNs 
are characteristic of the evolving pathology of AD. These findings support the 
proposal that 13-amyloid deposition inflicts chronic structural injury on surrounding 
neurons and their processes, evoking an axotomy-like reactive response. 
Additionally, these findings identified a novel pathological hallmark in preclinical 
and end-stage AD, namely a-internexin-labelled ring-like DNs, implicating a-
internexin containing cells as selectively, but differentially, vulnerable to AD 
pathology, relative to neurons containing neurofilament triplet proteins. 
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7.3 Discussion and implications of main thesis findings 
A lack of appropriate micro-environmental cues in the adult brain may be implicated 
in its poor regenerative ability (Mitchell et al., 2004; Emsley et al., 2005). If these 
cues can be discovered and manipulated, perhaps latent regenerative and neurogenic 
responses may be revealed. It is now evident that the adult mammalian brain is 
capable of extensive functional and structural plasticity (Nudo, 2003). A variety of 
approaches are being investigated and developed to promote recovery from CNS 
injury. Overall, these strategies aim to replace lost neurons, support the survival of 
damaged neurons and/or enhance axonal regeneration (reviewed by Olson, 1997). 
The individual chapters in this thesis have discussed extensively the findings from 
each study. The remainder of this discussion will therefore examine the broader 
findings of this thesis, in terms of potential experimental manipulations currently 
being developed to enhance endogenous neural repair. 
7.3.1 Manipulation of neural stem and progenitor cells as a therapeutic tool to 
promote brain repair following injury and in neurodegenerative diseases 
7.3.1.1 Stem and progenitor cells in the adult brain confer neurogenic potential 
The initial investigation in this thesis aimed to address a topical and contentious 
avenue of brain regeneration research, namely the ability of the injured adult 
mammalian brain to generate new neurons in the aftermath of a . physical injury. 
Previous studies, utilising diverse brain lesion paradigms (as detailed in Chapter 3), 
have demonstrated significant alterations in cell proliferation and progenitor cell 
generation in response to brain lesion, including the recruitment of endogenous 
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migrating and/or progenitor cells to lesion sites, the differentiation of these cells into 
both neuronal and glial cells and the generation of new neurons that may contribute 
to neuronal replacement of degenerated neurons (Clarke et al., 1994; Duggal et al., 
1997; HoImin et al., 1997; Li and Chopp, 1999; Sahin Kaya et al., 1999; . Gu et al., 
2000; Magavi et al., 2000; Dash et al., 2001; Jin et al., 2001; Kernie et al., 2001; 
Arvidsson et al., 2002; Chirumamilla et al., 2002; Parent et al., 2002a, b; Shi et al., 
2002; Chen et al., 2003a, b; Nakamura et al., 2003; Tonchev et al., 2003; Douen et 
al., 2004; Goings et al., 2004; Romanko et al., 2004; Salman et al., 2004; Gotts and 
Chesselet, 2005; Ramaswamy et al., 2005; Tatsumi et al., 2005). 
Rakic (2002) has noted many implications in the interpretation of neurogenic 
responses in experimental models. For example, many studies are performed in 
rodent models and may yield different results from studies performed in primates 
and, therefore, also humans. Additionally, Rakic (2002) highlights important aspects 
of the methods currently utilised to detect neurogenesis, such as BrdU incorporation 
and subsequent double labelling analysis. BrdU is incorporated into cells that are 
synthesising DNA and, thus, post-hoc labelling may detect proliferating cells as well 
as cells which are undergoing DNA repair and apoptosis (reviewed by Nowakowski 
and Hayes, 2001). However, BrdU detection of cells undergoing DNA repair is 
likely to be minimal (Cooper-Kuhn and Kuhn, 2002). Another noteworthy point 
involves studies that have concluded the occurrence of neurogenesis, when in fact 
the proliferating cells detected may actually be satellite glial cells, closely apposed to 
neurons (reviewed by Rakic, 2002). Recently developed methods for identifying 
neural precursor cells, including retroviruses combined with fluorescent markers and 
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transgenic mice specifically expressing fluorescent markers in a sub-set of precursor 
cells, in conjunction with sophisticated imaging techniques are now allowing this 
field to rapidly advance (reviewed by Song et al., 2005). Accumulating evidence 
indicating that endogenous neuro- and glio-genesis play roles in brain healing 
warrant further investigation, particularly if these processes can be appropriately 
manipulated (Plunchino et al., 2005). 
It is now widely accepted that the adult brain is capable of producing new neurons. 
Adult-born neurons arise from stem or progenitor cells, which may be parenchymal-
resident or retained within specific germinal zones (Gage, 2002; Emsley et al., 2005). 
In the SVZ, the exact origin of adult-born neurons is still debated, with evidence 
suggesting that ependymal cells, astrocytes, specialised adult radial glial and other 
precursor cells may all act as neural stem cells (Barres, 1999; Doetsch et al., 1999; 
Laywell et al., 2000; Seri et al., 2001; Doetsch, 2003; Morshead, 2004; Plunchino et 
al., 2005). Essentially, stem cells possess an unlimited capacity to self-renew and the 
ability to produce diverse mature cell types, whereas progenitor cells have a limited 
capacity for self-renewal and differentiation (McKay, 1997; Morshead, 2004). 
Additionally, the term 'precursor cell' may be used to describe a cell at an earlier 
developmental stage relative to another cell (McKay, 1997). Remarkably, discrete 
sub-sets of glia located throughout the brain may form an additional population of 
latent stem cells (Doetsch, 2003). 
Specific regions of the adult mammalian brain, including the dentate gyrus of the 
hippocampus and SVZ of the lateral ventricles harbour stem and progenitor cells 
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capable of generating new neurons throughout life (Lois and Alvarez-Buylla, 1993; 
Eriksson et al., 1998; Johansson et al., 1999; Kukekov et al., 1999; Doetsch, 2003). 
Stem/progenitor cell proliferation, survival, migration, differentiation and integration 
are controlled by a vast array of extracellular molecular regulators, including 
proteins, neurotransmitters and hormones (reviewed by Hagg, 2005). Adult-born 
neurons have been shown to integrate into functional circuits (Carla et al., 2002; 
van Praag et al., 2002). Although neural progenitor cells have been isolated from 
many regions of the adult brain (Reynolds and Weiss, 1992; Taupin and Gage, 2002; 
Lie et al., 2004; Emsley et al., 2005), whether the neocortex itself possesses the 
capacity for neurogenesis remains controversial (Kornack and Rakic, 2001; Gould 
and Gross 2002; Rakic, 2002; Koketsu et al., 2003). Accordingly, a large proportion 
of the literature, regarding neurogenesis in the normal adult brain and injury-induced 
neurogenic responses, indicates that new neurons are most likely to be derived from 
germinal regions such as the SVZ and subsequently migrate to lesion sites (Alvarez-
Buylla et al., 2002; Ramaswamy et al., 2005), although some neurons may be 
generated from parenchymal resident progenitors (Magavi et al., 2000; Emsley et al., 
2005). 
Findings from this thesis demonstrated that proliferating cells included astrocytes, 
microglia/macrophages, neural progenitor cells and neuroblasts. Moreover, 
alterations in the distribution and expression of the neural progenitor cell marker, 
nestin, were suggestive of migration from the SVZ to the lesion site. However, 
double-labelling analysis, in addition to proliferation assays utilising BrdU 
incorporation, revealed that progenitor and proliferating cells did not undergo 
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neuronal differentiation in response to acute focal neocortical lesion. Moreover, 
DCX-labelled neuroblasts were not recruited from their normal migratory route (the 
rostral migratory stream) to the lesion site. Collectively, these findings demonstrated 
that this particular lesion paradigm largely results in a gliogenic, and not neurogenic 
response, in accordance with previous investigations (HoImin et al., 1997; Kuroda et 
al., 2002; Yoshiya et al., 2003; Douen et al., 2004; Salman et al., 2004). Other 
studies have, however, demonstrated neurogenesis in response to brain injury 
(Kernie et al., 2001; Chen et al., 2003b; Rice et al., 2003; Tonchev et al., 2003). The 
reasons for these conflicting findings were discussed extensively in Chapter 3, thus 
the remainder of this section of the discussion will focus upon the therapeutic 
manipulation of stem and progenitor cells in the treatment of brain injury. 
7.3.1.2 Neural stem and progenitor cells may be manipulated to promote brain 
repair 
An important feature common to most brain lesion paradigms is the generation of 
new cells. As discussed above, numerous studies have demonstrated that stem and 
progenitor cells exist within the adult mammalian brain, capable of generating 
astrocytes, oligodendrocytes and neurons under both normal and pathological 
conditions. These factors combined hold great therapeutic promise. For example, 
endogenous progenitor cells may be manipulated to undergo neuronal differentiation 
to replace neurons lost by injury or disease (Frisen et al., 1998; Kruger and Morrison, 
2002; Lie et al., 2004; Mitchell et al., 2004; Schouten et al., 2004; Kulbatski et al., 
2005; Taupin, 2005). 
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Aside from the manipulation of endogenous neural precursor cells, the 
transplantation of stem or progenitor cells from autologous, allogeneic or xenogenic 
sources, provides a second therapeutic avenue for neural repair following brain 
injury and in certain neurodegenerative diseases (Kulbatski et al., 2005; Taupin, 
2005). Indeed, clinical trial have demonstrated that this may a viable method of cell 
replacement and recovery in Parkinson's disease (reviewed by Bjorklund, 2005; 
Snyder and Olanow, 2005; Sonntag et al., 2005) and studies are underway to adapt 
this technique to promote brain repair in Huntington's disease (reviewed by Dunnett 
and Rosser, 2004). The use of neural stem/progenitor cell transplantation also holds 
promise for the treatment of human brain trauma. Importantly, in autologous 
transplantation a patient's own stem cells may be harvested, propagated and 
manipulated in vitro and transplanted back into damaged or diseased regions, thus 
overcoming potential problems associated with host-donor reactions and ethical 
implications (Frisen et al., 1998). However, transplanted cells must survive, 
differentiate and integrate appropriately to be of beneficial value. 
Manipulation of endogenous cells may not be limited to producing new neurons. 
The transplantation of precursor cells or manipulation of endogenous progenitors to 
differentiate into glial cells capable of enhancing neuronal regeneration may be 
beneficial. Accordingly, as discussed in Chapter 4, both astrocytes and 
microglia/macrophages may play important molecular and/or physical functions in 
supporting neuronal re-growth. Thus promoting, for example, the generation of 
microglia and macrophages following injury may indirectly result in greater neuronal 
regeneration through the release of neurotrophic factors. The poor regenerative 
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capacity of the adult brain has been partially attributed to its immuno-privileged 
nature, which under normal circumstances acts to protect the CNS, but in cases of 
injury may act maladaptively to limit the activity of immune cells capable of evoking 
extensive tissue repair and remodelling (Schwartz et al., 1999). Indeed, studies by 
Batchelor et al. (1999, 2000, 2002a, b) indicate that microglial and macrophages 
provide extensive trophic support to regenerating axons following striatal injury. 
Moreover, neural progenitor cells may be genetically manipulated to produce a range 
of supportive factors (Pincus et al., 1998). Philips et al. (2001) have shown that stem 
progenitor transplants producing nerve growth factor result in improved cognitive 
and motor function following brain injury. The use of transplanted stem cells may 
also be of therapeutic value in terms of myelin replacement following CNS injury, as 
well as in a range of demyelinating diseases (reviewed by Keirstead, 2005). 
The literature to date has provided varied results regarding the capacity of 
transplanted stem and progenitor cells to differentiate, migrate and integrate into 
neuronal circuitry to bring about functional recovery from CNS lesion (for example 
Fricker et al., 1999; Englund et al., 2002; Hoane et al., 2004; Shear et al., 2004; 
Wennersten et al., 2004; Brunet et al.,. 2005). The transplantation of more 
differentiated neurons may be a more effective transplantation method (Frisen et al., 
1998). However, unless transplanted cells are able to integrate and function 
appropriately they will be of little use in assisting recovery of function following 
brain injury. Rakic (2002) notes that the relative lack of neurogenesis in the adult 
brain may not foster an environment that is facilitative for transplant therapies. 
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It is crucial that the manipulation of endogenous and transplanted neural 
stem/progenitor cells to promote brain repair be carefully regulated and monitored. 
The reasons for this are several fold. For instance, such therapies have a variety of 
ethical implications regarding sources for cell transplantation. Many technical 
problems are also of paramount importance, including the selection of the ideal cell 
types to transplant or manipulate and how these cells can be optimised, maintained 
and tracked (Kulbatski et al., 2005). Additionally, the restriction of neurogenesis in 
the adult mammalian brain to discrete regions may be an adaptive mechanism to 
prevent the development of aberrant circuitry. Whereas ongoing neurogenesis in the 
hippocampus is implicated in memory and learning, seizure-induced neurogenesis 
has been implicated in the development of abnormally hyper-excitatory circuitry 
(Parent and Lowenstein, 2002; Parent, 2002). 
Abrahams et al. (2004) review work describing de novo neurogenesis following 
stroke, bringing into question whether cell transplants are necessarily required, if 
endogenous neurogenic responses can be appropriately manipulated. Cell 
implantation also runs the risk of tumour development and the mechanisms 
underlying this response remain to be elucidated (Paul et al., 2002; Batchelor and 
Howells, 2003). Nevertheless, lesion-induced, potentially compensatory, 
neurogenesis is a viable avenue for future research and warrants further, yet careful, 
examination (Kozorovitskiy and Gould, 2003). The potential therapeutic effects of 
manipulating endogenous and transplanted neural precursor cells may be invaluable 
considering irreversible and extensive neuronal loss frequently accompanies brain 
injury (Hagg, 2005). 
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7.3.2 The intrinsic neuronal response to injury is more adaptive than 
historically appreciated 
7.3.2.1 Certain populations of mature CNS neurons demonstrate remarkable 
capacity to attempt regeneration following injury 
There now exists general agreement that the adult mammalian brain is able to mount 
a transient attempt at regeneration following injury. One of the major factors used to 
gauge regeneration is the degree spontaneous axonal regrowth following a traumatic 
incident.. Axonal regrowth is identified as the elaboration of fine axonal sprouts into 
or around lesion sites (Foerster, 1982; Povlishock and Becker, 1985; Kristt, 1987; 
McHale et al., 1995; Salin et al., 1995; Christman et al., 1997; Deller and Frostcher, 
1997; McKinney et al., 1997; Batchelor et al., 1999, 2002b; Dusart et al., 1999; 
Dickson et al., 2000; Moon et al., 2000; Pastor et al., 2000; King et al., 2001; Chung 
et al., 2002, 2003; Haas et al., 2004). Taken together, these studies establish that 
mature CNS neurons are able to re-initiate growth following injury and implicate the 
up-regulation of important growth related genes and cytoskeletal reorganisation in 
this process. Additionally, although glial reactions may be detrimental to axonal 
regrowth, accumulating evidence indicates that certain glial activities may in fact 
promote axonal regeneration (for example Prewitt et al., 1997; Batchelor et al., 1999, 
2002a, b; Dusart et al., 1999; King et al., 2001). 
Since the discovery that the adult CNS retains a remarkable degree of intrinsic 
regenerative capacity, a major avenue of contemporary neuronal repair research has 
been directed at facilitating axonal regrowth following injury through manipulation 
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of micro-environmental signals, glial modulation and cell/tissue transplant strategies. 
The ability of CNS neurons to undergo axonal regeneration depends on the combined 
influences of a neurons ability to re-express growth-related genes, the availability of 
substrate and trophic factors that facilitate regeneration and the presence of 
inhibitory molecules (Tuszynski and Gage, 1995). Intra-neuronal factors include the 
survival of the cell body, axonal sprouting from the proximal stump, axonal re-
myelination and appropriate formation of contacts between newly generated axon 
terminal and their targets (Rhodes and Fawcett, 2004). Repair strategies are aimed at 
addressing one or several of these factors. 
Findings from this thesis demonstrated that some of the aspects of attempted axonal 
regeneration recapitulate developmental patterns of growth, including morphological 
alterations, microtubule dynamics and cytoskeletal composition. However, 
regenerative growth cones were observed to be less complex than developmental 
growth cones and regenerative growth was less reliant on actin dynamics, as 
indicated by continued axonal sprouting in the presence of the actin depolymerising 
agent latrunculin A, which largely abolished developmental neurite growth. 
Additional discrepancies between developmental and regenerative growth have also 
been noted by other authors (reviewed by Selzer, 2003). These include an 
abundance of neurofilaments at the tips of regenerating axons, in addition to a lack of 
a discrete growth cone (McHale et al., 1995) and the formation of a dystrophic 
growth cones on regenerating axons (Tom et al., 2004). 
Axonal regrowth following injury may be either abortive or regenerative. It is useful 
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here to clarify the difference between these growth patterns. Essentially, axonal 
regeneration is the regrowth of a damaged axon to innervate its original target, 
whereas abortive growth defines a transient, but unsuccessful, attempt by an injured 
axon to regrow (Cotman et al., 1994; Kapfhammer, 1997). In this respect, neurons 
from the adult CNS are largely believed to undergo an abortive sprouting response 
following injury, whereas those in the PNS may effectively regenerate. Injury-
induced axonal sprouting in the adult CNS is usually localised to the local neuropil 
and does not involve long distance re-growth (Rhodes and Fawcett, 2004). The 
terms 'abortive' and 'regenerative' may also be used more loosely to describe the 
continuum or variety of different responses that may occur following axonal injury, 
involving both frank axonal growth from the injured axon in addition to collateral 
axonal growth from undamaged regions of the injured axon or entirely un-injured 
axons from other neurons. Ultimately, axonal growth may result in reinnervation of 
the original target or compensatory regrowth to approximate targets (see Figure 7.1). 
The formation of new synapses following an injury is referred to as reactive 
synaptogenesis (Cotman et al., 1994) and may have adaptive or maladaptive 
consequences. 
Collateral sprouting from undamaged axons is believed to be the major mechanism 
of functional regrowth in experimental models of CNS injury (DeIler and Frostcher, 
1997; Kapfhammer, 1997), however, some studies, including observations from this 
thesis, indicate that terminal sprouting may also occur (Povlishock and Becker, 1985; 
King et al., 2001). In many studies of brain lesion, including stroke (Stroemer et al., 
1995; von Euler et al., 2002; Carmichael, 2003) and physical trauma (as cited 
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Figure 7.1. Diagrammatic representation of potential neuronal responses to 
axotomy 
Axonal injury may evoke degenerative, reactive and/or regenerative outcomes. 
Attempted regeneration in the adult CNS manifests as an axonal sprouting response, 
generally restricted to the local neuropil. Post-injury sprouts are believed to arise 
from collateral sources, i.e. undamaged axons or undamaged regions of the injured 
axon. However, terminal sprouting may also occur, where sprouts are elaborated 
from the severed axonal tip. The occurrence of terminal sprouting in the CNS 
remains contentious. The diagram to the right shows how some of these processes 
may occur. Not all possibilities are illustrated and combinations of these processes 
may also occur. Axonal injury may result in cell death. Alternatively, the proximal 
axonal segment and cell body may survive following Wallerian degeneration of the 
distal segment. The proximal axonal segment may undergo no further change or 
exhibit a reactive axonal sprouting response. Reactive sprouting may proceed to 
abortive sprouting, localised to the local neuropil, or regenerative sprouting, whereby 
terminal sprouts and/or collateral sprouts re-innervate the original target cell(s). 
Notably, reactive sprouting may contribute to innervation of non-target cells and 
generate aberrant circuitry. This process has been implicated in the development of 
post-traumatic epilepsy following human brain trauma. Grey processes indicate 
terminal and collateral axonal sprouts elaborated from the axotomised neuron, the 
blue process represents collateral sprouting from an un-injured neuron. 
•••• 
Axonal injury 
Wallerian degeneration 
Cell death 
No further reaction 
is0,001110 
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above), it is not clear whether axonal sprouts derive from collateral sources or frank 
regeneration of damaged axons. Interestingly, studies from the PNS and nervous 
systems of lower vertebrates and invertebrates suggest that frank axonal regeneration 
is common in these systems (as discussed in Chapter 5) and therefore, potentially in 
the CNS of mammals. However, fundamental differences in growth cone formation 
may contribute to poorer regenerative potential in the mammalian CNS (Tom et al., 
2004). Utilising a neonatal spinal cord injury model Bernstein-Goral et al. (1997) 
have shown that collaterally sprouting and regenerating axons may have different 
growth requirements. Nevertheless, axonal sprouting is likely to be implicated in the 
gradual recovery observed following human brain trauma. Intriguingly, certain 
populations of neurons may survive for several months prior to undergoing an axonal 
sprouting response, as indicated in the case of cerebellar Purkinje cells (Dusart et al., 
1999). 
Historically it has commonly been assumed that neurons from the mature 
mammalian CNS have very limited capacity for regeneration. In light of 
accumulating data regarding CNS regeneration, it is now evident that certain 
populations of mature central neurons possess a capacity for repair following injury, 
which may be largely limited by a non-facilitative environment (Olson, 1997). In 
fact, studies reviewed by Fawcett (1997) and Olsen (1997) indicate that most CNS 
neurons are capable of extensive regeneration when provided with a facilitative 
environment. These studies demonstrate that peripheral neurons are able to grow in 
CNS white matter and regenerating CNS axons grow effectively into peripheral 
nerve grafts. This raises the possibility that injured CNS tissue, rather than non- 
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injured CNS tissue is the main inhibitory factor in CNS regeneration (Rhodes and 
Fawcett, 2004). In this respect, many growth inhibitory molecules, generally 
categorised as myelin- or extracellular matrix-associated, are only associated with, or 
are up-regulated in, the astroglial scar (reviewed by Rhodes and Fawcett, 2004). 
Although many studies have provided examples of axonal sprouting following 
injury, the mechanisms underlying this process are still not fully understood and the 
extent to which injured axons are able to undergo intrinsically driven attempts at 
regeneration remains to be elucidated. Findings from Chapters 4 and 5 of this thesis, 
in combination with the studies cited previously, demonstrate that neurons from the 
CNS are able to undergo an adaptive sprouting response following injury. Moreover, 
results from Chapter 5 of this thesis indicated that this response is likely to be an 
intrinsically driven process, at least for neocortical neurons, which were able to 
undergo a sustained axonal regrowth when grown in vitro, free of confounding glial 
effects. 
7.3.2.2 Numerous experimental approaches are now being developed to facilitate 
axonal regeneration 
Although no therapies currently exist to treat brain injury and resultant axonal 
damage, various strategies have been used to slow the progression of degeneration. 
These approaches include magnesium administration, as magnesium levels are often 
reduced following brain injury; administration of Dexanabinol, a non-competitive 
NMDA receptor antagonist; administration of hypertonic saline; mild post-injury 
hypothermia; decompressive craniectomy to combat raised intracranial pressure; and 
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CsA administration, which may prevent mitochondrial damage and abnormalities in 
calcium regulation that cause cytoskeletal and other damage (Sahuquillo and Poca, 
2002; Bayir et al., 2003). Many studies regarding the capacity of CNS neurons to 
regenerate have focused on injury to bundles or tracts of neurons associated with a 
high degree of myelination, such as those in the spinal cord. In this respect, the lack 
of regeneration of mammalian CNS neurons has been primarily attributed to 
inhibitory factors within CNS myelin and the extracellular matrix as well as factors 
associated with formation of the glial scar. A large proportion of experimental 
approaches are therefore directed at circumventing these factors. Interestingly, axons 
are capable of parallel, but not non-parallel, growth on CNS white matter, however, 
these studies were performed by applying cultured cells to sections of brain tissue 
and thus axons may have contacted potentially facilitative substrates, to which they 
are not normally exposed to during regenerative attempts (Pettigrew and Crutcher, 
1999). Additionally, work reviewed by Batchelor and Howells (2003) brings into 
question the extent of myelin-associated inhibitory activity during axonal 
regeneration. 
Due to the relative accessibility of the spinal cord compared to the brain, models of 
spinal cord injury are frequently utilised to assess the outcome of various 
experimental strategies to promote axonal regeneration. It is important to note, 
however, inherent problems associated with the methods utilised to perform spinal 
cord injuries. It is crucial to differentiate between fibres that extend into or across 
lesion sites, which may represent frank axonal regeneration of axons that were 
spared from the injury (Selzer, 2003). Nevertheless a variety of approaches have 
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been employed to promote regeneration of CNS axons. These strategies can be 
broadly divided into transplantation or cellular approaches and molecular approaches 
(reviewed by Tuszynski and Gage, 1995; Olson, 1997; Fawcett and Geller, 1998; 
Fawcett and Asher, 1999; Batchelor and Howells, 2003; Selzer, 2003). 
Peripheral nerve grafts or foetal tissue can be transplanted into the injured CNS to 
guide regrowing axons and to bridge lesions. Additionally, injection/transplantation 
of particular cell populations, including neural stem/progenitor/precursor cells, 
olfactory ensheathing cells, or macrophages, can be utilised to replace degenerated 
cells, guide axonal regrowth or produce trophic factors that enhance axonal growth, 
respectively. Molecular approaches target the underlying molecular mechanisms that 
inhibit axonal growth (Selzer, 2003). In this regard, a variety of strategies are under 
development, including the use of antibodies to block inhibitory molecules, the 
enzymatic digestion of inhibitory molecules, the addition of appropriate trophic 
factors and genetic manipulation of factors intrinsic to neurons, such as an up-
regulation of survival- and regeneration-associated genes. Additionally, studies have 
also determined that robust regenerative attempts can be promoted in the absence of 
CNS glia, however, this is not necessarily paralleled by increased functional outcome 
(Moon et al., 2000). Collectively, these studies demonstrate that, when provided 
with a facilitative environment, central neurons are capable of substantial and 
sustained regenerative growth. 
Interestingly, different forms of metallothionein may be crucial for regulating the 
neuronal response to injury. Metallothioneins are small zinc binding proteins found 
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predominantly within astrocytes and thought to confer neuroprotection to neurons 
from oxygen free radical and metal-induced neurotoxicity (reviewed by Chung and 
West, 2004). Recent studies also indicate that metallothioneins may have a pivotal 
role in the neuronal response to injury. Metallothionein III has been shown to inhibit 
axonal regeneration in vitro (Chung et al., 2002), whereas metallothionein IIA 
promotes axonal regeneration in vitro and brain healing in vivo (Chung et al., 2003). 
Interestingly, signals released from injured neurons appear to be crucial for 
stimulating metallothionein expression in astrocytes (Chung et al., 2004), reiterating 
the complex and dynamic interactions between neuronal and glial cells in the CNS 
response to injury. 
7.3.3 Aberrant sprouting responses may be generated by structural brain 
injury and the evolving pathology of AD 
7.3.3.1 Axonal injury may evoke maladaptive reactive and regenerative responses 
Similar to therapies that aim to promote post-injury neurogenesis or cell replacement, 
strategies that enhance regrowth of damaged axons must also be tightly controlled. 
Thus, although evading factors that inhibit axonal regeneration is a major aim for 
restoring connectivity within well defined long distance axonal tracts, such as in the 
spinal cord, inhibition of aberrant regeneration might prove a useful approach in 
certain forms of acquired brain injury. Accordingly, agents that specifically hinder 
or promote fundamental stages of the stereotypical axonal response to injury may be 
utilised to combat potentially maladaptive axonal responses. In this regard, findings 
from this thesis have demonstrated that targeting certain components of the neuronal 
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cytoskeleton, to cause microtubule stabilisation or destabilisation may be of 
therapeutic value. 
Microtubules are often lost following physical axonal injury, thus, stabilisation of the 
microtubule cytoskeleton, with agents such as taxol, may counteract microtubule 
dissolution, a notion supported by findings from Adlard et al. (2000). Moreover, 
findings from this study in addition to a studies by Letourneau (1984) and Vuorinen 
(1988, 1990) indicate that taxol induced microtubule interference impedes axonal 
regeneration and may therefore prevent maladaptive neurite growth. Perez-Espejo et 
al. (1996) demonstrated that taxol improves functional outcome following spinal 
cord injury. Additionally, Chung et al. (2002) have shown that metallothionein III 
application inhibits axonal regeneration in vitro, causing similar morphological 
alterations to those observed in taxol-induced microtubule stabilisation. 
Incorporated in the process of axonal growth following injury is the possibility of 
aberrant re-innervation of targets or innervation of inappropriate targets. In this 
regard, studies in both in vitro (McKinney et al., 1997) and in vivo (Salin et al., 
1995) experimental models suggest that post-injury sprouting may not always be 
functionally appropriate. These studies have provided evidence that aberrant hyper-
excitable axonal connectivity may result from experimental brain lesion. This 
phenomenon has been implicated in the development of post-traumatic epilepsy 
following human head trauma (Lamer, 1995; McKinney et al., 1997; Prince, 1997; 
Prince et al., 1997; Jacobs et al., 2000; Santhakumar et al., 2001). 
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Importantly, intrinsic mechanisms may be in place to actively prevent plasticity in 
certain regions of the adult CNS. Indeed, the existence of perineuronal nets 
(specialised accumulations of extracellular matrix molecules around the cell bodies 
and dendrites of certain populations of neurons, including cortical neurons) may act 
to inhibit aberrant neuronal growth and accidental circuitry formation (Rhodes and 
Fawcett, 2004). Thus, when endogenous reactive and regenerative mechanisms 
become pathological or when intrinsic regulation of regeneration is disrupted it may 
be necessary to therapeutically intervene. Taken together, these studies highlight the 
need for further investigation of true versus maladaptive regenerative attempts 
following neuronal/brain injury and indicate some agents which may be utilised 
therapeutically to target specific aspects of the neuronal response to injury to bring 
about appropriate axonal regrowth and inhibit detrimental alterations. 
7.3.3.2 The evolving pathology of AD involves similar reactive and regenerative 
cytoskeletal alterations to those observed following structural neuronal 
injury 
As discussed in Chapter 6 of this thesis, DNs associated with 13-amyloid plaques in 
preclinical and end-stages of AD are morphologically and neurochemically identical 
to the reactive alterations described in experimental models of structural 
neuronal/brain injury (Vickers et al., 1996, 2000; King et al., 1997, 2000a, b, 2001; 
Dickson et al., 1999, 2000; Woodhouse et al., 2005). This has lead to the proposition 
that 13-amyloid deposition causes structural axonal injury (reviewed by Vickers et al., 
2000; Woodhouse et al., 2005). One abnormality frequently observed in association 
with B-amyloid plaques is profuse, aberrant axonal sprouting (Masliah et al., 1991, 
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1992), indicating that, as a result of the chronically evolving nature of B-amyloid 
depositions, neurons are promoted into a state of un-regulated growth/regeneration 
(Vickers et al., 2000). As discussed above, microtubule stabilisation effectively 
blocks axonal sprouting. Common methods may be therefore utilised to prevent 
maladaptive B-amyloid plaque-associated axonal sprouting in AD. 
• AD is characterised by various abnormalities in protein folding and aggregation, 
including the accumulation of the microtubule binding and stabilising protein, tau, 
into fibrillar cytopathological inclusions and the extracellular deposition of B-
amyloid into B-amyloid plaques. Utilising an in vitro model, Michaelis et al. (1998, 
2005) demonstrated that taxol application was protective against B-amyloid toxicity 
and may therefore hinder neuronal degeneration in AD. Furthermore, pathological 
alterations in tau are associated with impeded axonal transport and brain 
degeneration (Trojanowski et al., 2005). Microtubules are the main conduit for 
axonal transport and their function relies upon appropriate interactions with 
microtubule-associated proteins including tau (Tanaka and Sabry, 1995; Korey and 
Van Vactor, 2000). Thus, microtubule stabilising compounds may be of therapeutic 
use in preventing tau-associated pathological disruptions (Zhang et al., 2005). 
Trojanowski et al. (2005) review a large body of literature indicating that protein 
misfolding, resulting in pathological loss- or gain-of-function, is common to many 
neurodegenerative diseases and is implicated in aberrant axonal transport. For 
example, tau recruitment into cytopathological inclusions, such as NFTs, DNs and 
neuropil threads, characteristic of AD, may result in microtubule destabilisation and 
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loss, warranting strategies that re-stabilise this cytoskeletal component (Trojanowski 
et al., 2005; Zhang et al., 2005). Microtubule-stabilising drugs may also have 
additional value in numerous disorders involving tauopathies (Trojanowslci et al., 
2005; Zhang et al., 2005). 
Taxol and its derivatives have been approved for the treatment of various cancers by 
the Federal Drug Administration (FDA) and therefore hold particular therapeutic 
promise in the treatment of AD and other related neurodegenerative diseases 
(Trojanowski et al., 2005). Although the studies discussed above indicate that 
certain interventions may be therapeutically viable in terms of preventing 
maladaptive neuronal responses and neurodegeneration, it is important to note that 
the underlying mechanisms these treatments aim to target must be fully elucidated. 
In this respect, microtubules are ubiquitous and thus interfering with this cytoskeletal 
component may have widespread and unanticipated outcomes. For instance, 
previous studies have indicated that taxol may be implicated in peripheral 
neuropathy, although the mechanisms underlying this are not fully understood 
(reviewed by Mielke et al., 2005). Investigations have demonstrated additional 
implications of taxol administration in the PNS, where taxol-induced microtubule 
accumulation resulted in the detachment of Schwann cells from axons (Roytta et al., 
1984, Roytta and Raine, 1985). Taxol has also been shown to induce apoptosis in 
cortical neurons (Figueroa-Masot et al., 2001). However, Trojanowski et al. (2005) 
suggest that taxol and its derivates may be utilised at relatively low doses in the 
treatment of neurodegenerative diseases, compared doses currently used in 
chemotherapy treatments, thus over coming neuropathological effects. 
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7.4 Concluding remarks 
In the race to develop strategies to effectively promote neural repair following brain 
trauma, some of the basic mechanisms underlying the endogenous aspects of this 
response have been overlooked. It is imperative to fully elucidate the mechanisms of 
endogenous brain and neuronal repair so that aspects of this response can be 
specifically targeted and/or manipulated towards effective brain repair. Moreover, it 
will be crucial to determine the ultimate effect of glial cell activation during 
attempted neuronal regeneration. So far, a multitude of conflicting results have been 
generated regarding the extent of endogenous neuronal regeneration and the role of 
microglia, astrocytes and oligodendrocytes in neural repair. In this respect, the 
potential for endogenous neuronal regeneration following brain injury has generally 
been viewed as bleak and glial cell populations have largely been attributed a 
deleterious role in this process, including formation of the glial scar and the 
generation of neurotoxic and inhibitory factors. 
This thesis specifically sought to determine the intrinsic potential for axonal 
regeneration following injury as well as the interactive, and potentially facilitative, 
role glial cells play in this process. Intriguingly, contrary to popular belief, mature 
central neurons were demonstrated to undergo a sustained regenerative attempt 
follow axotomy. This process was shown to rely heavily upon microtubule 
dynamics and, in many respects, recapitulated initial axonal development. This 
remarkable regenerative capacity was demonstrated in an in vitro model of axonal 
injury, highlighting the importance of in vitro systems in analysing intrinsic neuronal 
responses free of confounding glial reactions and as providing a platform for testing 
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potential physical, chemical and/or molecular therapies for promoting neuronal 
regeneration. Axonal sprouting was also demonstrated following in vivo acute focal 
brain injury and was associated with significant alterations in gene expression. This 
response was ultimately limited by formation of a glial scar, however, prior to this 
was associated with substantial cell proliferation, neural progenitor cell production 
and neuro-glial interactions, suggestive of an adaptive response directed toward brain 
healing. 
Overall, the results from this thesis demonstrate that mature neocortical neurons 
possess a remarkable and previously unappreciated capacity for regeneration and that 
structural brain injury, common to many human head traumas, evokes a repertoire of 
adaptive and interactive responses resulting in the restoration of relatively normal 
cytoarchitecture. The findings from this thesis also draw interesting parallels 
between the early reactive cytoskeletal alterations characterising the neuronal 
response to injury and the evolving pathology of AD, providing further evidence that 
physical displacement and/or compression of neurites by B-amyloid plaques may be 
an additional or alternative mechanism of neuronal degeneration in AD. 
The endogenous mechanisms utilised by injured neurons must be discovered if these 
responses are to be harnessed and therapeutically manipulated. In this regard, it will 
be imperative to determine why experimentally successful approaches to neural 
regeneration do not always translate to effective therapies in cases of human head 
trauma. It is likely that this is due to species differences, difficulties in modelling all 
aspects of human head trauma and, importantly, a lack of understanding of the basic 
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mechanisms underlying neuronal degeneration and regeneration. A combination of 
approaches will likely be required to bring about effective recovery from brain 
trauma. Interestingly, complete regeneration or replacement of damaged neurons 
may not be required to restore a substantial proportion of function. 
This thesis provides insight into the molecular and cellular mechanisms underlying 
endogenous neural repair and highlights important components of this response that 
may be targeted to enhance recovery from brain injury, for example driving neuronal 
differentiation of injury-induced proliferating and progenitor cells, promoting the 
facilitative effects of injury-activated glial cell populations and developing strategies 
to increase appropriate long distance axonal regrowth and synaptogenesis. 
Additionally, results from this thesis have provided evidence supporting the use of 
agents that act specifically on components of the cytoskeleton in preventing 
maladaptive sprouting responses following axonal trauma and in the pathogenesis of 
certain neurodegenerative diseases. Taken together, studies of neural regeneration 
indicate that the adult brain possesses remarkable capacity for repair and 
regeneration, which involves gross structural and functional adaptability in addition 
to plasticity on a minute scale involving synaptic, axonal and dendritic remodelling. 
In summary, these findings provide exciting new avenues for future research into 
neurodegeneration and regeneration involved in brain trauma and neurodegenerative 
diseases. 
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Appendix 
All solutions were made up in Mil1iQ®  water, unless otherwise stated. 
0.01M phosphate buffered saline (PBS), pH 7.4 
• 100m1 NaC1 - 90g/L stock solution 
• 40m1 di-sodium hydrogen orthophosphate (Na 2HPO4 12H20) - 28.4g/L stock 
solution 
• 10m1 sodium di-hydrogen orthophosphate (NaH 2PO4 .H20) - 31.2g/L stock 
solution 
• 850m1 Mil!i-Q® water 
• pH 7.4 
4% paraformaldehyde (PFA) (100m1) 
• 4g paraformaldehyde 
• 4g sucrose 
• 10m1 di -sodium hydrogen orthophosphate (NaH2PO4 .H20) - 31.2g/L stock 
solution 
• 40m1 sodium di -hydrogen orthophosphate (NaH2PO4) - 28.4g/L stock solution 
• 50m1 Milli-Q® water 
• dissolve by heating (-80°C ) on stirrer hotplate in fume hood 
Borate buffer 
• 38.16g/L di-sodium tetraborate (Na2B407.10H20) 
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• 6.18g/L boric acid (H 3B03) 
• add disodium tetraborate solution to the boric acid solution until pH 7.4 is 
reached 
10mM HEPES (N-2-hydroxyethyl piperazine-N-2 sulphonic acid) buffer 
• make up 10mM solution in 0.01M PBS (2.38g/L), filter sterilise before use 
Propridium iodide 
• 5mg propridium iodide 
• 100mg sodium citrate 
• Dissolve in 100m1 Milli-Q ® water 
Imaging buffer (50m1) 
• 1.55m1 NaC1 — 234g/L stock solution 
• 250111 KCI — 149.2g/L stock solution 
• 5RI CaCl 2 — 294g/L stock solution 
• 25R1 MgCl 2 — 406.6g/L stock solution 
• 750til Dextrose — 360.4g/L stock solution 
• 625[1,1 HEPES — 520.6g/L stock solution 
Diluent 
• 0.3% Triton X-100 in 0.01M PBS 
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0.1M Phosphate buffer 
, 
• 216m1 dibasic sodium phosphate (Na2HPO42H20) — 35.6g/L 
• 84m1 monobasic sodium phosphate (NaH 2PO42H20) — 20.76g/L 
• 300m1 Milli-Q® water 
• pH 7.4 
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